US5070215A - Novel vinyl carbonate and vinyl carbamate contact lens material monomers - Google Patents

Novel vinyl carbonate and vinyl carbamate contact lens material monomers Download PDF

Info

Publication number
US5070215A
US5070215A US07/346,204 US34620489A US5070215A US 5070215 A US5070215 A US 5070215A US 34620489 A US34620489 A US 34620489A US 5070215 A US5070215 A US 5070215A
Authority
US
United States
Prior art keywords
mmol
vinyl
added
vinyl carbonate
trimethylsiloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US07/346,204
Inventor
Ronald E. Bambury
David E. Seelye
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Bausch and Lomb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch and Lomb Inc filed Critical Bausch and Lomb Inc
Assigned to BAUSCH & LOMB INCORPORATED, A CORP. OF NY reassignment BAUSCH & LOMB INCORPORATED, A CORP. OF NY ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: BAMBURY, RONALD E., SEELYE, DAVID E.
Priority to US07/346,204 priority Critical patent/US5070215A/en
Priority to CA002014210A priority patent/CA2014210C/en
Priority to IE138490A priority patent/IE81155B1/en
Priority to JP11066490A priority patent/JP3274681B2/en
Priority to DE69030898T priority patent/DE69030898T2/en
Priority to ES90304659T priority patent/ES2104583T3/en
Priority to DE69032984T priority patent/DE69032984T2/en
Priority to SG1996007715A priority patent/SG49218A1/en
Priority to EP90304659A priority patent/EP0396364B1/en
Priority to EP96202972A priority patent/EP0757033B1/en
Priority to ES96202972T priority patent/ES2131907T3/en
Priority to KR1019900006178A priority patent/KR0171402B1/en
Priority to AU54616/90A priority patent/AU645749B2/en
Priority to BR909002045A priority patent/BR9002045A/en
Publication of US5070215A publication Critical patent/US5070215A/en
Application granted granted Critical
Priority to US08/450,510 priority patent/US5610252A/en
Priority to US08/784,637 priority patent/US6166236A/en
Priority to HK98100504A priority patent/HK1001565A1/en
Assigned to CREDIT SUISSE reassignment CREDIT SUISSE SECURITY AGREEMENT Assignors: B & L DOMESTIC HOLDINGS CORP., B&L CRL INC., B&L CRL PARTNERS L.P., B&L FINANCIAL HOLDINGS CORP., B&L MINORITY DUTCH HOLDINGS LLC, B&L SPAF INC., B&L VPLEX HOLDINGS, INC., BAUSCH & LOMB CHINA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB INTERNATIONAL INC., BAUSCH & LOMB REALTY CORPORATION, BAUSCH & LOMB SOUTH ASIA, INC., BAUSCH & LOMB TECHNOLOGY CORPORATION, IOLAB CORPORATION, RHC HOLDINGS, INC., SIGHT SAVERS, INC., WILMINGTON MANAGEMENT CORP., WILMINGTON PARTNERS L.P., WP PRISM INC.
Anticipated expiration legal-status Critical
Assigned to BAUSCH & LOMB INCORPORATED reassignment BAUSCH & LOMB INCORPORATED RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F218/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/14—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96—Esters of carbonic or haloformic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0838—Compounds with one or more Si-O-Si sequences
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896—Compounds having one or more Si-O-acyl linkages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F18/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid
    • C08F18/24—Esters of carbonic or haloformic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F218/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid
    • C08F218/24—Esters of carbonic or haloformic acids, e.g. allyl carbonate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F30/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
    • C08F30/04—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing a metal
    • C08F30/08—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing a metal containing silicon
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041—Lenses
    • G02B1/043—Contact lenses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Definitions

  • Biomedical materials which are particularly useful as contact lens materials fall into three general classifications; hydrogels, non-hydrophilic soft materials and rigid gas permeable materials.
  • contact lens hydrogels are almost completely described by polymer and copolymer systems comprised of either 2-hydroxyethylmethacrylate (HEMA) or N-vinyl-2-pyrrolidinone (NVP), or mixtures of HEMA and NVP. Minor components such as crosslinking agents are used in these systems to control tear strength, hydrolytic stability, modulus, etc.
  • HEMA 2-hydroxyethylmethacrylate
  • NVP N-vinyl-2-pyrrolidinone
  • Minor components such as crosslinking agents are used in these systems to control tear strength, hydrolytic stability, modulus, etc.
  • silicone based elastomers have also been known in the contact lens art for some time and have enjoyed limited commercial success.
  • silicone chemistries involve vinyl functional end capped polysiloxane polymers.
  • Rigid gas permeable contact lens materials are generally copolymers formed from copolymerizing acrylic or methacryl functional monomers which contain siloxane functionalities and often also contain fluorine atoms.
  • the present invention provides a novel monomer chemistry to the art of biomedical device materials.
  • the present invention provides novel monomers useful in biomedical devices. These novel monomers have the general formula ##STR2## where b is 0 or 1, a is 1, 2, 3 or 4, R 2 is a monovalent alkyl radical and R is an organic radical.
  • the novel monomers may be employed to produce novel copolymers useful as hydrogel, soft non-hydrogel and/or rigid gas permeable contact lens materials.
  • the present invention is directed to new crosslinked copolymers which employ novel monomers also disclosed in this application. These novel copolymers are particularly useful as biomedical materials, and are especially useful in the area of contact lens applications. These new crosslinked copolymers, when used in contact lens applications, can produce a wide variety of types of contact lens materials ranging from hard, gas permeable lens materials; soft, hydrogel lens materials; to soft, non-hydrogel lens materials.
  • novel monomers generally fall into the following classifications: a) hydrophilic monomers with the general formula ##STR3## where b is 0 or 1; a is 1, 2, 3 or 4
  • X denotes --NH--, --S-- or --O--;
  • R H denotes a hydrophilic moiety such as an organic radical with one or more amide hydroxyl, urea or carboxylic acid functionalities so that the monomer as a whole is relatively hydrophilic;
  • non- or slightly hydrophilic monomers of the general formula ##STR5## where a, b and X are as defined above and R NH denote a non-hydrophilic organic radical.
  • hydrogel materials should have oxygen permeabilities with DK's greater than 20 ⁇ 10 -11 cm 3 ⁇ cm/sec. ⁇ cm 2 ⁇ mmHg (or DK units hereinafter) and preferably greater than 40 DK and most preferably greater than 60 DK. They should have a Young's modulus of elasticity in the range of 20 to 400 g/mm 2 , preferably 50 to 200 g/mm 2 as measured by ASTM test method D 638. They should have tear strengths greater than 1 g/mm 2 and preferably greater than 5 g/mm 2 as measured by ASTM test method D 1938.
  • Their water content should be between 10 to 80%, and preferably between 20 to 50%.
  • the contact angle which is a measurement of the wettability of the lens, should be less than 80° and should preferably be less than 40°.
  • the protein uptake of hydrogel lenses or hydrogel lens materials should be less than or equivalent to that of PHEMA.
  • Soft, non-hydrogel materials should have at a minimum oxygen permeabilities equal to or greater than hydrogel materials.
  • the water content should always be less than 10%, and preferably less than 5%.
  • the modulus of elasticity should be between 20 and 5,000 g/mm 2 and preferably should be in the range of 50 to 250 g/mm 2 .
  • Contact angle less than 80° and preferably less than 40° and the tear strength (both initial and propagation) of this material should be in excess of 5 g/mm 2 .
  • properties of hard, gas permeable lens materials should be similar to that of the hydrogel and the soft, non-hydrogel materials.
  • the glass transition temperature of such materials should be greater than 40° C. and preferably greater than 65° C.
  • the modulus of the material should be greater than 50,000 g/mm 2 and preferably greater than 75,000 g/mm 2 .
  • the following prepolymer formulations should be used: (a) between 25 and 90% of the prepolymer mixture should comprise a hydrophilic monomer portion. This portion will preferably comprise in part at least a hydrophilic monomer represented by the general formula ##STR6## where b is 0 or 1 and X is --S--, --O--, or --NR 3 -- and R h denotes a relatively hydrophilic moiety.
  • This hydrophilic monomer portion may also include at least one of the hydrophilic monomers chosen from the group consisting of wetting monomers N-vinyl-2-pyrrolidinone, 2-hydroxyethyl vinyl carbonate, 2-hydroxyethyl vinyl carbamate, 3-(2-pyrrolidinon-1-yl)-propyl vinyl carbonate, 2-(2-pyrrolidinon-1-yl)ethyl vinyl carbonate, N-(vinyloxycarbonyloxy)pyrrolidin-2,5-dione, N-[vinyloxycarbonyloxyethyl]pyrrolidin-2,5-dione, N-vinylacetamide, N-methyl-N-vinylacetamide, N,N-dimethyl vinyl carbamate, N,N-diethyl vinyl carbamate.
  • These monomers may, of course, comprise only a portion of the hydrophilic monomer portion of prepolymer mix which can further be comprised of other hydrophilic monomers.
  • the hydrogel prepolymer formulation should also preferably contain (b) between 40 to 80 weight percent of a non- or weakly hydrophilic monomer as combination of monomers chosen from the group consisting of 3-[tris(tri-methylsiloxy)silyl]propyl vinyl carbonate, t-butyl vinyl carbonate, t-butyldimethylsiloxyethyl vinyl carbonate, 3-[tris(trimethylsiloxy)silyl]propyl vinyl carbamate, 3-(vinyloxycarbonylthio)propyl[tris(trimethylsiloxy)]silane, 3-[tris(trimethylsiloxy)silyl]propyl allyl carbamate, t-butylphenyl vinyl carbamate.
  • a non- or weakly hydrophilic monomer as combination of monomers chosen from the group consisting of 3-[tris(tri-methylsiloxy)silyl]propyl vinyl carbonate, t-butyl vinyl carbonate, t-
  • hydrogel prepolymer compositions further comprise (c) between about 0.1 to 10% of a crosslinking agent, which may be chosen from a list of preferred crosslinking agents later disclosed in this application, or one of the crosslinking monomers known in the prior art as exemplified and/or taught in U.S. Pat. Nos. 4,060,678; 4,182,822; 4,267,295; 4,640,941 and/or 4,690,993.
  • a crosslinking agent which may be chosen from a list of preferred crosslinking agents later disclosed in this application, or one of the crosslinking monomers known in the prior art as exemplified and/or taught in U.S. Pat. Nos. 4,060,678; 4,182,822; 4,267,295; 4,640,941 and/or 4,690,993.
  • the amount of hydrophilic monomer used to prepare the hydrogel material in the present invention is adjusted within the above limits to give a water content in the hydrated hydrogel of from about 5 to approximately 80% by weight.
  • the non- or weakly hydrophilic monomer content is adjusted within the stated limits to maximize other desirable properties such as oxygen permeability, modulus and/or tear strength.
  • the quantity of the crosslinking monomer used to produce a hydrogel material is adjusted to maximize desirable properties such as water content, modulus, lens strength, and also aids in the hydrolytically stability of the final material.
  • UV absorbing monomers or tinting monomers may also be added to enhance the properties of the final material.
  • Hard lenses are prepared using: (I) one or more of the non-hydrophilic monomers of the present invention; (II) a crosslinking agent; (III) a small amount of a wetting monomer; and (IV) optionally other agents such as strengthening agents or UV absorbing or dye monomers.
  • the three main components are used in the following ratios; the non-hydrophilic monomer component (I) is used in amounts of about 60 to about 95 weight percent, the crosslinking monomer (II) in amounts from 0.1 to 10 weight percent, and the wetting monomer (III) in amounts from about 1 to 20 weight percent.
  • the content of the crosslinking agent is chosen to provide a dimensionally stable lens material resistant to breakage and stress crazing.
  • the amount of wetting monomer used is adjusted within limits to provide sufficient wetting characteristics so as to maintain a stable tear film while at the same time keeping a sufficiently low water content.
  • the non-hydrophilic monomers used to make the hard contact lens materials include one or more of the following monomers: 2,2,2-trifluoroethyl vinyl carbonate, 2,2,2-trifluoroethyl vinyl carbamate, 1,1,1,3,3,3-Hexafluoroprop-2-yl vinyl carbonate, 2,2,2-trifluoroethyl allyl carbonate, 2,2,2-trifluoro-1-phenylethyl vinyl carbonate, trimethylsilylmethyl vinyl carbonate, trimethylsilylethyl vinyl carbonate, 3-(trimethylsilyl)propyl vinyl carbonate, t-butyldimethylsiloxyethyl vinyl carbonate, 3-[tris(trimethylsiloxy)silyl]propyl vinyl carbonate, 3-[tris-(trimethylsiloxy)silyl]propyl vinyl carbamate, 3-(vinyloxycarboxylthio) propyl-[tris(trimethylsiloxy)silane].
  • crosslinking agents used preferably to make hard contact lens materials include crosslinking agents known in the prior art as taught in the U.S. patents referenced supra, but most preferably crosslinking agents chosen from the group consisting of crosslinking monomers represented by the formula ##STR7## wherein: X denotes --S--, --O--, or --NH-- and at least one X denotes a --NH-- in formula B; b is 0 or 1;
  • R c1 denotes a multivalent organic radical and a is 2, 3, or 4; and R x1 denotes a divalent organic radical.
  • the preferred crosslinkers includes:
  • the wetting monomers useful in hard contact lenses include N-vinylpyrrolidinone, 2-hydroxyethylmethacrylate, itaconic acid, methacrylic acid, N,N-diethylacrylamide, N,N-diethyl vinyl carbamate, N,N-dimethyl vinyl carbamate, N-Methyl-N-Vinyl acetamide, and all hydrophilic monomers listed in the hydrogel section supra.
  • Soft, non-hydrogel contact lens materials with little or no water content can be prepared by polymerizing prepolymer mixtures with the following formulations: between 50 and 90 weight percent of non-hydrophilic monomers with the following general formula: ##STR9## where X denotes either --O--, --S-- or --NH--; and
  • R NH represents an organic radical that is largely non-hydrophilic, and a is 1, 2, 3 or 4;
  • R H the largely non-hydrophilic moiety in the above formula, is typically a monovalent radical--but it may be multivalent.
  • the main functional requirement is that it is largely non-hydrophilic, generally nonreactive to free-radical vinyl addition reactions and may be incorporated into the above formula from a synthetic perspective.
  • R NH may be described by the following formulae: ##STR10## where R 1 denotes a monovalent organic radical such as an alkyl radical with 1 to 6 carbon atoms, or a fluoroalkyl radical with 1 to 6 carbon atoms;
  • R c1 denotes ##STR11##
  • p 1 to 6;
  • d is 1-200
  • n 1, 2, 3 or 4
  • the non-hydrophilic monomers specifically include 3-[tris(trimethylsiloxy)silyl]propyl vinyl carbonate; 1,3-bis[4-(vinyloxycarbonyloxy)but-1-yl]tetramethyldisiloxane; 3-(trimethylsilyl)propyl vinyl carbonate; t-butyldimethylsiloxyethyl vinyl carbonate; trimethylsilylmethyl vinyl carbonate; trimethylsilylethyl vinyl carbonate; 2,2,2-trifluoroethyl vinyl carbonate; t-butyl vinyl carbonate; 3-[tris(trimethylsiloxy)silyl] propyl vinyl carbonate; 2,2,2-trifluoroethyl vinyl carbamate; 1,1,1,3,3,3-hexafluoro-2-propyl vinyl carbonate; 3-(vinyloxycarbonylthio)propyl-[tris(trimethylsiloxy)silane]; 3-[tris-(trimethylsiloxy)silyl
  • the hydrophilic monomers used to produce the proper wetting conditions in combination with the soft non-hydrogel materials are selected from hydrophilic monomers used in contact lenses in general, including N-vinyl lactams e.g., N-vinyl pyrrolidinone; hydroxyalkyl acrylates and methacrylates such as 2-hydroxyethyl methacrylate (HEMA) and preferably, the hydrophilic vinyl carbonates and vinyl carbamates disclosed in this application such as hydroxyethyl vinyl carbonate; N,N-dimethyl vinyl carbamate; or N-hydroxyethyl vinyl carbamate; N-[vinyloxycarbonyloxyethyl]pyrrolidin-2,5-dione; and 3-(2-pyrrolidinon-1-yl)propyl vinyl carbonate.
  • N-vinyl lactams e.g., N-vinyl pyrrolidinone
  • hydroxyalkyl acrylates and methacrylates such as 2-hydroxyethyl
  • Crosslinkers used for the soft, non-hydrogel contact lens materials include the crosslinkers known in the prior art such as methylene glycol dimethacrylate and divinylbenzene, but preferably are crosslinking agents described in the present application by formulas A, B and C.
  • the preferred non-hydrophilic monomers are the long chain siloxane monomers of the present invention such as the so-called "V 2 D 25 " monomers.
  • soft non-hydrogel prepolymer formulations include:
  • copolymers of the present invention are formed by way of a free radical polymerization the details of which are generally known in the art.
  • the various comonomers are chosen and combined, as required to form the desired final copolymers, and a free radical catalyst is added to the mixture.
  • the mixture is then polymerized to form the desired copolymer.
  • Free radical catalysts are known in the art and are mostly of two general types: heat initiated free radical catalysts, and photoinitiated free radical catalysts, more specifically, ultraviolet radiation initiated free radical catalysts.
  • Heat initiated catalysts include peroxides such as 2,5-dimethyl-2,5-bis(2-ethylhexanoylperoxy) hexane (Lupersol 256TM Pennwalt Chemicals), bisisopropylperoxydicarbarate, acetylperoxide, lauroyl peroxide or benzoyl peroxide, photoinitiators include compounds such as 2-hydroxy-2-methyl-1-phenylpropan-1-one (DarocurTM, EM Chemicals), and the like.
  • Diluents may be employed in the process of polymerizing the copolymers of the present invention in order to modify the resultant physical characteristics of the finished copolymer.
  • the comonomer mixture used to produce a hydrogel like material may also include a portion of methylethylketone.
  • the amount of diluent used should be less than 50 wt. %. In most cases, the diluent content will be less than 30 wt. %. In a particular copolymer system, the actual limit will be dictated by the solubility of the various comonomers in the diluent.
  • the maximum amount of diluent which may be used will depend on the amount of swelling the diluent causes the final copolymers. Excessive swelling will or may cause the copolymer to collapse when the diluent is replaced with water upon hydration.
  • Suitable diluents include ethyleneglycol; glycerine; liquid polyethyleneglycol; alcohols; alcohol/water mixtures; ethylene oxide/propylene oxide block copolymers; low molecular weight linear polyhydroxyethylmethacrylates; glycol esters of lactic acid; formamides; ketones; dialkylsulfoxides; butyl carbitol; and the like.
  • X denotes an --O--, --S--, or --NR 3 -- divalent radical
  • R 1 denotes an organic radical
  • R 2 denotes --H or --CH 3 ;
  • R 3 denotes --H, or a monovalent alkyl radical
  • a is 1, 2, 3, or 4;
  • b is 0 or 1.
  • copolymers may also contain further additives such as wetting agents, tints, dyes, strengthening agents and the like to tailor specific material properties as desired.
  • the copolymers of the present invention are useful as biomedical devices, and in particular, are well suited as contact lens materials.
  • the copolymers can be formed into contact lenses by many of the techniques known in the art to be useful in contact lens production. For instance, prepolymer mixtures containing heat initiated free radical catalysts can be placed in polypropylene tubes which are then heat cured over time to form copolymeric rods which are then cut to form button shaped articles. These button shaped articles can then be lathed into contact lenses.
  • the prepolymer mixture can be molded per the methods disclosed in U.S. Pat. Nos. 4,085,459 or 4,197,266.
  • Spin casting techniques may also be used with the present materials and such methods as described in U.S. Pat. Nos. 3,408,429 and 3,496,254 can be so adopted to be useful with the present copolymers.
  • FTIR (neat, capillary) 3500.56, 3477.38, 3379.94, 2960.20, 1805.29, 1753.69, 1650.79, 1558.65, 1540.44, 1506.71, 1481.33, 1455.89, 1388.72, 1373.25, 1299.19, 1244.25, 1154.19, 1067.30, 1015.59, 995.52, 969.77, 944.14, 913.44, 875.08, 859.65, 779.15, 717.53, 684.06, 666.45, 649.43.
  • FTIR (neat, capillary) 2962.91, 1754.66, 1679.48, 1646.22, 1494.64, 1462.88, 1438.22, 1424.48, 1393.77, 1368.15, 1327.55, 1286.44, 1237.47, 1152.71, 1113.47, 1085.63, 1046.25, 1018.86, 979.70, 946.17, 894.98, 877.43, 853.32, 779.37, 735.01, 697.06, 650.86.
  • the reaction mixture was filtered through 20.0 g of activated F20 alumina to give a light yellow oil.
  • the oil was heated at 80° C. at 0.25 Torr for 31/2 hours to remove volatiles, giving 13.4 g (5.90 mmol, 49.4%) of a light yellow oil.
  • FTIR nitrogen-activated fluorescent spectroscopy
  • N is an average value that gives the polypropylene glycol moiety an average molecular weight of about 1000.
  • N is an average value that gives the polyethylene glycol moiety an average molecular weight of about 1000.
  • Soft hydrogel copolymers of the present invention were produced by copolymerizing a monomer of the formula ##STR57## with N-vinylpyrrolidinone (NVP), and the crosslinker monomer 1,5-bis-(vinyloxycarbonyloxy)-2,2,3,3,4,4-hexacluoropentane, in the presence of a nonreactive diluent and a UV irradiation, free radical initiator in the following weight ratios:
  • These films were prepared by placing the prepolymer mixtures between glass plates separated by a Teflon® peripheral gasket and were UV irradiated for 2 hours. The samples were then prepared for physical characterization.
  • Oxygen permeabilities were measured by the method reported by Relojo, M. et al in Contact and Intraocular Lens Medical Journal, Vol. 3, issued p. 27 (1977) and edge effects were accounted for per the methods described by Fatt, et al. in International Contact Lens Clinic, v. 14, p. 389 (1987).
  • Water content is measured per a gravimetric method.
  • Refractive index was measured per typical methods on hydrated samples using a refractometer.
  • Hard, gas permeable contact lens materials were made using the novel vinylcarbonate functional monomers described herein by polymerizing 1,1,1,3,3,3-hexafluoroprop-2-yl vinyl carbonate (hfpvc) ##STR58## with a variety of hydrophilic monomers and crosslinkers, such as those known in the prior art and the preferred hydrophilic monomers and crosslinkers disclosed herein.
  • Films were made by the general method described in the hydrogel film example.
  • the films were polymerized from monomer mixtures with the following formulations.
  • a series of films were made by the general film casting technique described in the hydrogel materials example except that prepolymer mixtures for the various films were employed as hereinafter disclosed.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Eyeglasses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Novel monomers of the general formula ##STR1## where b is 0 or 1, a is 1, 2, 3 or 4, R2 is a monovalent alkyl radical and R is an organic radical. The novel monomers may be employed to produce novel copolymers useful as hydrogel, soft non-hydrogel and/or rigid gas permeable contact lens materials.

Description

BACKGROUND OF THE INVENTION
Biomedical materials which are particularly useful as contact lens materials fall into three general classifications; hydrogels, non-hydrophilic soft materials and rigid gas permeable materials.
The chemistries of contact lens hydrogels are almost completely described by polymer and copolymer systems comprised of either 2-hydroxyethylmethacrylate (HEMA) or N-vinyl-2-pyrrolidinone (NVP), or mixtures of HEMA and NVP. Minor components such as crosslinking agents are used in these systems to control tear strength, hydrolytic stability, modulus, etc. These hydrogel systems are generally well known and have been successful on a commercial basis, but they are not without shortcomings.
Polysiloxane based elastomers have also been known in the contact lens art for some time and have enjoyed limited commercial success. In general, the silicone chemistries involve vinyl functional end capped polysiloxane polymers.
Rigid gas permeable contact lens materials are generally copolymers formed from copolymerizing acrylic or methacryl functional monomers which contain siloxane functionalities and often also contain fluorine atoms.
The present invention provides a novel monomer chemistry to the art of biomedical device materials.
SUMMARY OF THE INVENTION
The present invention provides novel monomers useful in biomedical devices. These novel monomers have the general formula ##STR2## where b is 0 or 1, a is 1, 2, 3 or 4, R2 is a monovalent alkyl radical and R is an organic radical. The novel monomers may be employed to produce novel copolymers useful as hydrogel, soft non-hydrogel and/or rigid gas permeable contact lens materials.
DETAILED DESCRIPTION OF THE INVENTION
The present invention is directed to new crosslinked copolymers which employ novel monomers also disclosed in this application. These novel copolymers are particularly useful as biomedical materials, and are especially useful in the area of contact lens applications. These new crosslinked copolymers, when used in contact lens applications, can produce a wide variety of types of contact lens materials ranging from hard, gas permeable lens materials; soft, hydrogel lens materials; to soft, non-hydrogel lens materials.
The novel monomers generally fall into the following classifications: a) hydrophilic monomers with the general formula ##STR3## where b is 0 or 1; a is 1, 2, 3 or 4
X denotes --NH--, --S-- or --O--; and
RH denotes a hydrophilic moiety such as an organic radical with one or more amide hydroxyl, urea or carboxylic acid functionalities so that the monomer as a whole is relatively hydrophilic;
b) silicone containing monomers of the general formula ##STR4## where a, b, and X are defined as above and RSi denotes a silicone containing organic radical;
c) non- or slightly hydrophilic monomers of the general formula ##STR5## where a, b and X are as defined above and RNH denote a non-hydrophilic organic radical.
In general, there are no clear cut demarcations between any of the three classifications of contact lens materials. However, in general, hydrogel materials should have oxygen permeabilities with DK's greater than 20×10-11 cm3 ×cm/sec.×cm2 ×mmHg (or DK units hereinafter) and preferably greater than 40 DK and most preferably greater than 60 DK. They should have a Young's modulus of elasticity in the range of 20 to 400 g/mm2, preferably 50 to 200 g/mm2 as measured by ASTM test method D 638. They should have tear strengths greater than 1 g/mm2 and preferably greater than 5 g/mm2 as measured by ASTM test method D 1938. Their water content should be between 10 to 80%, and preferably between 20 to 50%. The contact angle, which is a measurement of the wettability of the lens, should be less than 80° and should preferably be less than 40°. The protein uptake of hydrogel lenses or hydrogel lens materials should be less than or equivalent to that of PHEMA.
Soft, non-hydrogel materials should have at a minimum oxygen permeabilities equal to or greater than hydrogel materials. The water content should always be less than 10%, and preferably less than 5%. The modulus of elasticity should be between 20 and 5,000 g/mm2 and preferably should be in the range of 50 to 250 g/mm2. Contact angle less than 80° and preferably less than 40° and the tear strength (both initial and propagation) of this material should be in excess of 5 g/mm2.
Properties of hard, gas permeable lens materials should be similar to that of the hydrogel and the soft, non-hydrogel materials. In addition, the glass transition temperature of such materials should be greater than 40° C. and preferably greater than 65° C. The modulus of the material should be greater than 50,000 g/mm2 and preferably greater than 75,000 g/mm2.
HYDROGEL MATERIALS
To prepare a soft, non-hydrogel material the following prepolymer formulations should be used: (a) between 25 and 90% of the prepolymer mixture should comprise a hydrophilic monomer portion. This portion will preferably comprise in part at least a hydrophilic monomer represented by the general formula ##STR6## where b is 0 or 1 and X is --S--, --O--, or --NR3 -- and Rh denotes a relatively hydrophilic moiety. This hydrophilic monomer portion may also include at least one of the hydrophilic monomers chosen from the group consisting of wetting monomers N-vinyl-2-pyrrolidinone, 2-hydroxyethyl vinyl carbonate, 2-hydroxyethyl vinyl carbamate, 3-(2-pyrrolidinon-1-yl)-propyl vinyl carbonate, 2-(2-pyrrolidinon-1-yl)ethyl vinyl carbonate, N-(vinyloxycarbonyloxy)pyrrolidin-2,5-dione, N-[vinyloxycarbonyloxyethyl]pyrrolidin-2,5-dione, N-vinylacetamide, N-methyl-N-vinylacetamide, N,N-dimethyl vinyl carbamate, N,N-diethyl vinyl carbamate. These monomers may, of course, comprise only a portion of the hydrophilic monomer portion of prepolymer mix which can further be comprised of other hydrophilic monomers.
The hydrogel prepolymer formulation should also preferably contain (b) between 40 to 80 weight percent of a non- or weakly hydrophilic monomer as combination of monomers chosen from the group consisting of 3-[tris(tri-methylsiloxy)silyl]propyl vinyl carbonate, t-butyl vinyl carbonate, t-butyldimethylsiloxyethyl vinyl carbonate, 3-[tris(trimethylsiloxy)silyl]propyl vinyl carbamate, 3-(vinyloxycarbonylthio)propyl[tris(trimethylsiloxy)]silane, 3-[tris(trimethylsiloxy)silyl]propyl allyl carbamate, t-butylphenyl vinyl carbamate. These non- or slightly hydrophilic monomers enhance the oxygen permeability of the final copolymer.
The hydrogel prepolymer compositions further comprise (c) between about 0.1 to 10% of a crosslinking agent, which may be chosen from a list of preferred crosslinking agents later disclosed in this application, or one of the crosslinking monomers known in the prior art as exemplified and/or taught in U.S. Pat. Nos. 4,060,678; 4,182,822; 4,267,295; 4,640,941 and/or 4,690,993.
The amount of hydrophilic monomer used to prepare the hydrogel material in the present invention is adjusted within the above limits to give a water content in the hydrated hydrogel of from about 5 to approximately 80% by weight. The non- or weakly hydrophilic monomer content is adjusted within the stated limits to maximize other desirable properties such as oxygen permeability, modulus and/or tear strength. The quantity of the crosslinking monomer used to produce a hydrogel material is adjusted to maximize desirable properties such as water content, modulus, lens strength, and also aids in the hydrolytically stability of the final material. In addition, UV absorbing monomers or tinting monomers may also be added to enhance the properties of the final material.
For instance, the following prepolymer formulations would produce hydrogel materials within the scope of the present invention.
______________________________________                                    
I.   A.     25-90   wt % hydrophilic monomer, 2-hydroxy-                  
                    ethyl vinyl carbamate;                                
     B.     10-30   wt % non- or weakly hydrophilic monomer               
                    3-N-[tris(trimethylsiloxy)silylpropyl]                
                    vinyl carbamate; and                                  
     C.     0.1-10  wt % crosslinker, 1,2-bis-(vinyloxy                   
                    carbonyloxy)ethane.                                   
II.  A.i)   25-90   wt % hydrophilic monomer 2-hydroxyethyl               
                    vinyl carbamate; and                                  
     ii)    25-90   wt % hydrophilic monomer N-vinyl                      
                    pyrrolidinone, where the combination                  
                    of i and ii comprises between 25 to 90                
                    wt % of the final prepolymer                          
                    compositions.                                         
     B.     10-90   wt % of non-, or weakly hydrophilic                   
                    monomer t-butyldimethylsiloxyethyl                    
                    vinyl carbamate; and                                  
     C.     0.1-10  wt % crosslinker, α,ω-bis-(vinyloxy-      
                    carbonyl) polyethylene glycol.                        
III. A.     25-90   wt % hydrophilic monomer, 3-(2-pyrroli-               
                    dinon-1-yl)propyl vinyl carbamate;                    
     B.     10-30   wt % weak or non-hydrophilic monomer,                 
                    t-butyl vinyl carbamate; and                          
     C.     0.1-10  wt % crosslinker, α,ω-bis-(vinyloxy-      
                    carbonyl) polyethylene glycol.                        
______________________________________
HARD, GAS PERMEABLE MATERIALS
Hard lenses are prepared using: (I) one or more of the non-hydrophilic monomers of the present invention; (II) a crosslinking agent; (III) a small amount of a wetting monomer; and (IV) optionally other agents such as strengthening agents or UV absorbing or dye monomers. The three main components are used in the following ratios; the non-hydrophilic monomer component (I) is used in amounts of about 60 to about 95 weight percent, the crosslinking monomer (II) in amounts from 0.1 to 10 weight percent, and the wetting monomer (III) in amounts from about 1 to 20 weight percent. The content of the crosslinking agent is chosen to provide a dimensionally stable lens material resistant to breakage and stress crazing. The amount of wetting monomer used is adjusted within limits to provide sufficient wetting characteristics so as to maintain a stable tear film while at the same time keeping a sufficiently low water content.
The non-hydrophilic monomers used to make the hard contact lens materials include one or more of the following monomers: 2,2,2-trifluoroethyl vinyl carbonate, 2,2,2-trifluoroethyl vinyl carbamate, 1,1,1,3,3,3-Hexafluoroprop-2-yl vinyl carbonate, 2,2,2-trifluoroethyl allyl carbonate, 2,2,2-trifluoro-1-phenylethyl vinyl carbonate, trimethylsilylmethyl vinyl carbonate, trimethylsilylethyl vinyl carbonate, 3-(trimethylsilyl)propyl vinyl carbonate, t-butyldimethylsiloxyethyl vinyl carbonate, 3-[tris(trimethylsiloxy)silyl]propyl vinyl carbonate, 3-[tris-(trimethylsiloxy)silyl]propyl vinyl carbamate, 3-(vinyloxycarboxylthio) propyl-[tris(trimethylsiloxy)silane].
The crosslinking agents used preferably to make hard contact lens materials include crosslinking agents known in the prior art as taught in the U.S. patents referenced supra, but most preferably crosslinking agents chosen from the group consisting of crosslinking monomers represented by the formula ##STR7## wherein: X denotes --S--, --O--, or --NH-- and at least one X denotes a --NH-- in formula B; b is 0 or 1;
Rc1 denotes a multivalent organic radical and a is 2, 3, or 4; and Rx1 denotes a divalent organic radical.
The preferred crosslinkers includes:
1,5-bis-(vinyloxycarboxyloxy)-2,2,3,3,4,4-hexafluoropentane;
1,2-bis(vinyloxycarboxyloxy)ethane;
α,ω-bis(vinyloxycarbonyl)polyethylene glycol;
N,O-bis(vinyloxycarbonyl)ethanolamine;
2,2'-dimethyl-1,3-bis(vinyloxycarbonyloxy)propane;
α,ω-bis-(vinyloxycarbonyl)triethylene glycol;
2,2-dimethyl-N,N-bis(vinyloxycarbonyl)-1,3-propandiamine;
1,3-bis-[4-(vinyloxycarbonyloxy)but-1-yl] tetramethyldisiloxane;
N,N-bis-(vinyloxycarbonyl)-1,6-diaminohexane: ##STR8## where X=25 on the average.
The wetting monomers useful in hard contact lenses include N-vinylpyrrolidinone, 2-hydroxyethylmethacrylate, itaconic acid, methacrylic acid, N,N-diethylacrylamide, N,N-diethyl vinyl carbamate, N,N-dimethyl vinyl carbamate, N-Methyl-N-Vinyl acetamide, and all hydrophilic monomers listed in the hydrogel section supra.
SOFT, NON-HYDROGEL MATERIALS
Soft, non-hydrogel contact lens materials with little or no water content can be prepared by polymerizing prepolymer mixtures with the following formulations: between 50 and 90 weight percent of non-hydrophilic monomers with the following general formula: ##STR9## where X denotes either --O--, --S-- or --NH--; and
RNH represents an organic radical that is largely non-hydrophilic, and a is 1, 2, 3 or 4;
from 5 to about 25 weight percent of a hydrophilic monomer and between 0.1 and about 10% of a crosslinking monomer.
RH, the largely non-hydrophilic moiety in the above formula, is typically a monovalent radical--but it may be multivalent. The main functional requirement is that it is largely non-hydrophilic, generally nonreactive to free-radical vinyl addition reactions and may be incorporated into the above formula from a synthetic perspective.
In general, RNH may be described by the following formulae: ##STR10## where R1 denotes a monovalent organic radical such as an alkyl radical with 1 to 6 carbon atoms, or a fluoroalkyl radical with 1 to 6 carbon atoms;
Rc1 denotes ##STR11##
p is 1 to 6; and
d is 1-200, and
where n is 1, 2, 3 or 4, m is 0, 1, 2, 3, 4, or 5, or RNH denotes a partially or fully fluorinated alkyl, alkylaryl or aryl radical.
The non-hydrophilic monomers specifically include 3-[tris(trimethylsiloxy)silyl]propyl vinyl carbonate; 1,3-bis[4-(vinyloxycarbonyloxy)but-1-yl]tetramethyldisiloxane; 3-(trimethylsilyl)propyl vinyl carbonate; t-butyldimethylsiloxyethyl vinyl carbonate; trimethylsilylmethyl vinyl carbonate; trimethylsilylethyl vinyl carbonate; 2,2,2-trifluoroethyl vinyl carbonate; t-butyl vinyl carbonate; 3-[tris(trimethylsiloxy)silyl] propyl vinyl carbonate; 2,2,2-trifluoroethyl vinyl carbamate; 1,1,1,3,3,3-hexafluoro-2-propyl vinyl carbonate; 3-(vinyloxycarbonylthio)propyl-[tris(trimethylsiloxy)silane]; 3-[tris-(trimethylsiloxy)silyl]propyl vinyl carbamate; "V2 D25", 2,2,2 -trifluoro-1-phenylethyl vinyl carbonate; 1-adamantane vinyl carbonate, 1-adamantanemethyl vinyl carbonate, 1-adamantaneethyl vinyl carbonate; and 1-adamantane vinyl carbamate.
The hydrophilic monomers used to produce the proper wetting conditions in combination with the soft non-hydrogel materials are selected from hydrophilic monomers used in contact lenses in general, including N-vinyl lactams e.g., N-vinyl pyrrolidinone; hydroxyalkyl acrylates and methacrylates such as 2-hydroxyethyl methacrylate (HEMA) and preferably, the hydrophilic vinyl carbonates and vinyl carbamates disclosed in this application such as hydroxyethyl vinyl carbonate; N,N-dimethyl vinyl carbamate; or N-hydroxyethyl vinyl carbamate; N-[vinyloxycarbonyloxyethyl]pyrrolidin-2,5-dione; and 3-(2-pyrrolidinon-1-yl)propyl vinyl carbonate.
Crosslinkers used for the soft, non-hydrogel contact lens materials include the crosslinkers known in the prior art such as methylene glycol dimethacrylate and divinylbenzene, but preferably are crosslinking agents described in the present application by formulas A, B and C.
The preferred non-hydrophilic monomers are the long chain siloxane monomers of the present invention such as the so-called "V2 D25 " monomers.
Some examples of soft non-hydrogel prepolymer formulations include:
______________________________________                                    
I)    80    wt % V.sub.2 D.sub.25 ;                                       
      10    wt % N-vinyl-2-pyrrolidinone;                                 
      5     wt % 2,2,2-trifluoroethyl vinyl carbonate; and                
      5     wt % N-O-bis-(vinylcarbonyl)ethandamine.                      
II)   60    wt % 3-(trimethylsiloxy)propyl vinyl                          
            carbonate;                                                    
      30    wt % α,ω-bis(vinyloxycarbonyl) polyethylene       
            glycol;                                                       
      5     wt % 1,1,1,3,3,3-Hexafluoroprop-2-yl vinyl                    
            carbonate; and                                                
      5     wt % N-vinyl-N-methyl acetamide.                              
III)  25    wt % 3-(trimethylsilyl)propyl vinyl carbonate;                
      64    wt % 3-[tris-(trimethylsiloxy)silyl]propyl                    
            vinyl carbamate;                                              
      10    wt % N-vinylpyrrolidinone; and                                
      1     wt % 2,2-dimethyl-1,3-bis(vinyloxycarbonyloxy)                
            propane.                                                      
IV)   20    wt % t-butyldimethylsiloxyethyl vinyl carbonate;              
      70    wt % 3-[tris(trimethylsiloxy)silyl]propyl vinyl               
            carbamate;                                                    
      9     wt % N-vinylpyrrolidinone; and                                
      1     wt % 2,2-dimethyl-1,3-bis(vinyloxycarbonyloxy)                
            propane.                                                      
V)    20    wt % trimethylsilylethyl vinyl carbonate;                     
      69    wt % 3-[tris(trimethylsiloxy)silyl]propyl vinyl               
            carbamate;                                                    
      10    wt % N-vinylpyrrolidinone; and                                
      1     wt % 2,2-dimethyl-1,3-bis(vinyloxycarbonyloxy)                
            propane.                                                      
______________________________________
The copolymers of the present invention are formed by way of a free radical polymerization the details of which are generally known in the art. In general, the various comonomers are chosen and combined, as required to form the desired final copolymers, and a free radical catalyst is added to the mixture. The mixture is then polymerized to form the desired copolymer.
Free radical catalysts are known in the art and are mostly of two general types: heat initiated free radical catalysts, and photoinitiated free radical catalysts, more specifically, ultraviolet radiation initiated free radical catalysts. Heat initiated catalysts include peroxides such as 2,5-dimethyl-2,5-bis(2-ethylhexanoylperoxy) hexane (Lupersol 256™ Pennwalt Chemicals), bisisopropylperoxydicarbarate, acetylperoxide, lauroyl peroxide or benzoyl peroxide, photoinitiators include compounds such as 2-hydroxy-2-methyl-1-phenylpropan-1-one (Darocur™, EM Chemicals), and the like.
Diluents may be employed in the process of polymerizing the copolymers of the present invention in order to modify the resultant physical characteristics of the finished copolymer. For instance, the comonomer mixture used to produce a hydrogel like material may also include a portion of methylethylketone. In general, the amount of diluent used should be less than 50 wt. %. In most cases, the diluent content will be less than 30 wt. %. In a particular copolymer system, the actual limit will be dictated by the solubility of the various comonomers in the diluent. In order to produce an optically clear copolymer, it is important that a phase separation does not occur between the comonomers and the diluent, or the diluent and the final copolymer.
Furthermore, as a practical matter, the maximum amount of diluent which may be used will depend on the amount of swelling the diluent causes the final copolymers. Excessive swelling will or may cause the copolymer to collapse when the diluent is replaced with water upon hydration.
Suitable diluents include ethyleneglycol; glycerine; liquid polyethyleneglycol; alcohols; alcohol/water mixtures; ethylene oxide/propylene oxide block copolymers; low molecular weight linear polyhydroxyethylmethacrylates; glycol esters of lactic acid; formamides; ketones; dialkylsulfoxides; butyl carbitol; and the like.
These novel copolymers in general are made from polymerizing mixtures comprising:
a) from 1 to 99 wt. % of a base monomer of the general chemical formula ##STR12## wherein:
X denotes an --O--, --S--, or --NR3 -- divalent radical;
R1 denotes an organic radical;
R2 denotes --H or --CH3 ;
R3 denotes --H, or a monovalent alkyl radical;
a is 1, 2, 3, or 4; and
b is 0 or 1.
b) from 0.1 to 20 wt. % of a crosslinking agent known in the biomedical material art, or a novel crosslinker represented by the chemical formulae: ##STR13## wherein: X is --O-- or --NH-- with at least one X being --NH--; Rc1 denotes a multivalent organic radical, b is 0 or 1, and a is 2, 3 or 4.
These copolymers may also contain further additives such as wetting agents, tints, dyes, strengthening agents and the like to tailor specific material properties as desired.
The copolymers of the present invention are useful as biomedical devices, and in particular, are well suited as contact lens materials. The copolymers can be formed into contact lenses by many of the techniques known in the art to be useful in contact lens production. For instance, prepolymer mixtures containing heat initiated free radical catalysts can be placed in polypropylene tubes which are then heat cured over time to form copolymeric rods which are then cut to form button shaped articles. These button shaped articles can then be lathed into contact lenses.
Alternately, the prepolymer mixture can be molded per the methods disclosed in U.S. Pat. Nos. 4,085,459 or 4,197,266. Spin casting techniques may also be used with the present materials and such methods as described in U.S. Pat. Nos. 3,408,429 and 3,496,254 can be so adopted to be useful with the present copolymers.
SYNTHESIS OF MONOMERS Part I--Synthesis of Hydroxalkyl Monomers Useful as Hydrogel Base Monomers and Wetting Agents 1.0 2-Hydroxyethyl Vinyl Carbonate C6 H8 O4
To a 1000 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, N2 blanket, thermometer, and a dropping funnel 5.0 g (81.66 mmol) of ethylene glycol. 7.12 g (90.0 mmol) of pyridine and 500 mL of chloroform were added. To this reaction mixture 8.779 g (81.66 mmol) of vinyl chloroformate was added over 20 minutes. The reaction mixture was stirred for 16 hours. The volume of the mixture was reduced to 75 mL on a rotary evaporator and the residue washed with 100 mL of 2N HCl. The aqueous phase was set aside. The organic phase was dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil was purified by chromatography (silica gel, gradient starting with 60% cyclochexane 40% chloroform) to give an oil. The 2N HCl wash was saturated with sodium chloride and extracted three times with 50 mL chloroform. The combined chloroform extracts were dried with magnesium sulfate and flash evaporated to an oil. The oils combined to give 2.3 g (17.4mmol, 21.3%) of a light yellow oil. FTIR (neat, capillary) 3500.56, 3477.38, 3379.94, 2960.20, 1805.29, 1753.69, 1650.79, 1558.65, 1540.44, 1506.71, 1481.33, 1455.89, 1388.72, 1373.25, 1299.19, 1244.25, 1154.19, 1067.30, 1015.59, 995.52, 969.77, 944.14, 913.44, 875.08, 859.65, 779.15, 717.53, 684.06, 666.45, 649.43. NMR (CDCl3) δ 6.83-7.177 (1H,m), 4.56-5.0 (2H,m), 4.13-4.37 (2H,m), 3.70-3.93 (2H,m), 3.07-3.43 (1H,s). The instrumental analyses were consistent with a compound represented by the following formula: ##STR14##
1.1 2-Hydroxyethyl Vinyl Carbamate C5 H9 NO3
To a 500 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, N2 blanket, thermometer, and dropping funnel 20.0 g (327.4 mmol) of ethanolamine and 200 mL of chloroform were added. 17.44 g (163.7 mmol) of vinyl chloroformate was added to the mixture over 20 minutes raising the temperature to 53° C. The reaction mixture was cooled to room temperature and stirred for 16 hours. The resolution precipitate was removed by filtration. The filtrate was evaporated to remove solvent and the residual oil was distilled (125° C.±5° C. 0.89 Torr) to give 21.2 g (161.7 mmol, 98.8%) of a light yellow oil. FTIR (neat, capillary) 3314.69, 2940.08, 2885.15, 1705.86, 1648.26, 1522.62, 1458.28, 1432.05, 1403.96, 1363.49, 1339.67, 1294.21, 1244.90, 1160.44, 1116.66, 1059.67, 1010.44, 947.03, 921.01, 861.00, 768.57, 731.09, NMR (CDCl3) δ 6.90-7.23 (1H,m), 5.76-6.3 (1H,s), 4.26-4.83 (2H,m), 3.50-3.93 (3H,m), 3.07-3.47 (2H,m). The spectral analyses were consistent with the following chemical structure. ##STR15##
1.2 N-(Vinyloxycarbonyloxy)-pyrrolidin-2.5-dione
To a 500 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, dropping funnel, ice-saltwater bath, and thermometer were added 10.0 (87.0 mmol) of N-hydroxy succinimide, 6.9 g (87.0 mmol) of pyridine, and 100 mL tetrahydrofuran was added. To the reaction mixture 9.25 g (87.0 mmol) of vinyl chloroformate was added so that the temperature remained below 10° C. After stirring at room temperature for 18 hours the reaction mixture was washed with 100 mL 2N HCl, and 100 mL 2N NaOH. The organic phase was dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting liquid chromatographed (silica gel, chloroform) to yield 10.0 g (54.0 mmol, 62.1% yield) of an oil. FTIR (neat, capillary) 3516.50, 3132.04, 3099.40, 3003.94, 2960.21, 1830.80, 1823.25, 1792.36, 1734.05, 1671.98, 1653.62, 1646.30, 1429.97, 1380.77, 1368.60, 1306.35, 1260.89, 1241.83, 1201.12, 1162.09, 1154.49, 1134.29, 1087.59, 1049.93, 1005.21, 990.18, 948.77, 941.86, 908.06, 897.29, 892.42, 812.37, 769.04, 756.85, 724.90, 707 81. NMR (CDCl3) 6.73-7.09 (1H,q), 4.61-5.24 (2H,m), 2.78 (4H,S). ##STR16##
1.3 N-(Vinyloxycarbonyloxyethyl)pyrrolidin-2,5-dione
To a 500 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, dropping funnel, ice-saltwater bath, and thermometer were added 5.0 (35.0 mmol) of N-(2-hydroxyethyl) succinimide, 2.8 g (35.0 mmol) of pyridine, and 100 mL chloroform. To the reaction mixture was added 3.7 g (35.0 mmol) of vinyl chloroformate so that the temperature remained below 10° C. After stirring at room temperature for 18 hours the reaction mixture was washed with 100 mL 2N HCl and 100 mL 2N NaOH. The organic phase was dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting red liquid chromatographed (silica gel, chloroform). The recovered oil totaled 3.0 g (14.1 mmol, 40.2% yield). FTIR (neat, capillary) 1755.10, 1694.90, 1648.77, 1427.00, 1396.38, 1366.15, 1329.97, 1298.34, 1239.58, 1185.85, 1152.26, 1111.20, 1085.92, 1024.25, 1005.00, 946.53, 894.87, 882.46, 848.52, 818.51, 778.99, 700.00, 661.32. NMR (CDCl3) 6.50-6.83 (1H,q), 4.13- 4.66 (2H,m), 3.93-4.13 (2H,m), 3.33-3.66 (2H,m), 2.41 (4H,S). ##STR17##
Part II--Synthesis of Pyrrolidinone Moiety Containing Monomers 2.0 3-(2-Pyrrolidinon-1-yl)propyl Vinyl Carbonate C10 H5 NO4
To a 250 mL 1-neck round bottom flask fitted with a magnetic stirrer, dropping funnel, and ice bath, 12.5 g (87.3 mmol) of N-(3-hydroxypropyl)-2-pyrrolidinone, 7.6 g (96.0 mmol) of pyridine and 100 mL of chloroform were added. To the ice cold reaction mixture 9.3 g (87.3 mmol) of vinyl chloroformate was added over 5 minutes. After 5 minutes a precipitate formed. The reaction mixture was adsorbed on silica gel then purified by chromatography (silica gel, methylene chloride) to give 17.3 g (81.1 mmol, 93.0%) of a straw colored oil. FTIR (neat, capillary) 2963.22, 1754.09, 1676.89, 1646.83, 1566.02, 1494.64, 1463.44, 1425.05, 1396.11, 1357.91, 1336.92, 1296.25, 1239.43, 1152.41, 1085.28, 1024.06, 998.00, 946.11, 882.00, 761.74, 737.53, 697.39, 651.25. NMR (CDCl3) 6.82-7.17 (1H,m), 4.40-4.96 (2H,m), 4.06-4.28 (2H,m), 3.24-3.47 (4H,m), 1.68-2.56 (6H,m). The spectral analyses were consistent with the following chemical structure. ##STR18##
2.1 2-(2-Pyrrolidinon-1-yl)ethyl Vinyl Carbonate C9 H13 NO3
To a 250 mL 1-neck round bottom flask fitted with a magnetic stirrer, dropping funnel, and ice bath, were added 10.0 g (77.4 mmol) of N-2-(hydroxyethyl) pyrrolidinone, 6.7 g (84.7 mmol) of pyridine and 100 mL of chloroform. To the ice cold solution 8.3 g (78.0 mmol) of vinyl chloroformate was added. The mixture was stirred for 30 minutes, forming a precipitate. The reaction mixture was chromatographed (silica gel, methylene chloride) 90% toluene 10%) to give 8.3 g (41.7 mmol, 53.9%) of a light yellow oil. FTIR (neat, capillary) 2962.91, 1754.66, 1679.48, 1646.22, 1494.64, 1462.88, 1438.22, 1424.48, 1393.77, 1368.15, 1327.55, 1286.44, 1237.47, 1152.71, 1113.47, 1085.63, 1046.25, 1018.86, 979.70, 946.17, 894.98, 877.43, 853.32, 779.37, 735.01, 697.06, 650.86. NMR (CDCl3) δ 6.84-7.17 (1H,m), 4.45-5.01 (2H,m), 4.18-4.35 (2H,m), 3.32-3.62 (4H,m), 1.70-2.50 (4H,m). Spectral analyses were consistent with the proposed chemical structure. ##STR19##
Part III--Synthesis of Haloalkyl Containing Monomers 3.0 2,2,2-Trifluoroethyl Vinyl Carbonate C5 H5 O3
To a 2 liter 4-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, thermometer, ice-water bath, and dropping funnel 47.45 g (0.6 moles) of pyridine and 600 mL of methylene chloride was added. The mixture was cooled to between 5° and 8° C., a white precipitate formed. Then 60.02 g (0.6 moles) of 2,2,2-trifluoroethanol was added. The reaction was warmed to room temperature for 20 hours. A precipitate remained but had changed texture. The organics were washed thrice with 200 mL 2N HCl, once with saturated NaCl then twice with 200 mL 2N NaOH. The organics were dried over magnesium sulfate then distilled through an 8 inch vigreux to give a colorless oil which had the following characteristics (bp 107° C., 760.0 Torr), 66.1 g (0.389 mole, 64.8%). FTIR (neat, capillary) 2985.97, 1790.03, 1653.80, 1447.48, 1412.48, 1386.07, 1316.41, 1255.45, 1185.52, 1157.41, 1098.83, 1082.16, 995.88, 962.47, 941.20, 910.72, 881.10, 777.15, 694.53, 665.95. NMR (CDCl3) δ 6.88-7.26 (1H,m), 4.33-5.20 (4H,m). The spectral analyses were consistent with the following structure. ##STR20##
3.1 2,2,2-Trifluoroethyl Vinyl Carbamate C5 H6 F3 NO2
To a 1 L 3-neck round bottom flask fitted with a mechanical stirrer, condenser, thermometer, and ice water bath 32.11 g (406.0 mmol) of pyridine and 450 mL of ether was added. After the temperature was stabilized at 12.5° C.±2.5° C. 21.6 203.0 mmol of 2,2,2-trifluoroethyl amine hydrochloride was added in one portion, then the reaction was stirred to room temperature for 18 hours. The organics were washed twice with 300 mL 2N HCl, once with 100 mL 2N NaOH, then dried with magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil was distilled at (70° C., 30 Torr) to give a white crystalline solid (mp 43°-44° C.) 6.8 g (40.2 mmol, 21.8%). FTIR (SRATR) 3325.47, 2957.22, 2921.47, 2852.61, 1722.84, 1651.46, 1540.06, 1458.41, 1427.89, 1396.91, 1299.01, 1281.24, 1237.54, 1150.23, 1121.40, 1023.84, 956.16, 946.33, 871.75, 830.76, 771.03, 669.23. NMR (CDCl3) 6.95- 7.27 (1H,m), 5.07-5.66 (1H,b), 4.33-4.86 (2H,m), 3.50-4.13 (2H,m). ##STR21##
3.2 1,1,1,3,3,3-Hexafluoroprop-2-yl Vinyl Carbonate C6 H4 F6 O3
To a 1000 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, thermometer, dropping funnel, and ice-water bath 43.50 g (550.0 mmol) of pyridine and 600 mL methylene chloride was added. After cooling to 5° C.±2° C. 53.3 g (500.0 mmol) of vinyl chloroformate was added while maintaining the temperature. A white precipitate formed immediately. When the addition was complete, 92.4 g (550.0 mmol) 1,1,1,3,3,3-hexafluoro-2-propanol was added. The reaction was stirred at room temperature for 18 hours. The organics were washed twice with 500 mL ice cold 2N HCl, once with 500 mL ice-cold saturated NaCl, dried over magnesium sulfate, and then distilled through an 8 inch vigreux to give a colorless oil (bp 97° C., 760.0 Torr), 21.5 g (90.3 mmol, 18.1%). FTIR (neat, capillary) 2980.79, 1782.53, 1654.02, 1383.67, 1363.76, 1309.32, 1296.81, 1252.69, 1196.39, 1098.72, 1021.71, 936.52, 922.78, 905.85, 887.05, 866.80, 773.96, 712.08, 689.17. NMR (CDCl3) δ 6.83-7.23 (1H,m), 5.26-5.86 (1H,m), 4.56-5.23 (2H,m). ##STR22##
3.3 2,2,2-Trifluoro-1-phenylethyl Vinyl Carbonate C11 H9 F3 O3
To a 250 mL round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, thermometer, ice-water bath, and dropping funnel 12.5 g (71.0 mmol) of 1-phenyl-2,2,2-trifluoroethanol, 7.6 g (71.0 mmol) triethylamine and 100 mL ethylether was added. After cooling to 12.5° C.±3° C., 7.6 g (71.0 mmol) of vinyl chloroformate was added while maintaining the temperature. The reaction mixture was filtered to remove triethylamine-hydrochloride. The filtrate was washed twice with 2N HCl, once with distilled water then dried with magnesium sulfate. The solvent was removed on a rotary evaporator and the crude oil was distilled to give a colorless oil (bp 90° C., 4.5 Torr), 12.2 g (49.6 mmol, 69.8%). FTIR (neat, capillary) 1800.23, 1767.51, 1733.45, 1653.30, 1558.52, 1499.70, 1458.25, 1383.98, 1355.92, 1312.00, 1301.65, 1273.65, 1241.93, 1208.55, 1182.79, 1157.35, 1131.65, 1088.2, 1031.72, 998.12, 938.91, 928.82, 913.17, 877.34, 849.19, 776.46, 760.96, 696.97. NMR (CDCl3) δ 7.30 (5H,S), 6.76-7.03 (1H,m), 5.66-6.00 (1H,m), 4.36-9.33 (2H,m). ##STR23##
Part IV--Silicon Containing Monomers 4.0 Trimethylsilylmethyl Vinyl Carbonate C7 H14 O3 Si
To a 250 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, dropping funnel, and thermometer was added 3.8 g (48.0 mmol) of pyridine then 50 mL of chloroform. The mixture was cooled to 12° C.±3° C. with an ice-water bath. Next 5.0 g (48.0 mmol) of trimethylsilyl methanol then 5.1 g (48.0 mmol) of vinyl chloroformate were slowly added so that the temperature was maintained. The cooling bath was removed and the reaction mixture was stirred for one hour. The organics were washed four times with 100 mL 2N HCl, twice with distilled water and then dried over magnesium sulfate. The solvent was removed under reduced pressure to give an oil. The oil was passed through silica gel to give 4.8 g (27.56 mmol, 57.1%) of colorless oil. FTIR (neat, capillary) 2958.37, 1754.67, 1648.09, 1420.24, 1383.80, 1302.02, 1226.95, 1155.20, 1085.49, 944.10, 913.47, 840.69, 779.53, 735.76, 669.81, 668.88. NMR (CDCl3) δ 6.73-7.07 (1H, m), 4.25-4.85 (2H,m), 3.73 (2H,S), 0.00 (9H,S). ##STR24##
4.1 Trimethylsilylethyl Vinyl Carbonate C8 H16 O3 Si
To a 250 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, dropping funnel, and thermometer was added 6.69 g (85.0 mmol) of pyridine then 100 mL of chloroform. The reaction was cooled to 12° C.±3° C. with an ice-water bath. Next 10.0 g (85.0 mmol) of trimethylsilyl ethanol and 9.01 g (85.0 mmol) of vinyl chloroformate were added so that the temperature was maintained. The cooling bath was removed and the reaction mixture was stirred for one hour. The organic phase was washed four times with 100 mL 2N HCl, twice with distilled water then dried over magnesium sulfate. The solvent was removed under reduced pressure to give an oil. The oil was passed through silica gel to give 6.0 g (31.9 mmol, 37.5%) of colorless oil. FTIR (neat, capillary) 2955.56, 1754.65, 1648.64, 1456.39, 1414.83, 1388.75, 1298.51, 1239.97, 1178.60, 1154.64, 1082.23, 1061.84, 1043.84, 1026.67, 943.56, 918.45, 856.41, 832.97, 784.30, 767.03, 694.35, 663.60. NMR (CDCl3) 6.80-7.13 (1H,m), 4.42-4.91 (2H,m), 4.03-4.40 (2H,m), 0.87-1.15 (2H,m), 0.00 (9H,S). ##STR25##
4.2 3-(Trimethylsilyl)propyl Vinyl Carbonate C9 H18 O3 Si
To a 500 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, thermometer, and dropping funnel was added 25.0 g (189 mmol) of trimethylsilyl-3-propanol, 16.45 g (208 mmol) of pyridine and 175 mL of toluene. In one portion, 22.1 g (208 mmol) of vinylchloroformate was added to the reaction mixture. An exotherm to 73° C. was noted. The mixture was stirred for 3 hours at room temperature then at 50° C. for 2 hours then at room temperature for 18 hours. The organic phase was washed with 250 mL 2N HCl then with 250 mL 2N NaOH3 and the organic phase dried with magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil distilled to give a colorless oil (bp 115° C., 35 Torr), 14.7 g (7.27 mmol, 38.5%). FTIR (neat, capillary) 2955.00, 2898.21, 1758.60, 1649.23, 1468.16, 1453.00, 1439.73, 1414.72, 1391.72, 1350.50, 1298.51, 1239.70, 1190.91, 1157.19, 1090.25, 1057.10, 1031.32, 995.02, 944.19, 902.70, 856.58, 833.86, 782.42, 753.39, 691.98. NMR (CDCl3) δ 6.86-7.18 (1H,m), 4.36-4.88 (2H,m), 3.96-4.18 (2H,m), 1.40-1.91 (2H,m), 0.36-0.65 (2H,m), 0.00 (9H,S). ##STR26##
4.3 t-Butyldimethylsiloxyethyl Vinyl Carbonate C11 H22 O4 Si
To a 500 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, thermometer, dropping funnel, and ice-water bath was added 19.8 g (112.3 mmol) of tert-butyldimethylsiloxy ethyleneglycol, 9.8 g (112.3 mmol) of pyridine and 300 mL of ether. After cooling to 10° C.±5° C., 11.96 g (112.3 mmol) of vinyl chloroformate was added dropwise so that the temperature was maintained. A precipitate was formed and the reaction was stirred to room temperature over 16 hours. The organic phase was washed twice with 100 mL 2NHCl, twice with 100 mL 2N NaOH then dried over magnesium sulfate. The solvent was flashed off on a rotary evaporator and the resulting oil was passed through a short chromatography column (silica gel, chloroform) to give 26.9 g (109.2 mmol, 97.2%) of clear liquid. FTIR (neat, capillary) 2955.19, 2929.89, 2857.80, 1759.76, 1651.09, 1743.16, 1463.41, 1386.69, 1373.24, 1362.91, 1339.85, 1298.68, 1239.45, 1159.95, 1136.18, 1110.98, 1084.87, 1026.06, 1005.69, 944.16, 902.24, 869.65, 828.32, 812.16, 774.36, 714.82, 682.03, 661.17. NMR (CDCl3)δ 6.78-7.12 91H,m), 4.35-4.93 (2H,m), 4.03-4.26 (2H,m), 3.60-3.83 (2H,m) 0.82 (9H,S), 0.00 (6H,S). ##STR27##
4.4 3-[Tris(trimethylsiloxy)silyl]propyl vinyl Carbonate C15 H36 O6 Si4
To a 100 mL 3-neck round bottom flask fitted with a magnetic stirrer, dropping funnel, thermometer, and condenser, was added 9.5 g (38.0 mmol) of 3-(trimethoxysilyl) propyl vinylcarbonate and 16.6 g (125.3 mmol) of trimethylsilylacetate. To this reaction mixture was added 3.45ml of a catalyst prepared by mixing 23.8 g (242.7 mmol) of sulfuric acid, 11.6 g (251.8 mmol) of absolute ethanol and 16.5 g (916.0 mmol) of water. The addition took twenty minutes and an 8° C. exotherm was noted. The reaction was allowed to stir at room temperature for 16 hours and was then diluted with 200 mL of chloroform, washed twice with 100 mL 2N NaOH, and dried over magnesium sulfate. The solvent was removed on a rotary evaporator to give 15.3 g of crude oil. Following chromatography (silica gel, 80% Heptane, 20% methylene chloride) the oil was distilled (bp 125° C., 0.8 Torr), 3.5 g (8.24 mmol, 21.7%). FTIR (neat, capillary) 2958.06, 2898.76, 1762.06, 1650.84, 1543.76, 1393.82, 1319.20, 1298.62, 1245.44, 1199.11, 1160.19, 1041.77, 975.14, 946.32, 833.42, 782.42, 753.08, 714.62, 686.73, 658.57. NMR (CDCl3) 6.71-7.10 (1H,m), 4.28-4.83 (2H,m), 3.85-4.08 (2H,m), 1.36-1.85 (2H,m), 0.23-0.50 (2H,m), 0.00 (27H,S). ##STR28##
4.5 3-[Tris(trimethylsiloxy)silyl]propyl Vinyl Carbamate C15 H17 NO5 Si4
To a 100 mL 3-neck round bottom flask fitted with a magnetic stirrer, and dropping funnel was added 5.0 g (14.1 mmol) of 3-amino propyl(trimethylsiloxy)silane, 1.23 g (15.6 mmol) of pyridine and 50 mL of chloroform. Five minutes after adding 1.5 g (14.1 mmol) of vinyl chloroformate, an exotherm resulted. The reaction mixture was checked by gas chromatography after 10 minutes and the starting amine was consumed. The organic phase was washed once with 100 mL 2N HCl then dried with magnesium sulfate. The solvent was removed on a rotary evaporator to afford 5.8 g of crude brown oil. Following chromatography (silica gel, 50% heptane 40% methylenechloride), 5.0 g (11.8 mmol, 83.3%) of colorless oil (bp 130° C., 0.8 Torr) was obtained. FTIR (neat, capillary) 2957.80, 1751.43, 1718.38, 1648.64, 1529.69, 1445.45, 1407.29, 1293.71, 1249.76, 1195.93, 1165.08, 1041.17, 972.34, 951.33, 833.18, 752.97, 715.26, 686.34, 656.45. NMR (CDCl3) 6.91-7.26 (1 H,m), 4.16-4.66 (3H,m), 2.80-3.20 (2H,m), 1.20-1.71 (2H,m), 0.20-0.48 (2H,m), 0.00 (27H,S). ##STR29## 4.6 3-(Vinyloxycarbonylthio)propyl-[tris(trimethylsiloxy) silane]
To a 500 mL 1-neck round bottom flask fitted with a magnetic stirrer and a condenser, was added 33.0 g (123.9 mmol) of 3-(trimethoxysilyl) propyl thio vinyl carbonate and 81.9 g (619.2 mmol) of trimethyl silyacetate. With rapid stirring, 11.3 mL of an acid catalyst prepared by mixing 23.8 g (242.7 mmol) of sulfuric acid, 11.6 g (251.8 mmol) of absolute ethanol and 16.5 g (916.0 mmol) of water) unsaturated. A vigorous exotherm was noted. After 30 minutes the reaction mixture was dissolved in 300 mL chloroform and washed twice with 100 mL of 2N NaOH and dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil was chromatographed (silica gel, chloroform). The product was distilled (160° C., 0.8 Torr) to afford 25.5 g (57.86 mmol, 46.7%) of a colorless oil. FTIR (neat, capillary) 2957.71, 1720.75, 1645.91, 1250.16, 1136.24, 1113.53, 1098.48, 1038.97, 944.04, 912.93, 833.12, 751.61, 717.00, 686.49, 658.44. NMR (CDCl3) δ6.95-7.32 (1H,m), 4.32-4.85 (2H,m), 2.63-2.88 (2H,m), 1.62-1.88 (2H,m), 0.28-0.62 (2H,m), 0.00 (27,S). ##STR30##
4.7 3-[Tris(trimethylsiloxy)silyl]propyl Allyl Carbamate
To a 100 mL 3-neck round bottom microware flask fitted with a magnetic stirrer, condenser, N2 blanket, and dropping funnel, was added 4.8 g (13.57 mmol) of 3-aminopropyltris(trimethylsiloxy) silane, 1.18 g (15.0 mmol) of pyridine and 50 mL of chloroform. To the reaction mixture, 1.65 g (13.6 mmol) of allyl chloroformate was added dropwise resulting in a pink color and an exotherm to near reflux. After 72 hours, the light yellow organic phase was washed once with 100 mL 2N HCl, once with 100 mL 2N NaOH, and then dried with magnesium sulfate. The solvent was removed on a rotary evaporator to afford an oil. Following chromatography (silica gel, CHCl3), the product was distilled (bp 123° C., 0.7 Torr) to give 4.0 g (9.1 mmol, 66.6%) of a colorless oil. FTIR (neat, capillary) 2957.56, 1702.88, 1527.57, 1445.45, 1409.33, 1249.69, 1195.48, 1039.35, 993.11, 928.34, 833.37, 753.07, 717.02, 686.29, 656.22. NMR (CDCl3) δ 5.52-6.13 (1H,m), 4.88-5.34 (2H,m), 4.36-4.80 (3H,m), 2.83-3.22 (2H,m), 1.16-2.00 (2H,m), 0.16-0.47 (2H,m), 0.00 (27H,S). ##STR31##
4.8 1,3-Bis[4-(vinyloxycarbonyloxy)but-1-yl]-tetramethyl disiloxane
To a 500 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, N2 blanket, dropping funnel, and thermometer, was added 10.0 g (35.9 mmol) of 1,3-bis (4-hydroxylbutyl) tetramethylsiloxane, 6.24 g (78.9 mmol) of pyridine and 100 mL of chloroform. Next, 7.64 g (71.8 mmol) of vinyl chloroformate was added to the mixture dropwise producing an exotherm to 54° C. The reaction mixture was cooled to room temperature and stirred for 19 hours. The organic phase was washed twice with 100 mL 2N HCl, twice with 100 mL 2N NaOH, then dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil was chromatographed (silica gel, chloroform) to give 13.22 g (31.6 mmol, 88.1%) of a light yellow oil. FTIR (neat, capillary) 2955.52, 1756.77, 1650.72, 1456.32, 1394.01, 1296.50, 1237.62, 1185.46, 1157.25, 1043.91, 990.80, 944.43, 868.86, 836.27, 781.65, 701.78. NMR (CDCl3) δ 6.80-7.13 (2H,m), 4.37-4.92 (4H,m), 4.00-4.20 (4H,m), 1.55-1.88 (8H,m), 0.33-0.60 (4H,m), 0.00 (12H,S). ##STR32##
4.9 "V2 D25 "
To a 100 mL 1-neck round bottom microware flask fitted with a magnetic stirrer, and a drying tube was added 5.0 g (11.95 mmol) of 1,3-bis(4-vinyl butyl carbonate) tetramethyldisiloxane, 22.15 g (74.7 mmol) of octamethylcyclotetrasiloxane was added. Then 0.679 g (0.452 mmol) of trifluoromethanesulfonic acid was added to the reaction mixture. The reddish reaction mixture was stirred for 24 hours, then 0.38 g (4.52 mmol) of sodium bicarbonate was added which resulted in foaming. After 24 hours a small amount of black solids formed. The reaction mixture was filtered through 20.0 g of activated F20 alumina to give a light yellow oil. The oil was heated at 80° C. at 0.25 Torr for 31/2 hours to remove volatiles, giving 13.4 g (5.90 mmol, 49.4%) of a light yellow oil. FTIR (neat, capillary) 2960.92, 1763.97, 1255.70, 1219.52, 1160.33, 1008.42, 946.68, 864.60, 782.03, 700.22, 686.57, 661.36. NMR (CDCl3) δ 6.83-7.16 (2H,m), 4.36-4.93 (4H,m), 4.00-4.20 (4H,m), 1.16-1.91 (8H,m), 0.32-0.62 (4H,m), 0.000 (168,S). ##STR33##
4.10 -Methyl-N-Tris(trimethylsiloxy)silylpropyl vinyl carbamate
To a 300 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, dropping funnel was added 514.2 g (3.186 mmols) of hexamethyldisilazane. To the reaction flask was added 675 mL of methanol over 30 minutes, when the addition was finished 75.0 g (318.6 mmol) of N-methyl-3-aminopropyltris(trimethoxy) silane was added. To the reaction was added 57.3 g (3.186 mmols) of distilled water. The reaction was stirred for 21 days and monitored by GC. During the 21 days 60.0 g (3.33 mmols) of water, 340 mL methanol, and 228.0 g (1.41 mmols) of hexamethyldisilazane were added. The reaction mixture was reduced to 125.76 g of crude oil by rotary evaporation. The crude material was distilled to give 62.6 g (169.2 mmol, 53.1%) of liquid N-methyl-3-aminopropyltris(trimethylsiloxy)silane bp. 64' 0.125mm Hg. FTIR (neat, capillary) 2957.80, 2899.02, 2790.57, 2361.73, 1471.38, 1443.26, 1412.16, 1343.04, 1249.97, 1218.84, 1187.71, 1083.76, 833.11, 751.60, 715.03, 686.34, 658.34. NMR (CDCl3) 2.20-2.52 (2H,t), 2.24 (3H,s), 1.13-1.66 (2H,m), 0.99 (1H,s), 0.21-0.66 (2H,m), 0.00 (27H,s). ##STR34##
To a 500 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, dropping funnel, thermometer, ice-water bath was added 10.0 g (27.2 mmol) of N-methyl-3aminopropyltris (trimethylsiloxy) silane, 2.37 g (30.0 mmol) pyridine, and 200 mL ether. Next was added 3.19 g (30.0 mmol) vinyl chloroformate so that the temperature remained below 15° C. After stirring for 18 hours the reaction mixture was washed with 100 mL 2N HCl and 100 mL 2N NaOH, and the organic phase was dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil was chromatographed (silica gel, methylene chloride). The product was recovered as an oil and was distilled (94°-98° C., 0.1 mm Hg) to yield 8.0 g (18.3 mmol, 67.2% yield). FTIR (neat, capillary) 2957.78, 2900.92, 1646.60, 1461.07, 1453.17, 1424.97, 1404.46, 1376.48, 1345.30, 1308.70, 1290.62, 1250.02, 1180.15, 1151.93, 1097.66, 1039.05, 952.11, 928.39, 833.42, 787.00, 753.10, 715.30. NMR (2H,t), 2.78 (3H,s), 1.20-1.70 (2H,m), 0.14-0.41 (2H,m), 0.00 (27H,s). ##STR35##
4.11 N-Vinyloxycarbonyl-N'-[tris(trimethylsiloxy)silylpropyl]piperazine
To a 500 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, dropping funnel, thermometer, oil bath was added 5.0 g (58.0 mmol) of piperazine and 230 mL o-xylene. The reaction mixture was heated to 125°±5° and 11.0 g (29.0 mmol) of 3-chloropropyltris(trimethylsiloxy) silane was added dropwise. The reaction was heated for 48 hours, cooled, and dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil was distilled to give the product 4.5 g (10.7 mmol, 18.4% yield). FTIR (neat, capillary) 3272.01, 2955.61, 2900.63, 2805.76, 2764.47, 2363.11, 1445.48, 1411.45, 1368.66, 1342.63, 1319.87, 1249.85, 1188.87, 1144.26, 1039.34, 833.42, 751.53, 712.61, 686.39, 656.40. NMR (CDCl3) 3.60-3.93 (4H,m), 2.06-2.43 (6H,m), 1.66 (1H,s), 0.97-1.66 (2H,m), 0.12-0.40 (2H,m), 0.00 (27H,s). ##STR36##
To a 250 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, dropping funnel, thermometer and ice-water bath was added 5.0 g (11.8 mmol) of 3-tris(trimethylsiloxy)silylpropyl piperazine, 0.98 g (12.4 mmol) pyridine and 100 mL ether. To the reaction mixture was added 1.32 g (12.4 mmol) vinyl chloroformate so that the temperature remained below 15°. After stirring for 18 hours the reaction mixture was washed with 100 mL 2N HCl, 100 mL 2N NaOH and the organic phase was dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil was chromatographed (silica gel, methylene chloride). The product was recovered as an oil 4.0 g (8.1 mmol, 68.8% yield). FTIR (neat, capillary) 2957.40, 2900.69, 2808.30, 2770.50, 1646.32, 1460.48, 1429.87, 1373.46, 1353.45, 1334.61, 1291.27, 1249.73, 1227.01, 1187.92, 1152.02, 1100.89, 1039.50, 1000.33, 952.03, 833.45, 752.98, 712.79, 686.52, 656.44. NMR (CDCl3) 6.89-7.30 (1H,dd), 4.28- 4.76 (2H,m), 3.30-3.60 (2H,m), 2.19-2.40 (2H,m), 1.21-1.63 (2H,m), 0.17-0.63 (2H,m), 0.00 (27H,s). ##STR37##
4.12 2,2-Dimethyl N,N-bis(vinyloxycarbonyl)-1,3-propandiamine C11 H18 N2 O4
To a 250 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, thermometer, nitrogen blanket, dropping funnel, and ice-water bath was added 15.5 g (196.0 mmol) of pyridine, 100 mL of chloroform, 10.0 g (98.0 mmol) of 2,2-dimethyl-1,3-diamino propane. After cooling to 12.5° C.±2.5° C., 20.8 g (196.0 mmol) of vinyl chloroformate was added so that the temperature was maintained. When the addition was completed, the reaction was stirred at room temperature for one hour. The organic phase was washed twice with 100 mL 2N HCl, once with distilled water, twice with 2N NaOH, once with distilled water, once with 100 mL 2N HCl, once with distilled water then was dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting solid was chromatographed (silica gel, ethyl acetate) to afford a white solid (mp 92°-98° C.), 14.4 g (59.5 mmol, 60.7%). FTIR 3356.25, 3330.18, 3101.77, 3091.71, 3047.38, 2967.99, 2962.39, 2932.08, 2875.70, 1733.54, 1725.58, 1710.82, 1676.99, 1649.18, 1527.92, 1473.90, 1458.90, 1440.71, 1394.41, 1371.29, 1360.72, 1299.03, 1257.64, 1244.48, 1201.55, 1157.95, 1106.46, 1062.40, 1025.93, 998.01, 979.97, 961.45, 951.57, 876.82, 866.36, 774.00, 720.42, 671.33. NMR (CDCl3) 6.93-7.27 (2H,m), 5.46-5.93 (2H,s), 4.428-4.86 (4H,m), 2.83-3.10 (4H,d), 0.90 (6H,s). ##STR38##
4.13 N-(2-ethyl vinyl carbonate)-3-aminopropyltris(trimethylsiloxy) silane
To a 250 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, dropping funnel, oil bath, thermometer was added 104.3 g (1021.0 mmol) 2,2-dimethyl-1,3-diaminopropane, 29.3 g (79.0 mmol) of 3-chloropropyltris (trimethylsiloxy) silane. The reaction was heated at 120° C. for 3 hours and stirred to room temperature for 24 hours. The reaction mixture was washed with 100 mL 2N NaOH then the organics were dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil distilled to give 23.8 g (54.3 mmol, 68.6% yield) bp 100° C. FTIR (neat, capillary) 2955.72, 2807.97, 2361.44, 1614.95, 1463.73, 1409.81, 1362.71, 1249.98, 1185.85, 1039.44, 833.64, 753.04, 714.78, 686.41, 657.85. NMR (CDCl3) 2.25-2.56 (6H,m), 1.19-1.63 (2H,m), 1.06 (3H,s), 0.78 (6H,s), 0.07-0.45 (2H,m), 0.00 (27H,s).
To a 250 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, dropping funnel, ice-water bath, thermometer was added 6.3 g (15.8 mmol) N-(2-hydroxyethyl)-3-aminopropyltris(trimethylsiloxy) silane, 1.37 g (17.4 mmol) of pyridine, 100 mL ether. To the reaction mixture was added 1.68 g (15.8 mmol) of vinyl chrloroformate so that the temperature remained below 5° C.
After stirring to room temperature for 24 hours the reaction mixture was washed with 100 mL 2N HCl then 100 mL 2N NaOH then the organics were dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil, 4.3 g, chromatographed (silica gel, ethyl acetate 20% methylene chloride 80%). The oil recovered weighed 2.99 g (6.4 mmol, 25.4% yield). FTIR (neat, capillary) 2957.62, 2899.00, 1720.60, 1702.33, 1648.16 1470.55, 1420.23, 1373.91, 1291.12, 1249.88, 1196.62, 1152.74, 1039.27, 951.52, 833.44, 753.18, 715.26, 686.53, 658.78. NMR (CDCl3) 6.85-7.20 (1H,dd), 4.20-4.69 (2H,m), 3.36-3.71 (2H,bd), 3.00-3.36 (4H,m), 1.00-1.65 (2H,m), 0.09-0.40 (2H,m), 0.00 (27H,s).
4.14 3-[Tris(trimethylsiloxy)silyl]propylaminoethyl vinyl carbonate
To a 500 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, oil bath and thermometer was added 100 mL ethanolamine, 20.0 g (53.5 mmol) of 3-chloropropyltris (trimethylsiloxy) silane. The reaction was heated at 120° C. for 4 hours then at 140° C. for 1 hour. The reaction was cooled then diluted with 400 mL distilled water then extracted twice with 100 mL ether. The combined organics were dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil, 23.0 g, chromatographed (silica gel, gradient from 98.75% CH2 Cl2, 1.25% EtOAc to 100% MeOH) to give 6.6 g (16.6 mmol, 31.1%) FTIR (neat, capillary) 2957.55, 2898.62, 2834.28, 1453.19, 1411.46, 1249.92, 1191.11, 1039.00, 833.12, 751.49, 714.58, 686.18, 657.92. NMR (CDCl3) 3.09-3.68 (4H,m), 2.25-2.43 (4H,m), 1.17-1.71 (2H,m), 0.07-0.47 (2H,m), 0.00 (27H,s).
To a 250 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, dropping funnel, ice-water bath and thermometer was added 6.3 g (15.8 mmol) N-(2-hydroxyethyl)-3-aminopropyltris(trimethylsiloxy) silane, 1.37 g (17.4 mmol) of pyridine and 100 mL ether. To the reaction mixture was added 1.68 g (15.8 mmol) of vinyl chloroformate so that the temperature remained below 5° C. After stirring at room temperature for 24 hours the reaction mixture was washed with 100 mL 2N HCl, 100 mL 2N NaOH and the organic phase was dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil, 4.3 g, chromatographed (silica gel, ethyl acetate 20% methylene chloride 80%). The oil recovered weighed 2.99 g (6.4 mmol, 25.4% yield). FTIR (neat, capillary) 2957.62, 2899.00, 1720.60, 1702.33, 1648.16, 1470.55, 1420.23, 1373.91, 1291.12, 1249.88, 1196.62, 1152.74, 1039.27, 951.52, 833.44, 753.18, 715.26, 686.53, 658.78. NMR (CDCl.sub. 3) 6.85-7.20 (1H,dd), 4.20-4.69 (2H,m), 3.36-3.71 (2H,bd), 3.00-3.36 (4H,m), 1.00-1.65 (2H,m), 0.09-0.40 (2H,m), 0.00 (27H,s). ##STR39##
PART V--CYCLOALKYL AND CYCLOARYL CONTAINING MONOMERS 5.0 4-s-Butylphenyl Vinyl Carbonate C13 H16 O3
To a 250 mL 1-neck round bottom flask fitted with a magnetic stirrer, dropping funnel, ice-bath was added 10.0 g (66.6 mmol) of 4-s-butylphenol, 5.8 g (73.3 mmol) of pyridine and 100 mL of chloroform. To the stirred solution 7.08 g (66.6 mmol) of vinyl chloroformate was added over 5 minutes and the reaction mixture stirred for 30 minutes until pyridine hydrogen chloride precipitated. The organic phase was washed twice with 100 mL of 2NHCl, dried over magnesium sulfate and the solvent removed on a rotary evaporator to give an oil. Following chromatography (silica gel, toluene), 9.6 g (43.6 mmol, 65.4%) of colorless oil was obtained. FTIR (neat, capillary) 2962.40, 2929.59, 2875.00, 1770.07, 1650.57, 1507.20, 1456.70, 1378.92, 1298.73, 1218.82, 1201.06, 1172.56, 1128.61, 1052.11, 1016.02, 997.93, 941.57, 913.17, 874.55, 835.99, 771.64, 730.98, 707.91, 696.57. NMR (CDCl3) 7.08 (4H,S), 6.90-7.23 (1H,m), 4.50-5.10 (2H,m), 2.31-2.78 (1 H,m), 1.33-1.81 (2H,m), 1.16-1.23 (2H,d), 0.68-1.00 (3H,m). ##STR40##
5.1 4-t-Butylphenyl Vinyl Carbamate C13 H17 NO2
To a 250 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, thermometer, dropping funnel, ice water bath was added 7.1 g (80.0 mmol) of pyridine, 87.5 mL of chloroform, 12.0 g (80.0 mmol) of 4-t-butylaniline. After cooling to 12.5° C., 8.6 g (80.0 mmol) of vinyl chloroformate was added so that the temperature was maintained. When the addition is completed, reaction was stirred at room temperature for 3 hours. The organic phase was washed twice with 100 mL 2N HCl, once with distilled water, twice with 2N NaOH, once with distilled water, once with 100 mL 2NHCl, once with distilled water, and dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting solid was chromatographed (silica gel, CHCl3) to give a white solid (mp 83°-85° C.) 14.0 g (65.1 mmol, 81.4%). FTIR (KBr) 3317.67, 3248.14, 2960.58, 2903.46, 2868.29, 1718.64, 1649.04, 1615.15, 1600.07, 1543.48, 1476.36, 1460.81, 1412.07, 1363.76, 1324.04, 1301.85, 1270.05, 1244.76, 1152.47, 1123.96, 1113.56, 1064.50, 1016.24, 954.13, 858.83, 828.57, 744.72, 704.65, 681.65. NMR (CDCl3) 7.27 (4H,S), 7.03-7.40 (1H,m), 6.64-6.82 (1H,S), 4.37-4.90 (2H,m), 1.27 (9H,S). ##STR41##
5.2 4-t-Butylcyclohexyl Vinyl Carbonate
To a 250 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, thermometer, ice water bath, dropping funnel, was added 10.0 g (64.0 mmol) of 4-t-butylcyclohexanol, 5.6 g (70.3 mmol) of pyridine and 100 mL of chloroform. The reaction mixture was cooled to less than 10° C. and 6.8 g (64.0 mmol) of vinyl chloroformate was added so that the temperature remained below 15° C. The reaction mixture was stirred at room temperature for 20 hours, then washed with 100 mL 2N HCl, 100 mL distilled water and dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil chromatographed (silica gel, methylene chloride) to afford 7.3 g (32.28 mmol, 50.4%) of an oil. FTIR (neat, capillary) 2949.85, 2867.24, 1753.81, 1650.71, 1478.96, 1468.77, 1452.57, 1393.73, 1385.90, 1361.15, 1325.03, 1296.75, 1246.94, 1193.82, 1178.29, 1155.10, 1118.52, 1106.53, 1083.32, 1041.01, 1016.58, 1005.94, 946.14, 923.71, 902.63, 867.23, 843.74, 804.43, 783.98, 758.83, 696.74, 668.14. NMR (CDCl3) δ 6.86-7.22 (1H,m), 4.37-4.97 (2H,m), 1.00-2.30 (10H,m), 0.85 (9H,S). ##STR42##
PART VI--ADDITIONAL MONOMER SYNTHESIS 6.0 1-Adamantane vinyl carbonate
To a 500 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, dropping funnel, ice-saltwater bath and thermometer was added 17.6 g (116.0 mmol) of 1-adamantanol, 9.3 g (117.0 mmol) of pyridine and 200 mL chloroform. To the reaction misture was added 12.5 g (117.0 mmol) of vinyl chloroformate so that the temperature remained below 10 degrees centigrade. After stirring at room temperature for 18 hours the reaction mixture was washed with 100 mL 2N HCl and 100 mL 2N NaOH and the organic phase was dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting white solid chromatographed (silica gel, chloroform). The white solid recovered 19.3 g (86.4 mmol, 74.5% yield) melting point 35-37 degrees centigrade. FTIR (KBr) 3430.92, 2914.51, 2855.03, 1756.33, 1651.33, 1458.19, 1321.61, 1312.23, 1296.45, 1246.83, 1160.25, 1103.75, 1082.53, 1041.68, 964.82, 892.90, 784.44. NMR (CDCl3) 6.81-7.20 (1H,dd), 4.33-4.96 (2H,m), 1.50-2.40 (15H,m) ##STR43##
6.1 1-Adamantanemethyl Vinyl Carbonate
To a 500 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, dropping funnel, ice-saltwater bath and thermometer was added 10.0 g (60.0 mmol) of 1-adamantanmethanol, 4.8 g (60.0 mmol) of pyridine and 150 mL chloroform. To the reaction mixture was added 6.4 g (60.0 mmol) of vinyl chloroformate so that the temperature remained below 10° C. After stirring at room temperature for 18 hours the reaction mixture was washed with 100 mL 2N HCl and 100 mL 2N NaOH and the organic phase was dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting solid chromatographed (silica gel, chloroform). The white solid recovered totaled 12.0 (50.8 mmol, 84.5% yield), melting point 44°-45° C. FTIR (KBr) 3423.04, 2906.49, 2580.27, 1759.74, 1649.15, 1391.84, 1322.44, 1260.77, 1231.42, 1190.53, 1147.22, 1087.78, 982.05, 951.64, 938.71, 889.75. NMR (CDCl3) 6.89-7.27 (1H,dd), 4.40-5.05 (2H,m), 3.75 (2H,s), 1.43-2.13 (15H,m) ##STR44##
6.2 1-Adamantane Vinyl Carbonate)
To a 500 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, dropping funnel, ice-saltwater bath, thermometer was added 5.0 g (27.7 mmol) of 1-adamanthanethanol, 2.2 g (27.7 mmol) of pyridine and 150 mL chloroform. To the reaction mixture was added 2.95 g (28.0 mmol) of vinyl chloroformate so that the temperature remained below 10 degrees centigrade. After stirring at room temperature for 18 hours the reaction mixture was washed with 100 mL 2N HCl and 100 mL 2N NaOH and the organic phase dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil chromatographed (silica gel, chloroform). The oil recovered totaled 27.6 g (10.8 mmol, 38.5% yield). FTIR (neat, capillary) 2898.57, 2846.95, 1756.14, 1648.61, 1450.70, 1398.71, 1312.71, 1296.74, 1240.05, 1155.26, 1106.22, 1097.88, 1090.63, 975.27, 944.26, 933.77, 923.00, 900.75, 867.0, 782.34. NMR (CDCl3) 6.86-7.20 (1H,dd), 4.38-4.92 (2H,m), 4.072-4.37 (2H,t), 1.33-2.18 (17H,m). ##STR45##
6.3 1-Adamantane Vinyl Carbamate
To a 500 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, dropping funnel, ice-saltwater bath and thermometer was added 10.0 g (66.0 mmol) of 1-adamantaneamine, 5.5 g (70.0 mmol) of pyridine and 150 mL chloroform. To the reaction mixture was added 7.4 g (70.0 mmol) of vinyl chloroformate so that the temperature remained below 10° C. After stirring at room temperature for 18 hours the reaction mixture was washed with 100 mL 2N HCl and 100 mL 2N NaOH and the organic phase was dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting solid was chromatographed (silica gel, chloroform). The tan solid totaled 5.2 g (23.5 mmol, 35.6% yield). FTIR (KBr) 3435.97, 3341.23, 2919.85, 2906.82, 2852.95, 1738.71, 1718.23, 1648.31, 1522.76, 1362.95, 1347.11, 1296.03, 1280.55, 1229.09, 1188.08, 1173.23, 1131.46, 1054.34, 1044.05, 952.14, 849.30. NMR (CDCl3) 6.94-7.33 (1H,dd), 4.25-4.88 (3H,m), 1.56-2.26 (15H,m). ##STR46##
6.4 N-(2-adamantyl)-0-2-Vinyloxycarbonylaminoethyl Carbamate
To a 250 mL 3-neck round bottom flask that was fitted with a magnetic stirrer, condenser, nitrogen blanket, was added 6.33 g (41.8 mmol) of 2-adamantamine, 20.7 g (41.8 mmol) of 20% phosgene in toluene and 90 mL of dry toluene. By means of a heating mantle the reaction was refluxed for eight hours, then allowed to cool to room temperature over night. To the reaction mixture was added 5.0 g (38.0 mmol) of 2-hydroxyethyl vinyl carbamate in 100 mL of dry toluene. The reaction mixture was refluxed for eight hours then cooled to room temperature and the product was filtered and dried to give 5.4 g (17.5 mmol, 46.1% yield). FTIR (Kbr) 3320.53, 2911.77, 2854.81, 2708.48, 2622.82, 2587.66, 2530.60, 2062.48, 1710.68, 1648.47, 1625.62, 1604.50, 1594.43, 1514.68, 1476.34, 1453.03, 1403.83, 1363.71, 1348.91, 1323.96, 1311.36, 1295.64, 1250.12, 1185.17, 1111.58, 1056.19, 1012.80, 974.49, 949.05, 913.42, 863.76, 810.32, 769.55, 730.73, 694.94, 649.43. NMR (CDCl3) 8.54-7.54 (2H,bs), 7.33-6.96 ( 1H,q), 4.85-4.26 (2H,m), 3.79-3.20 (4H,m), 2.33-1.33 (15H,m).
6.5 N,N-dimethyl vinyl carbamate
To a 100 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, thermometer, fritted gas delivery tube, methanol-dry ice-bath was added 23.8 g (223.4 mmol) of vinyl chloroformate, 650 mL of ether. When the reaction mixture was at -65° C. a stream of dimethylamine was added for 30 minutes. By gas chromatography the vinyl chloroformate was consumed. The reaction was stirred to room temperature over night. The organics were washed with 500 mL distilled water then dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil (20.3 g) distilled to give 9.3 g (80.8 mmol, 36.2%). FTIR (neat, capillary) 3091.32, 2932.23, 1712.80, 1645.80, 1520.23, 1488.98, 1445.42, 1396.96, 1370.59, 1291.08, 1275.79, 1165.47, 1144.50, 1082.71, 1042.05, 951.61, 923.80, 859.37, 835.80, 758.66, 699.77, 681.97. NMR (CDCl3) 7.02-7.33 (1H,q), 4.25-4.79 (2H,m), 2.92 (6H,s).
6.6 N,N-diethyl vinyl carbamate
To a 250 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, dropping funnel was added 3.2 g (26.25 mmol) of potassium t-butoxide, 50 mL anhydrous tetradhydrofuran. After the solid was dissolved 5.6 g (25.0 mmol) of N,N-diethyl 2-bromoethyl carbamate was added and the reaction stirred for 30 minutes. To the reaction was added 100 mL distilled water then the solvent was removed on the rotary evaporator. The residue was taken up in ether and filtered then distilled to give an oil 2.57 g (17.9 mmol, 71.8% yield). FTIR (neat, capillary) 2976.21, 2936.84, 2878.45, 1710.65, 1645.97, 1522.34, 1474.22, 1458.46, 1422.71, 1379.10, 1366.22, 1350.76, 1316.26, 1290.78, 1269.99, 1224.27, 1160.58, 1143.97, 1097.99, 1085.35, 1077.10, 1059.36, 987.36, 951.76, 858.41, 820.83, 781.32, 760.94, 699.54. NMR (CDCl3) 7.07-7.39 (1H,q), 4.31-4.89 (2H,m), 3.12-3.46 (4H,q), 1.05-1.31 (6H,t).
ADDITIONAL INTERMEDIATES 2-Bromoethyl vinyl carbonate
To a 1 L 4-neck round bottom flask fitted with a mechanical stirrer, thermometer, condenser, dropping funnel and nitrogen blanket was added 31.2 g (250 mmol) of 2-bromoethanol, 21.4 g (270 mmol) of pyridine and 400 mL of ether. The reaction was cooled with an ice-water bath to less than 10° C. then 28.8 g (270 mmol) of vinyl chloroformate was added so that the temperature remained below 10° C. The reaction was stirred to room temperature for 27 hours. Then the organics were washed twice with 2N HCl, twice with 2N NaOH, then dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil was passed through a short silica gel column, to remove most of the color, to give 38.4 g (197 mmol, 78.8% yield). FTIR (neat, capillary) 3672.76, 3469.03, 3096.75, 2972.97, 2155.40, 2057.14, 1754.37, 1648.44, 1563.96, 1455.87, 1443.36, 1427.17, 1388.17, 1299.17, 1285.60, 1244.29, 1221.29, 1152.23, 1095.86, 1049.38, 988.10, 940.93, 897.08, 875.78, 828.81, 778.74, 738.01, 694.54, 663.28. NMR (CDCl3) 6.85-7.23 (1H,q), 4.40-5.10 (4H,m), 3.42-3.59 (2H,t).
N,N-diethyl-2-bromoethyl carbamate
To a 500 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, thermometer, dropping funnel was added 19.3 g (263.8 mmol) of diethylamine and 250 mL of dry toluene. To the reaction mixture was added 24.7 g (131.9 mmol) of 2-bromoethyl chloroformate. An exotherm to 40° C. was noted along with the formation of a precipitate. After 1 hour at 70° C. the organics were washed with 2N HCl then dried over magnesium sulfate. The solvent was removed on the rotary evaporator and the resulting oil distilled to give 6.5 g (29.0 mmol, 22% yield). FTIR (neat, capillary) 2973.85, 2934.58, 2875.90, 1692.95, 1478.36, 1458.21, 1422.49, 1379.09, 1365.61, 1350.53, 1314.77, 1267.60, 1224.49, 1164.67, 1093.11, 1075.29, 1003.67, 962.05, 948.43, 766.15, 647.29. NMR (CDCl3) 4.23-4.49 (2H,t), 3.49-3.66 (2H,t), 3.10-3.52 (4H,q), 1.04-1.33 (6H,t).
PREFERRED CROSSLINKERS PART VII--SYNTHESIS OF SIMPLE CROSSLINKERS 7.0 Propargyl Vinyl Carbonate C6 H6 O3
To a 500 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, thermometer, dropping funnel, and cooled within ice water bath was added 20.0 g (356.8 mmol) of propargyl alcohol, 31.0 g (356.8 mmol) of pyridine, 100 mL of acetonitrile and 250 mL of ether. After cooling to 5° C., 38.0 g (356.8 mmol) of vinyl chloroformate was added so that the temperature stayed below 10° C. The organic phase was washed with 400 mL 2NHCl, 200 mL 2N NaOH and dried with magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil was passed through an 8 gram silica gel pad to afford a colorless oil 36.0 g (285.5 mmol, 80%). FTIR (neat, capillary) 3297.26, 1757.06, 1652.22, 1439.81, 1386.65, 1299.36, 1152.11, 1087.82, 1016.04, 964.84, 941.81, 915.98, 879.03, 779.08, 676.61, 663.07, 656.20. NMR (CDCl3) 6.83-7.17 (1H,m), 4.43-5.05 (2H,m), 4.63-4.87 (2H,m), 2.46-2.60 (1H,m). ##STR47##
PART VIII--OXYALKYLENE BRIDGED CROSSLINKERS 8.0 1,2-bis-(Vinyloxycarbonyloxy)ethane
To a 100 mL 3-neck round bottom microware flask fitted with a magnetic stirrer, condenser, N2 blanket, and dropping funnel was added 5.0 g (81.6 mmol) of ethylene glycol, 12.8 g (163.0 mmol) of pyridine and 50 mL of chloroform. To the reaction mixture, 17.38 g (163.2 mmol) of vinyl chloroformate was added over 5 minutes. The black reaction mixture was stirred at room temperature for 72 hours. The reaction mixture was washed once with 100 mL 2N HCl, once with 100 mL 2N NaOH and then dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil chromatographed (silica gel, chloroform). The product was distilled (110° C., 5 Torr) to afford 6.5 g (32.2 mmol, 39.4%) of a colorless oil. FTIR (neat, capillary) 1752.03, 1648.58, 1455.73, 1445.68, 1406.42, 1386.28, 1373.53, 1345.23, 1301.17, 1268.47, 1221.46, 1152.52, 1080.66, 1028.57, 1007.91, 941.86, 903.05, 866.96, 777.05, 696.37. NMR (CDCl3)δ 6.85-7.18 (2H,m), 4.52-5.04 (4H,m), 4.40 (4H,S). ##STR48##
8.1 α,ω-bis-(Vinyloxycarbonyl)triethyleneglycol C12 H18 O8
To a 500 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, thermometer, nitrogen blanket, and dropping funnel was added 10.0 g (66.6 mmol) of triethyleneglycol, 5.79 g (73.3 mmol) of pyridine and 100 mL of chloroform. Next, was added 7.80 g (73.3 mmol) of vinyl chloroformate, an exotherm was noted and the reaction mixture was stirred at room temperature for 18 hours. The organic phase was washed twice with 100 mL 2N HCl, twice with 100 mL 2N NaOH and dried with magnesium sulfate. The solvent was removed on a rotary evaporator to give an oil that was chromatographed (silica gel, CHCl3) to afford an oil 2.6 g (8.9 mmol, 13.5%). FTIR (neat, capillary) 2959.95, 2877.99, 1752.00, 1648.22, 1453.36, 1388.35, 1368.46, 1355.89, 1337.65, 1298.80, 1234.17, 1152.82, 1082.40, 1023.62, 943.56, 902.67, 869.75, 779.08, 697.03. NMR (CDCl3) 6.98-7.63 (2H,m), 4.40-5.03 (4H,m), 4.20-4.40 (4H,m), 3.60-3.80 (48,m). ##STR49##
8.2 α,ω-bis-(Vinyloxycarbonyl)polyethylene Glycol C26 H46 O15
To a 500 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, thermometer, and dropping funnel was added 10.0 g (16.6 mmol) of poly(ethyleneglycol), 3.2 g (36.5 mmol) of pyridine and 200 mL of chloroform. Next, 3.9 g (36.5 mmol) of vinyl chloroformate in 5 mL chloroform was added. A slight exotherm to 30° C. was noted. The reaction was stirred at room temperature for 48 hours and the organic phase washed twice with 100 mL 2N HCl, twice with 100 mL 2NaOH, and dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil was chromatographed (silica gel, CHCl3) to afford 1.3 g (2.17 mmol, 13.0%) of colorless oil. FTIR (neat, capillary) 2867.87, 1756.21, 1648.17, 1455.18, 1388.46, 1350.26, 1298.44, 1247.57, 1083.45, 1026.37, 944.30, 871.74, 781.69. NMR (CDCl3) 6.85-7.17 (2H,m), 4.34-5.00 (4H,m), 3.60-4.35 (40H,m). ##STR50##
8.3 α,ω-bis(Vinyloxycarbonyl) Polypropylene Glycol (mw approx. 1000)
To a 500 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, dropping funnel, ice-saltwater bath and thermometer was added 20.0 g (47.0 mmol) polypropylene glycol (mw 1000) 7.6 g (96.0 mmol) of pyridine and 200 mL chloroform. To the reaction mixture was added 10.2 g (96.0 mmol) of vinyl chloroformate so that the temperature remained below 10 degrees centigrade. After stirring at room temperature for 48 hours the reaction mixture was washed with 100 mL 2N HCl, 100 mL 2N NaOH and the organic phase dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting oil chromatographed (short column silica gel, chlorform). The oil recovered weighed 14.6 g (25.9 mmol, 55.0% yield). FTIR (neat, capillary) 3096.15, 2973.01, 2934.02, 2870.93, 2335.49, 1754.56, 1648.30, 1568.82, 1453.53, 1375.64, 1349.76, 1296.84, 1249.99, 1152.61, 1083.39, 1051.95, 1018.85, 944.06, 923.43, 908.46, 868.85, 783.82, 697.48, 668.50. NMR (CDCl3) 6.86-7.23 (2 H,dd), 4.61-5.06 (4H,m), 3.33-3.76 (21H,m), 1.03-1.43 (21H,m). ##STR51## Where N is an average value that gives the polypropylene glycol moiety an average molecular weight of about 1000.
8.4 α,ω-Bis(Vinyloxycarbonylpolyethylene Glycol mw approx. 1000
To a 500 mL 3-neck round bottom flask fitted with a mechanical stirrer, condenser, nitrogen blanket, dropping funnel, ice-saltwater bath and thermometer was added 20.0 g (20.0 mmol) polyethylene glycol (mw 1000), 3.5 g (44.0 mmol) of pyridine, 200 mL chloroform. To the reaction mixture was added 4.7 g (44.0 mmol) of vinyl chloroformate so that the temperature remained below 10° C. After stirring at room temperature for 48 hours the reaction mixture was washed with 100 mL 2N HCl and 100 mL 2N NaOH and the organic phase was dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting low melting solid weighed 18.0 g (16.0 mmol, 79.9% yield). FTIR (neat, capillary) 3477.73, 2868.36, 2360.96, 1959.64, 1758.88, 1725.44, 1648.24, 1465.99, 1453.61, 1388.65, 1358.03, 1342.58, 1298.64, 1255.02, 1142.06, 1100.49, 1060.10, 944.47, 872.48, 841.08, 782.12, 756.09, 730.85, 699.44. NMR (CDCl3) 6.83-7.20 (2H,dd), 4.40-4.96 ( 4H,m), 3.58 (88H,s). ##STR52## Where N is an average value that gives the polyethylene glycol moiety an average molecular weight of about 1000.
PART IX--SYNTHESIS OF BRANCHED ALKYL BRIDGED CROSSLINKERS 9.0 2,2-Dimethyl-1,3-bis-(Vinyloxycarbonyloxy)propane
To a 500 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, thermometer, ice-water bath, and dropping funnel was added 20.0 g (192.0 mmol) of 2,2-dimethyl-1,3-propaneidiol, 16.7 g (211.2 mmol) of pyridine and 200 mL of chloroform. To the reaction mixture was added 20.45 g (192.0 mmol) of vinyl chloroformate was added over 20 minutes. After 1 hour, the reaction was allowed to warm to room temperature for 20 hours. The organic phase was washed twice with 100 mL 2N HCl, twice with 100 mL 2N NaOH and then dried over magnesium sulfate. The solvent was removed on a rotary evaporator to afford an oil. Following chromatography (silica gel, 80% heptane, 20% methylene chloride) 6.4 g (26.2 mmol, 13.6%) of colorless oil was obtained. FTIR (neat, capillary) 2970.57, 1754.14, 1650.67, 1566.46, 1540.34, 1476.77, 1406.71, 1386.46, 1375.68, 1299.22, 1227.23, 1152.73, 1085.68, 1054.54, 1020.91, 961.81, 941.38, 871.66, 779.08, 696.42. NMR (CDCl.sub. 3) δ 6.80-7.18 (1H,m), 4.45-4.98 (2H,m), 3.98 (4H,S), 1.04 (6H,S). ##STR53##
9.1 N,O-bis-(Vinyloxycarbonyl1ethanolamine C8 H11 O5
To a 250 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, thermometer, nitrogen blanket, dropping funnel and an ice-water bath was added 27.2 g (344.0 mmol) of pyridine, 10.0 g (164.0 mmol) of aminoethanol and 100 mL of ether. Next, 36.7 g (344.0 mmol) of vinyl chloroformate was added so that the temperature remained below 15° C. The reaction was stirred at room temperature for 72 hours and 50 mL acetonitrile and 5.0 g (50.0 mmol) of vinyl chloroformate were added. The mixture was stirred 24 hours and the organic phase washed thrice with 100 mL 2N HCl, twice with 100 mL distilled water, thrice with 100 mL 2N NaOH, twice with 100 mL distilled water, once with 100 mL 2N HCl, once with 100 mL distilled water and then dried with magnesium sulfate. The solvent was removed on a rotary evaporator to give a solid which was chromatographed (silica gel, CHCl3) recrystallized (toluene: heptane, 2:8) to afford a white solid (mp 45°-46° C.), 9.4 g (46.7 mmol, 27.2%). FTIR (KBr) 3507.66, 3318.44, 3124.82, 3047.20, 2998.82, 2967.94, 2952.25, 2849.60, 2754.60, 1761.20, 1734.02, 1707.59, 1679.14, 1650.91, 1540.99, 1465.42, 1433.12, 1399.05, 1383.81, 1368.76, 1306.65, 1275.59, 1173.28, 1156.81, 1116.49, 1088.57, 1033.54, 1008.11, 964.70, 948.83, 928.54, 902.88, 887.36, 877.39, 850.91, 782.45, 699.45, 699.43. NMR (CDCl3) 6.83-7.32 (1H,m), 5.06-5.43 (1H,S), 4.37-5.06 (2H,m), 4.27-4.36 (2H,m), 3.30-3.70 (2H,m). ##STR54##
9.2 2,2-Dimethyl-N,N-bis(vinyloxycarbonyl)-1,3-propanediamine C11 H18 N2 O4
To a 250 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, thermometer, nitrogen blanket, dropping funnel, and ice-water bath was added 15.5 g (196.0 mmol) of pyridine, 100 mL of chloroform and 10.0 g (98.0 mmol) of 2,2-dimethyl-1,3-diaminopropane. After cooling to 12.5° C.±2.5° C., 20.8 g (196.0 mmol) of vinyl chloroformate was added so that the temperature was maintained. When the addition was complete, the reaction was stirred at room temperature one hour. The organic phase was washed twice with 100 mL 2N HCl, once with distilled water, twice with 2N NaOH, once with distilled water, once with 100 mL 2N HCl, once with distilled water and then dried over magnesium sulfate. The solvent was removed on a rotary evaporator and the resulting solid was chromatographed (silica gel, ethyl acetate) to afford a white solid (mp 92°-98° C.), 14.4 g (59.5 mmol, 60.7%). FTIR 3356.25, 3330.18, 3101.77, 3091.71, 3047.38, 2967.99, 2962.39, 2932.08, 2875.70, 1733.54, 1725.58, 1710.82, 1676.99, 1649.18, 1527.92, 1473.90, 1458.90, 1440.71, 1394.41, 1371.29, 1360.72, 1299.03, 1257.64, 1244.48, 1201.55, 1157.95, 1106.46, 1062.40, 1025.93, 998.01, 979.97, 961.45, 951.57, 876.82, 866.36, 774.00, 720.42, 671.33. NMR (CDCl3) 6.93-7.27 (2H,m), 5.46-5.93 (2H,S), 4.428-4.86 (4H,m), 2.83-3.10 (4H,d), 0.90 (6H,S). ##STR55##
9.3 1,6-divinylhexyldicarbamate
To a 500 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, dropping funnel, thermometer was added 5.0 g (43 mmol) of 1,6 diaminohexane, 7.12 g (90 mmol) of pyridine, 100 mL anhydrous acetonitrile, 100 mL ether. After the starting material was dissolved 9.26 g (87 mmol) of vinyl chloroformate was added over 20 minutes an exoterm was noted, and a precipitate formed over 18 hours. The solvent was removed on a rotary evaporator and the residue was dissolved in methylene chloride, washed with 2N NaOH, thrice with distilled water then dried with magnesium sulfate. The solid was coated on silica gel and chromatographed (97% CH2 Cl2, 3% ETOAc) to give a solid that was dissolved in methylene chloride and slowly added to stirred heptane. The solid recovered was dried to give 5.7 g (22.2 mmol, 51.7% yield) melting point 94°-98° C. FTIR 3333.74, 3086.01, 3032.62, 2947.83, 2886.20, 2857.98, 1713.28, 1682.02, 1648.85, 1528.09, 1476.87, 1465.92, 1339.48, 1294.01, 1259.77, 1224.55, 1156.32, 1051.88, 1001.10, 954.5, 875.05, 866.57. NMR (CDCl3) 7.00-7.34 (2H,q) 4.62-5.13 (2H,bs), 4.29-4.75 (4H,m), 2.91-3.33 (4H,q), 1.31 (8H,bs).
9.4 1,8-divinyloctyldicarbamate
To a 500 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, dropping funnel, thermometer was added 5.0 g (34.6 mmol) of 1,8 diaminooctane, 6.1 g (76.1 mmol) of pyridine, 100 mL anhydrous acetonitrile, 100 mL ether. After the starting material was dissolved 8.0 g (87 mmol) of vinyl chloroformate was added over 20 minutes an exotherm was noted, and a precipitate formed over 18 hours. The solvent was removed on a rotary evaporator and the residue was dissolved in methylene chloride, washed with 2N NaOH, thrice with distilled water then dried with magnesium sulfate. The solid was coated on silica gel and chromatographed (97% CH2 Cl2, 3% ETOAc) to give a solid that was dissolved in methylene chloride and slowly added to stirred heptane. The solid recovered was dried to give 6.7 g (22.1 mmol, 64.1% yield) melting point 83°-88° C. FTIR 3336.20, 3086.75, 3032.18, 2996.55, 2942.19, 2926.73, 2872.60, 2855.14, 1709.82, 1676.68, 1649.06, 1530.29, 1478.71, 1464.03, 1362.59, 1308.80, 1257.38, 1252.87, 1213.85, 1168.05, 1083.04, 1062.73, 1031.76, 956.24, 874.73, 861.46. NMR (CDCl3) 6.95-7.34 (2H,q), 4.62-5.13 (2H,bs), 4.29-4.75 (4H,m), 2.97-3.30 (4H,q), 1.31 (10H,bs).
PART X--FLUOROALKYL BRIDGED CROSSLINKERS 10.0 1,5-bis-(Vinyloxycarbonyloxy)-2,2,3,3,4,4-hexafluoro-pentane C11 H10 F6 O6
To a 500 mL 3-neck round bottom flask fitted with a magnetic stirrer, condenser, nitrogen blanket, thermometer, dropping funnel, and ice-water bath was added 12.3 g (155.5 mmol) of pyridine and 200 mL of methylene chloride. After cooling to 5° C.±2° C. add 16.57 g (155.5mmol) of vinyl chloroformate was added so that the temperature was maintained. A white precipitate formed immediately. When the addition was complete, 15.0 g (70.7 mmol) of 2,2,3,3,4,4-hexafluoro-1,5-pentaneidiol in one portion as a slurry with 250 mL methylene chloride was added. The reaction was allowed to warm to room temperature for 18 hours. The organics were washed twice with 250 mL of 2N HCl then dried with magnesium sulfate. The solvent was removed on a rotary evaporator to afford 24.7 g of a straw oil. Following chromatography (silica gel, toluene), 21.8 g (61.9 mmol, 87.6%) of colorless oil was obtained. FTIR (neat, capillary) 3102.29, 2983.43, 1767.41, 1651.43, 1442.83, 1404.75, 1303.52, 1247.26, 1151.88, 1125.91, 1095.64, 1031.24, 1005.65, 985.71, 939.37, 882.43, 776.53, 697.20, 673.23, 650.18. NMR (CDCl3)δ 6.83-7.26 (2H,m), 4.30-5.23 (8H,m). ##STR56##
COPOLYMER FILM EXAMPLES A. Hydrogel Materials
Soft hydrogel copolymers of the present invention were produced by copolymerizing a monomer of the formula ##STR57## with N-vinylpyrrolidinone (NVP), and the crosslinker monomer 1,5-bis-(vinyloxycarbonyloxy)-2,2,3,3,4,4-hexacluoropentane, in the presence of a nonreactive diluent and a UV irradiation, free radical initiator in the following weight ratios:
______________________________________                                    
      hydrophilic                                                         
film #                                                                    
      monomer   NVP    X-linkers                                          
                               % H.sub.2 O                                
                                     DK × 10.sup.-11                
______________________________________                                    
1     22.5      65.0   2.5     73    45                                   
2     62.5      25.0   2.5     19    91                                   
3     64.5      24.7   0.5     25    97                                   
4     23.5      45.0   1.5     63    41                                   
5     53.5      25.0   1.5     27    79                                   
6     42.5      25.0   2.5     33    65                                   
7      2.5      65.0   2.5     85    56                                   
8     23.5      65.0   1.5     77    51                                   
9     44.5      45.0   0.5     58    46                                   
10    21.5      64.7   0.9     80    49                                   
11    43.1      43.1   0.9     53    47                                   
12    64.7      21.5   0.9     23    115                                  
13    32.5      45.0   2.5     51    37                                   
______________________________________
These films were prepared by placing the prepolymer mixtures between glass plates separated by a Teflon® peripheral gasket and were UV irradiated for 2 hours. The samples were then prepared for physical characterization.
Physical properties for films were determined using the following test procedures:
1. Tensile strength (g/mm2) and modulus of elasticity were measured per ASTM test a method D1708.
2. Elongation was measured per ASTM 1708.
3. Initial tear strength and propagation tear strength were measured per ASTM 1438.
4. Oxygen permeabilities were measured by the method reported by Relojo, M. et al in Contact and Intraocular Lens Medical Journal, Vol. 3, issued p. 27 (1977) and edge effects were accounted for per the methods described by Fatt, et al. in International Contact Lens Clinic, v. 14, p. 389 (1987).
5. Water content is measured per a gravimetric method.
6. Refractive index was measured per typical methods on hydrated samples using a refractometer.
The physical characterization of these films is reported in the following table.
______________________________________                                    
                                   Tear (initial/                         
      Modulus   Tensile   Elongation                                      
                                   propagation)                           
Film  (g/mm.sup.2)                                                        
                (g/mm.sup.2)                                              
                          %        (g/mm.sup.2)                           
______________________________________                                    
1     38        15        60       1.4/1.0                                
2     970       170       130      52/52                                  
3     203       77        330      56/56                                  
4     52        28        70       1.4/1.4                                
5     370       100       160      30/30                                  
6     262       72        90       17/17                                  
7     27         7        42       --/--                                  
8     17        13        120      1.1/1.0                                
9     18        20        280      6.5/6.5                                
10    72        43        75       0.8/0.6                                
11    49        27        180       --/5.5                                
12    430       110       200      --/46                                  
13    86        40        70       3.2/3.1                                
______________________________________
As can be seen, all of the above film samples meet the general requirements for a hydrogel contact lens material.
B. Hard Contact Lens Material Examples
Hard, gas permeable contact lens materials were made using the novel vinylcarbonate functional monomers described herein by polymerizing 1,1,1,3,3,3-hexafluoroprop-2-yl vinyl carbonate (hfpvc) ##STR58## with a variety of hydrophilic monomers and crosslinkers, such as those known in the prior art and the preferred hydrophilic monomers and crosslinkers disclosed herein.
Other materials can be made by substituting the 1,1,1,3,3,3-hexafluoroprop-2-yl vinyl carbonate monomer with a fluoroalkyvinyl carbonate or carbamate monomer preferably chosen from the group consisting of trifluoroethyl vinyl carbonate (tfevc); 1,5-bis-(Vinyloxycarbonyloxy)-2,2,3,3,4,4-hexafluoropentane (hfpdvc); and 2,2,2-trifluoro-1-phenylethyl Vinyl carbonate (tfpvc).
Films were made by the general method described in the hydrogel film example. The films were polymerized from monomer mixtures with the following formulations.
______________________________________                                    
film #14:                                                                 
        65     wt % hfpvc                                                 
        30     wt % 3-[tris(trimethylsiloxy)silyl]propyl                  
               vinyl carbamate                                            
        5      wt % hfpdvc and about                                      
        0.5    wt % free radical initiator                                
film #15:                                                                 
        65     wt % hfpvc                                                 
        30     wt % 3[tris(trimethylsiloxy)silyl]propyl                   
               vinyl carbonate and                                        
        0.5    wt % free radical initiator                                
film #16:                                                                 
        65     wt % hfpvc                                                 
        30     wt % 3-[tris(trimethylsiloxy)silyl] propyl                 
               vinyl carbamate                                            
        4.0    wt % 2,2-dimethyl-1,3-bis(vinyloxycarbonyl-                
               oxy)propane                                                
        0.5    wt % free radical initiator                                
film #17:                                                                 
        60     wt % hfpvc                                                 
        25     wt % 3[tris(trimethylsiloxy)silyl] propyl                  
               vinyl carbonate                                            
        5      wt % V.sub.2 D.sub.25                                      
        5      wt % 2,2-dimethyl-1,3-bis(vinyloxycarbonyl-                
               oxy)propane                                                
        5      wt % N-vinyl-2-pyrrolidinone                               
        0.5    wt % free radical initiator                                
film #18:                                                                 
        60     wt % hfpvc                                                 
        25     wt % 3[tris(trimethylsiloxy)silyl]propyl                   
               vinyl carbonate                                            
        5      wt % V.sub.2 D.sub.25                                      
        5      wt % hfpdvc                                                
        5      wt % N-vinyl-2-pyrrolidinone                               
        0.5    wt % free radical initiator                                
film #19:                                                                 
        60     wt % hfpvc                                                 
        25     wt % 3-(vinyloxycarbonylthio)propyl-[tris                  
               (trimethylsiloxy)silane]                                   
        5      wt % V.sub.2 D.sub.25                                      
        5      wt % hfpdvc                                                
        5      wt % N-vinyl-2-pyrrolidinone                               
        0.5    wt % free radical initiator                                
film #20:                                                                 
        60     wt % hfpvc                                                 
        25     wt % 3-tris(trimethylsiloxy) propylsilane                  
               allylcarbamate                                             
        5      wt % V.sub.2 D.sub.25                                      
        5      wt % 2,2,3,3,4,4-hexafluoro-1,5-pentane                    
               dinvinylcarbonate                                          
        5      wt % N-vinyl-2-pyrrolidinone                               
        0.5    wt % free radical initiator                                
______________________________________
The physical characteristics of these films as measured are reported in the following table.
______________________________________                                    
       modulus   tensile             O2 Perm                              
film # (g/mm.sup.2)                                                       
                 (g/mm.sup.2)                                             
                           % elongation                                   
                                     × 10.sup.-11                   
______________________________________                                    
14     75000     1250      14        130                                  
15     82000     1500      13        140                                  
16     80000     2100      8         130                                  
17     73000     2000      8         120                                  
18     85000     1600      16        130                                  
19     84000     1800      7         100                                  
20     101000    2500      7         100                                  
______________________________________
All of these films are acceptable as hard gas permeable contact lens materials.
c. Soft Non-Hydrogel Material Examples
A series of films were made by the general film casting technique described in the hydrogel materials example except that prepolymer mixtures for the various films were employed as hereinafter disclosed.
______________________________________                                    
film #21:                                                                 
       50     wt % 3-(trimethylsilyl)propyl vinyl carbonate               
       35     wt % 3-[tris(trimethylsiloxy)silyl]propyl                   
              vinyl carbamate                                             
       10     wt % N-vinyl-2-pyrrolidinone                                
       5      wt % 2,2-dimethyl-1,3-bis(vinyloxy-                         
              carbonyloxy)propane                                         
       0.5    wt % UV free radical initiator                              
film #22:                                                                 
       25     wt % 3-(trimethylsilyl)propyl vinyl carbonate               
       64     wt % 3-[tris(trimethylsiloxy)silyl]propyl                   
              vinyl carbamate                                             
       10     wt % N-vinyl-2-pyrrolidinone                                
       1      wt % 2,2-dimethyl-1,3-bis(vinyloxy-                         
              carbonyloxy)propane                                         
       0.5    wt % UV free radical initiator                              
film #23:                                                                 
       44     wt % 3-(trimethylsilyl)propyl vinyl carbonate               
       44     wt % 3-[tris(trimethylsiloxy)silyl]propyl                   
              vinyl carbamate                                             
       10.5   wt % N-vinyl-2-pyrrolidinone                                
       1      wt % 2,2-dimethyl-1,3-bis(vinyloxy-                         
              carbonyloxy)propane                                         
       0.5    wt % UV free radical initiator                              
film #24:                                                                 
       54     wt % 3-(trimethylsilyl)propyl vinyl carbonate               
       35     wt % 3-[tris(trimethylsiloxy)silyl]propyl                   
              vinyl carbamate                                             
       10     wt % N-vinyl-2-pyrrolidinone                                
       1      wt % 2,2-dimethyl-1,3-bis(vinyloxy-                         
              carbonyloxy)propane                                         
       0.5    wt % UV free radical initiator                              
film #25:                                                                 
       65     wt % 3-(trimethylsilyl)propyl vinyl carbonate               
       25     wt % 3-[tris(trimethylsiloxy)silyl]propyl                   
              vinyl carbamate                                             
       10     wt % N-vinyl-2-pyrrolidinone                                
       1      wt % 2,2-dimethyl-1,3-bis(vinyloxy-                         
              carbonyloxy)propane                                         
       0.5    wt % UV free radical initiator                              
film #26:                                                                 
       40     wt % 3-(trimethylsilyl)propyl vinyl carbonate               
       40     wt % 3-[tris(trimethylsiloxy)silyl]propyl                   
              vinyl carbamate                                             
       20     wt % N-vinyl-2-pyrrolidinone                                
       1      wt % 2,2-dimethyl-1,3-bis(vinyloxy-                         
              carbonyloxy)propane                                         
       0.5    wt % UV free radical initiator                              
film #27:                                                                 
       34     wt % 3-(trimethylsilyl)propyl vinyl carbonate               
       34     wt % 3-[tris(trimethylsiloxy)silyl]propyl                   
              vinyl carbamate                                             
       30     wt % N-vinyl-2-pyrrolidinone                                
       1      wt % 2,2-dimethyl-1,3-bis(vinyloxy-                         
              carbonyloxy)propane                                         
       0.5    wt % UV free radical initiator                              
film #28:                                                                 
       28     wt % 3-(trimethylsilyl)propyl vinyl carbonate               
       68     wt % 3-[tris(trimethylsiloxy)silyl]propyl                   
              vinyl carbamate                                             
       4      wt % N-vinyl-2-pyrrolidinone                                
       1      wt % 2,2-dimethyl-1,3-(vinyloxy-                            
              carbonyloxy)propane                                         
       0.5    wt % UV free radical initiator                              
film #29:                                                                 
       20     wt % trimethylsilylmethyl vinyl carbonate                   
       70     wt % 3-[tris(trimethylsiloxy)silyl]propyl                   
              vinyl carbamate                                             
       10     wt % N-vinyl-2-pyrrolidinone                                
       1      wt % 2,2-dimethyl-1,3-(vinyloxy-                            
              carbonyloxy)propane                                         
       0.5    wt % free radical initiator                                 
film #30:                                                                 
       20     wt % trimethylsilylethyl vinyl carbonate                    
       70     wt % 3-[tris(trimethylsiloxy)silyl]propyl                   
              vinyl carbamate                                             
       10     wt % N-vinyl-2-pyrrolidinone                                
       1      wt % 2,2-dimethyl-1,3-bis(vinyloxy-                         
              carbonyloxy)propane                                         
       0.5    wt % free radical initiator                                 
______________________________________
The films were cured, samples were taken of the film and the following characteristics measured:
______________________________________                                    
               tensile  %     Tear Strength                               
      modulus  strength elon- (initial/                                   
                                       O.sub.2 DK                         
film #                                                                    
      (g/mm.sup.2)                                                        
               (g/mm.sup.2)                                               
                        gation                                            
                              propagation)                                
                                       × 10.sup.-11                 
______________________________________                                    
21    2200     440      106   120/120  76                                 
22    270      150      234   80/80    140                                
23    143      140      266   70/70    100                                
24    120      140      270   70/70    90                                 
25    110      120      270   80/80    72                                 
26     35       40      210   14/14    56                                 
27     50       70      290   30/30    80                                 
28    400      120      200   100/100  110                                
29    --       --       --    --       100                                
30    --       --       --    --       100                                
______________________________________
The above sample films demonstrated characteristics which would be useful as a soft, elastomeric, contact lens material with low or no water content.
1,2,3-tris(vinyloxycarbonyloxy)propane
To a 250 ml three neck round bottom flask fitted with a mechanical stirrer, condensor, nitrogen blanket, and a dropping funnel was added 3.1 g (33.7 mmol) of glycerol, 8.7 g (110 mmol) of pyridine and 125 mL of anhydrous acetonitrile. The reaction flask was cooled in an ice water bath so that the temperature did not exceed 5° C. To the reaction mixture was added 11.7 g (110 mmol) of vinylchloro formate over 30 minutes. The reaction mixture was allowed to stir to room temperature overnight. The solvent was removed on a rotary evaporator and the crude product was taken up in ethyl acetate and washed with 2 100 mL portions of 2N HCl, then 2 100 mL portions of 2N NaOH, then 2 100 mL portions of brine. The organics were dried with magnesium sulfate, the the solvent removed and the crude product is distilled to obtain the pure product. ##STR59##
1,3-bis(vinyloxycarbonyloxy)-2,2- bis (vinyloxycarbonyloxymethyl) propane
To a 250 ml three neck round bottom flask fitted with a mechanical stirrer, condensor, nitrogen blanket, and a dropping funnel was added 3.0 g (22.0 mmol) of pentaerythritol, 7.7 g (97 mmol) of pyridine and 125 mL of anhydrous acetonitrile. The reaction flask was cooled in an ice water bath so that the temperature did not exceed 5° C. To the reaction mixture was added 10.3 g (97 mmol) of vinylchloroformate over 30 minutes. The reaction mixture was allowed to stir at room temperature overnight. The solvent was removed on a rotary evaporator and the crude product was taken up in ethyl acetate and washed with two 100 mL portions of 2N HCl, then two 100 mL portions of 2N NaOH, then two 100 mL portions of brine. The organic phase was dried with magnesium sulfate, the the solvent removed and the crude product distilled to obtain the pure product. ##STR60##
V2 DF25
To a 100 mL one neck round bottom flask fitted with a magnetic stirrer, and a drying tube was added 5.0 g (11.95 mmol) of 1,3-bis (4-vinylbutylcarbonate) tetramethyldisiloxane, and 46.6 g (99.6 mmol) of 1,3,5-methyl,1,3,5-trifluoropropylcyclotrisiloxane. To the reaction mixture was added 0.0679 g (0.452 mmol) of triflurormethanesulfonic acid. The mixture was stirred at room temperature for 24 hours then 0.38 g (4.52 mmol) of sodium bicarbonate was added, and the mixture was allowed to stir an addtional 24 hours. The reaction mixture was filtered thruogh 20.0 g of activated F20 alumina to give a lite yellow oil. The crude product was vacuum stripped at 90° C. 0.025 Torr for 4 hours to give the desired product.

Claims (8)

What is claimed is:
1. Compounds of the general formula
wherein
R2 denotes --H or --CH3 ;
b is 0 or 1;
a is 1, 2, 3, or 4; and
R is an organosilicon radical chosen from the groups of radicals represented by the formulae: ##STR62## wherein x is 25 on the average; ##STR63## where R1 denotes a monovalent organic radical selected from the group consisting of an alkyl radical with 1 to 6 carbon atoms, or a fluoroalkyl radical with 1 to 6 carbon atoms;
Rcl denotes ##STR64## p is 1 to 6; m is 0 to 5; and d is 1-200.
2. The compound of claim 1, trimethylsilylmethyl vinyl carbonate.
3. The compound of claim 1, trimethylsilylethyl vinyl carbonate.
4. The compound of claim 1, 3-(trimethylsilyl)propyl vinyl carbonate.
5. The compound of claim 1, t-butyldimethylsiloxyethyl vinyl carbonate.
6. The compound of claim 1, 3-[tris(trimethylsiloxy) silyl]propyl vinyl carbonate.
7. The compound of claim 1, 1,3-bis[4-(vinyloxycarbonyloxy)but-1-yl]-tetramethyl disiloxane.
8. The compound 3-[tris(trimethylsiloxy) silyl]propylaminoethyl vinyl carbonate.
US07/346,204 1989-05-02 1989-05-02 Novel vinyl carbonate and vinyl carbamate contact lens material monomers Expired - Lifetime US5070215A (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
US07/346,204 US5070215A (en) 1989-05-02 1989-05-02 Novel vinyl carbonate and vinyl carbamate contact lens material monomers
CA002014210A CA2014210C (en) 1989-05-02 1990-04-09 Vinyl carbonate and vinyl carbamate contact lens material monomers
IE138490A IE81155B1 (en) 1989-05-02 1990-04-18 Copolymers of vinyl carbonate and vinyl carbamate as contact lens material
JP11066490A JP3274681B2 (en) 1989-05-02 1990-04-27 New vinyl carbonate and vinyl carbamate contact lens material monomers
ES96202972T ES2131907T3 (en) 1989-05-02 1990-04-30 VINYL CARBONATE AND VINYL CARBAMATE MONOMERS FOR A CONTACT LENS MATERIAL.
ES90304659T ES2104583T3 (en) 1989-05-02 1990-04-30 MONOMER POLYMERS VINYL CARBONATE AND VINYL CARBAMATE FOR CONTACT LENS MATERIALS.
DE69032984T DE69032984T2 (en) 1989-05-02 1990-04-30 Vinyl carbonate and vinyl carbamate monomers as a material for contact lenses
SG1996007715A SG49218A1 (en) 1989-05-02 1990-04-30 Novel vinyl carbonate and vinyl carbamate contact lens material monomers
EP90304659A EP0396364B1 (en) 1989-05-02 1990-04-30 Copolymers of vinyl carbonate and vinyl carbamate as contact lens material
EP96202972A EP0757033B1 (en) 1989-05-02 1990-04-30 Vinyl carbonate and vinyl carbamate monomers for a contact lens material
DE69030898T DE69030898T2 (en) 1989-05-02 1990-04-30 Copolymers of vinyl carbonate and vinyl carbamate monomers as a material for contact lenses
KR1019900006178A KR0171402B1 (en) 1989-05-02 1990-05-01 Novel vinyl carbonated and vinyl carbamate contact lens material monomers
AU54616/90A AU645749B2 (en) 1989-05-02 1990-05-01 Novel vinyl carbonate and vinyl carbamate contact lens material monomers
BR909002045A BR9002045A (en) 1989-05-02 1990-05-02 COPOLIMERO; COPOLIMERO HIDROGEL; COPOLIMERO NON-HYDROGEL; CONTACT LENS MATERIAL FOR GAS AND COMPOUNDS; AND ITS PREPARATION PROCESSES
US08/450,510 US5610252A (en) 1989-05-02 1995-05-25 Vinyl carbonate and vinyl carbamate contact lens material monomers
US08/784,637 US6166236A (en) 1989-05-02 1997-01-21 Vinyl carbonate and vinyl carbamate contact lens material monomers
HK98100504A HK1001565A1 (en) 1989-05-02 1998-01-20 Copolymers of vinyl carbonate and vinyl carbamate as contact lens material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/346,204 US5070215A (en) 1989-05-02 1989-05-02 Novel vinyl carbonate and vinyl carbamate contact lens material monomers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US72409191A Division 1989-05-02 1991-07-19

Publications (1)

Publication Number Publication Date
US5070215A true US5070215A (en) 1991-12-03

Family

ID=23358395

Family Applications (3)

Application Number Title Priority Date Filing Date
US07/346,204 Expired - Lifetime US5070215A (en) 1989-05-02 1989-05-02 Novel vinyl carbonate and vinyl carbamate contact lens material monomers
US08/450,510 Expired - Lifetime US5610252A (en) 1989-05-02 1995-05-25 Vinyl carbonate and vinyl carbamate contact lens material monomers
US08/784,637 Expired - Fee Related US6166236A (en) 1989-05-02 1997-01-21 Vinyl carbonate and vinyl carbamate contact lens material monomers

Family Applications After (2)

Application Number Title Priority Date Filing Date
US08/450,510 Expired - Lifetime US5610252A (en) 1989-05-02 1995-05-25 Vinyl carbonate and vinyl carbamate contact lens material monomers
US08/784,637 Expired - Fee Related US6166236A (en) 1989-05-02 1997-01-21 Vinyl carbonate and vinyl carbamate contact lens material monomers

Country Status (12)

Country Link
US (3) US5070215A (en)
EP (2) EP0396364B1 (en)
JP (1) JP3274681B2 (en)
KR (1) KR0171402B1 (en)
AU (1) AU645749B2 (en)
BR (1) BR9002045A (en)
CA (1) CA2014210C (en)
DE (2) DE69032984T2 (en)
ES (2) ES2104583T3 (en)
HK (1) HK1001565A1 (en)
IE (1) IE81155B1 (en)
SG (1) SG49218A1 (en)

Cited By (437)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177165A (en) * 1990-11-27 1993-01-05 Bausch & Lomb Incorporated Surface-active macromonomers
US5260000A (en) * 1992-08-03 1993-11-09 Bausch & Lomb Incorporated Process for making silicone containing hydrogel lenses
US5260001A (en) * 1992-08-03 1993-11-09 Bausch & Lomb Incorporated Spincasting process for producing a series of contact lenses having desired shapes
US5274008A (en) * 1990-11-27 1993-12-28 Bausch & Lomb Incorporated Mold materials for silicone containing lens materials
US5288890A (en) * 1992-02-28 1994-02-22 Shin-Etsu Chemical Co., Ltd. Fluorine-containing organosilicon compound and process of producing the same
US5310779A (en) * 1991-11-05 1994-05-10 Bausch & Lomb Incorporated UV curable crosslinking agents useful in copolymerization
US5321108A (en) * 1993-02-12 1994-06-14 Bausch & Lomb Incorporated Fluorosilicone hydrogels
US5352816A (en) * 1993-12-28 1994-10-04 Three Bond Co., Ltd. Organosilicon compound
US5364918A (en) * 1990-11-27 1994-11-15 Bausch & Lomb Incorporated Surface modification of polymer objects
US5486579A (en) * 1991-11-05 1996-01-23 Bausch & Lomb Incorporated Wettable silicone hydrogel compositions and methods for their manufacture
US5510442A (en) * 1993-04-08 1996-04-23 Bausch & Lomb Incorporated Organosilicon-containing materials useful for biomedical devices
US5594085A (en) * 1993-12-17 1997-01-14 Bausch & Lomb Incorporated Urea and urethane monomers for contact lens materials
US5610252A (en) * 1989-05-02 1997-03-11 Bausch & Lomb Incorporated Vinyl carbonate and vinyl carbamate contact lens material monomers
WO1997041876A1 (en) * 1996-05-07 1997-11-13 Emory University Water-stabilized organosilanes and methods for use
US5708094A (en) * 1996-12-17 1998-01-13 Bausch & Lomb Incorporated Polybutadiene-based compositions for contact lenses
US5710302A (en) * 1995-12-07 1998-01-20 Bausch & Lomb Incorporated Monomeric units useful for reducing the modules of silicone hydrogels
US5714557A (en) * 1995-12-07 1998-02-03 Bausch & Lomb Incorporated Monomeric units useful for reducing the modulus of low water polymeric silicone compositions
US6071439A (en) * 1994-01-31 2000-06-06 Bausch & Lomb Incorporated Treatment of contact lenses with supercritical fluid
US6284911B1 (en) 1999-06-29 2001-09-04 Wright Chemical Corporation Synthesis of vinyl carbonates for use in producing vinyl carbamates
US6364934B1 (en) 2000-07-31 2002-04-02 Bausch & Lomb Incorporated Method of making ocular devices
US6414049B1 (en) * 2000-03-22 2002-07-02 Johnson & Johnson Vision Care, Inc. Stable initiator system
US6423820B1 (en) 1999-09-24 2002-07-23 Bausch & Lomb Incorporated Process for purifying and reusing solvent used to remove extractables
US20030000028A1 (en) * 2001-02-23 2003-01-02 Molock Frank F. Colorants for use in tinted contact lenses and methods for their production
US6514438B1 (en) 1999-12-21 2003-02-04 Bausch & Lomb Incorporated Pulse extraction of ocular medical devices
US6528464B1 (en) 2001-08-17 2003-03-04 Bausch & Lomb Incorporated Composition and method for inhibiting uptake of biguanide antimicrobials by hydrogels
US20030087022A1 (en) * 2000-10-24 2003-05-08 Bausch & Lomb Incorporated Prevention of bacterial attachment to biomaterials by cationic polysaccharides
US20030125498A1 (en) * 2001-09-10 2003-07-03 Mccabe Kevin P. Biomedical devices containing internal wetting agents
US6602930B2 (en) 2000-02-24 2003-08-05 Hoya Healthcare Corporation Materials for contact lenses comprising a macromer having the polysiloxane structure in the side chain
US20030162862A1 (en) * 2001-09-10 2003-08-28 Mccabe Kevin P. Biomedical devices containing internal wetting agents
US6638563B2 (en) 2000-09-19 2003-10-28 Bausch & Lomb Incorporated Method for applying renewable polymeric lens coating
WO2003089506A1 (en) * 2002-04-22 2003-10-30 Purdue Research Foundation Hydrogels having enhanced elasticity and mechanical strength properties
US20030222362A1 (en) * 2002-03-28 2003-12-04 Bausch & Lomb Incorporated Process for extracting biomedical devices
US20030236376A1 (en) * 2002-03-11 2003-12-25 Ture Kindt-Larsen Low polydispersity poly-HEMA compositions
US20040002556A1 (en) * 2002-06-25 2004-01-01 Molock Frank F. Macromer forming catalysts
US6702983B2 (en) 2001-05-15 2004-03-09 Bausch & Lomb Incorporated Low ionic strength method and composition for reducing bacterial attachment to biomaterials
US20040075039A1 (en) * 2002-08-16 2004-04-22 Dubey Dharmesh K. Molds for producing contact lenses
US20040116310A1 (en) * 2002-12-17 2004-06-17 Bausch & Lomb Incorporated Surface treatment of medical device
US20040116564A1 (en) * 2002-11-27 2004-06-17 Devlin Brian Gerrard Stabilization of poly(oxyalkylene) containing polymeric materials
US20040120982A1 (en) * 2002-12-19 2004-06-24 Zanini Diana Biomedical devices with coatings attached via latent reactive components
US20040121939A1 (en) * 2002-12-19 2004-06-24 Zanini Diana Biomedical devices with peptide containing coatings
US6762264B2 (en) 1999-07-27 2004-07-13 Bausch & Lomb Incorporated Contact lens material
US20040151755A1 (en) * 2000-12-21 2004-08-05 Osman Rathore Antimicrobial lenses displaying extended efficacy, processes to prepare them and methods of their use
US6772988B2 (en) 2000-03-31 2004-08-10 Bausch & Lomb Incorporated Method and mold to control optical device polymerization
US20040166232A1 (en) * 2002-12-23 2004-08-26 Bausch & Lomb Incorporated Surface treatment utilizing microwave radiation
US20040186248A1 (en) * 1998-03-02 2004-09-23 Vanderlaan Douglas G. Soft contact lenses
US6805836B2 (en) 2000-12-15 2004-10-19 Bausch & Lomb Incorporated Prevention of preservative uptake into biomaterials
US20040209973A1 (en) * 1998-03-02 2004-10-21 Steffen Robert B. Contact lenses
US20040214735A1 (en) * 2000-10-06 2004-10-28 Groemminger Suzanne F. Cleaner for contact lens
US20040213827A1 (en) * 2000-12-21 2004-10-28 Enns John B. Antimicrobial contact lenses and methods for their production
US6827885B2 (en) 2000-03-31 2004-12-07 Bausch & Lomb Incorporated Methods and devices to control polymerization
US6861123B2 (en) 2000-12-01 2005-03-01 Johnson & Johnson Vision Care, Inc. Silicone hydrogel contact lens
US20050054745A1 (en) * 2001-08-02 2005-03-10 Frank Molock Process for the synthesis of soluble, high molecular weight polymers
US20050070661A1 (en) * 2003-09-30 2005-03-31 Frank Molock Methods of preparing ophthalmic devices
US20050092680A1 (en) * 2003-10-31 2005-05-05 Shivkumar Mahadevan Purification of silicone containing compounds by supercritical fluid extraction
US6891010B2 (en) 2001-10-29 2005-05-10 Bausch & Lomb Incorporated Silicone hydrogels based on vinyl carbonate endcapped fluorinated side chain polysiloxanes
US20050117112A1 (en) * 2003-11-18 2005-06-02 Alvarez-Carrigan Nayiby Antimicrobial lenses, processes to prepare them and methods of their use
US20050124719A1 (en) * 2003-12-05 2005-06-09 Yu-Chin Lai Surface modification of contact lenses
US20050124776A1 (en) * 2003-12-05 2005-06-09 Yu-Chin Lai Novel prepolymers for improved surface modification of contact lenses
US20050153055A1 (en) * 2003-12-22 2005-07-14 Bausch & Lomb Incorporated Surface treatment utilizing supercritical fluid
US20050176980A1 (en) * 2004-01-28 2005-08-11 Bausch & Lomb Incorporated Vinylchloroformate-free synthesis of vinyl and allyl(thio) carbamates
US20050176911A1 (en) * 2004-02-11 2005-08-11 Diana Zanini (Meth)acrylamide monomers containing hydroxy and silicone functionalities
US20050255231A1 (en) * 2003-06-30 2005-11-17 Hill Gregory A Silicone hydrogels having consistent concentrations of multi-functional polysiloxanes
US20050258096A1 (en) * 2004-05-21 2005-11-24 Bausch & Lomb Incorporated Process for extracting biomedical devices
US20050288466A1 (en) * 2004-06-25 2005-12-29 Yu-Chin Lai Novel prepolymers for improved surface modification of contact lenses
WO2006011999A1 (en) 2004-06-30 2006-02-02 Johnson & Johnson Vision Care, Inc. Solutions for ophthalmic lenses containing at least one silicone containing component
US20060067981A1 (en) * 2004-09-29 2006-03-30 Bausch & Lomb Incorporated Contact lens with improved biocidal activity and related methods and materials
US20060069235A1 (en) * 2004-09-30 2006-03-30 Arnold Stephen C Lactam polymer derivatives
US20060074208A1 (en) * 2004-09-30 2006-04-06 Laredo Walter R Biomedical devices containing amphiphilic block copolymers
US20060072069A1 (en) * 2004-09-30 2006-04-06 Laredo Walter R Wettable hydrogels comprising reactive, hydrophilic, polymeric internal wetting agents
US20060078592A1 (en) * 2004-10-12 2006-04-13 Bausch & Lomb Incorporated Drug delivery systems
US20060093728A1 (en) * 2004-11-01 2006-05-04 Bausch & Lomb Incorporated Process for hydrating lenses
US20060100408A1 (en) * 2002-03-11 2006-05-11 Powell P M Method for forming contact lenses comprising therapeutic agents
US20060130881A1 (en) * 2004-12-21 2006-06-22 Sanjay Rastogi Method of cleaning optical tools for making contact lens molds using super-cooled fluids
US20060134169A1 (en) * 2004-12-22 2006-06-22 Linhardt Jeffrey G Polymerizable surfactants and their use as device forming comonomers
US20060131769A1 (en) * 2004-12-22 2006-06-22 Bausch & Lomb Incorporated Pre-polymer extraction using a super-cooled fluid
US7074876B2 (en) * 1997-08-21 2006-07-11 General Electric Company Blocked mercaptosilane coupling agents for filled rubbers
US7087222B2 (en) 2000-12-19 2006-08-08 Bausch & Lomb Incorporated Method for enhancing integrity of epithelium using retinoic acid
US20060226402A1 (en) * 2005-04-08 2006-10-12 Beon-Kyu Kim Ophthalmic devices comprising photochromic materials having extended PI-conjugated systems
US20060226401A1 (en) * 2005-04-08 2006-10-12 Wenjing Xiao Ophthalmic devices comprising photochromic materials with reactive substituents
US20060227287A1 (en) * 2005-04-08 2006-10-12 Frank Molock Photochromic ophthalmic devices made with dual initiator system
US20060292101A1 (en) * 2005-06-28 2006-12-28 Roya Borazjani In-eye method of cleaning and/or disinfecting silicone hydrogel contact lenses
US20060292202A1 (en) * 2005-06-27 2006-12-28 Bausch & Lomb Incorporated Drug delivery device
US20060293476A1 (en) * 2005-06-28 2006-12-28 Mahendra Nandu Novel system for synthesis of device forming monomers
US20070035693A1 (en) * 2005-08-11 2007-02-15 Coopervision Inc. Contact lenses and methods for reducing conjunctival pressure in contact lens wearers
US20070049713A1 (en) * 2005-08-30 2007-03-01 Bausch & Lomb Incorporated Polymeric materials having enhanced ion and water transport property and medical devices comprising same
US20070048349A1 (en) * 2005-08-29 2007-03-01 Bausch & Lomb Incorporated Surface-modified medical devices and methods of making
US20070087113A1 (en) * 2005-10-19 2007-04-19 Bausch & Lomb Incorporated Surface-modified medical devices and method of making
US20070092830A1 (en) * 2005-10-24 2007-04-26 Bausch & Lomb Incorporated Polymeric radiation-absorbing materials and ophthalmic devices comprising same
US20070104611A1 (en) * 2005-11-09 2007-05-10 Coopervision Inc. Methods for sterilizing silicone hydrogel contact lenses
US20070116740A1 (en) * 2005-11-21 2007-05-24 Bausch & Lomb Incorporated Contact lenses with mucin affinity
US20070116741A1 (en) * 2005-11-21 2007-05-24 Bausch & Lomb Incorporated Contact lenses with mucin affinity
US20070122540A1 (en) * 2005-11-29 2007-05-31 Bausch & Lomb Incorporated Coatings on ophthalmic lenses
US20070123602A1 (en) * 2005-11-29 2007-05-31 Bausch & Lomb Incorporated Use of thermal reversible associations for enhanced polymer interactions
US20070120279A1 (en) * 2005-11-29 2007-05-31 Bausch & Lomb Incorporated Method for coating lens material
US20070132120A1 (en) * 2005-12-08 2007-06-14 Bausch & Lomb Incorporated Preferential release of an ophthalmic lens using a super-cooled fluid
US20070132118A1 (en) * 2005-12-09 2007-06-14 Bausch And Lomb Incorporated Method and Apparatus for Treatment of a Device-in-Mold Assembly with a Supercritical Fluid
US20070132121A1 (en) * 2005-12-08 2007-06-14 Bausch & Lomb Incorporated Method of cleaning molds using super-cooled fluids
US20070132125A1 (en) * 2005-12-08 2007-06-14 Bausch & Lomb Incorporated Use of a super-cooled fluid in lens processing
US20070132119A1 (en) * 2005-12-08 2007-06-14 Bausch & Lomb Incorporated Use of a super-cooled fluid in the manufacture of contact lenses
US20070142584A1 (en) * 2005-12-21 2007-06-21 Derek Schorzman Silicon-containing monomers end-capped with polymerizable cationic hydrophilic groups
US20070138668A1 (en) * 2005-12-21 2007-06-21 Yu-Chin Lai Process for Extracting Biomedical Devices
US20070138669A1 (en) * 2005-12-21 2007-06-21 Yu-Chin Lai Process for Casting and Extracting Biomedical Devices
US20070142583A1 (en) * 2005-12-21 2007-06-21 Derek Schorzman Cationic hydrophilic siloxanyl monomers
US20070155851A1 (en) * 2005-12-30 2007-07-05 Azaam Alli Silicone containing polymers formed from non-reactive silicone containing prepolymers
US20070160643A1 (en) * 2006-01-06 2007-07-12 Schorzman Derek A Siloxane prepolymer containing pendant cationic and polymerizable groups
US20070161769A1 (en) * 2006-01-06 2007-07-12 Schorzman Derek A Polymerizable silicon-containing monomer bearing pendant cationic hydrophilic groups
US20070160649A1 (en) * 2006-01-06 2007-07-12 Schorzman Derek A Siloxane prepolymer containing pendant and end-capping cationic and polymerizable groups
US20070161810A1 (en) * 2006-01-06 2007-07-12 Schorzman Derek A Process for making cationic hydrophilic siloxanyl monomers
US20070185014A1 (en) * 2006-02-09 2007-08-09 The Schepens Eye Research Institute, Inc. Methods and compositions for modulating conjunctival goblet cells
US20070197733A1 (en) * 2006-02-22 2007-08-23 Bausch & Lomb Incorporated Star macromonomers and polymeric materials and medical devices comprising same
US20070196431A1 (en) * 2006-02-22 2007-08-23 Bausch & Lomb Incorporated Polymeric fluorinated dioxole and medical devices comprising same
US20070222094A1 (en) * 2006-03-23 2007-09-27 Azaam Alli Process for making ophthalmic lenses
US20070222095A1 (en) * 2006-03-23 2007-09-27 Diana Zanini Process for making ophthalmic lenses
US20070242215A1 (en) * 2006-04-13 2007-10-18 Bausch & Lomb Incorporated Cationic end-capped siloxane prepolymer for reduced cross-link density
US20070255014A1 (en) * 2006-04-28 2007-11-01 Salamone Joseph C Gas-permeable materials and medical devices
US20070264503A1 (en) * 2006-05-11 2007-11-15 Yu-Chin Lai Polymers comprising polyhydric alcohols, medical devices modified with same, and method of making
US20080000201A1 (en) * 2006-06-30 2008-01-03 Derek Schorzman Carboxylic tris-like siloxanyl monomers
US20080004410A1 (en) * 2006-06-30 2008-01-03 Yu-Chin Lai Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
US20080003252A1 (en) * 2006-06-30 2008-01-03 Yu-Chin Lai Functionalized hydrophilic macromonomers and medical devices incorporating same
US20080004414A1 (en) * 2006-06-30 2008-01-03 Derek Schorzman Carboxylic siloxanyl monomers with pendant polymerizable groups
US20080001318A1 (en) * 2006-06-30 2008-01-03 Derek Schorzman Polymerizable siloxane-quaternary amine copolymers
US20080003259A1 (en) * 2006-06-30 2008-01-03 Salamone Joseph C Modification of surfaces of polymeric articles by Michael addition reaction
US20080004413A1 (en) * 2006-06-30 2008-01-03 Derek Schorzman Carboxylic M2Dx-like siloxanyl monomers
US20080002146A1 (en) * 2006-06-28 2008-01-03 Stachowski Mark J Biocompatible, surface modified materials
US20080003261A1 (en) * 2006-06-30 2008-01-03 Derek Schorzman Fluorinated poly(ether)s end-capped with polymerizable cationic hydrophilic groups
US20080076893A1 (en) * 2006-09-27 2008-03-27 Schorzman Derek A Hydrophilic siloxanyl monomers with pendant polymerizable groups
US20080076898A1 (en) * 2006-09-27 2008-03-27 Salamone Joseph C Water soluble silicone macromonomers for ophthalmic materials
US20080102100A1 (en) * 2006-10-31 2008-05-01 Osman Rathore Processes to prepare antimicrobial contact lenses
US20080103231A1 (en) * 2006-10-31 2008-05-01 Diana Zanini Process for forming clear, wettable silicone hydrogel articles
US20080102095A1 (en) * 2006-10-31 2008-05-01 Kent Young Acidic processes to prepare antimicrobial contact lenses
US20080100797A1 (en) * 2006-10-31 2008-05-01 Nayiby Alvarez-Carrigan Antimicrobial contact lenses with reduced haze and preparation thereof
EP1918310A1 (en) 2006-10-31 2008-05-07 Johnson & Johnson Vision Care, Inc. Polymeric compositions comprising at least one volume excluding polymer
US20080110770A1 (en) * 2006-11-10 2008-05-15 Bausch & Lomb Incorporated Packaging solutions
US20080142038A1 (en) * 2006-12-15 2008-06-19 Bausch & Lomb Incorporated Surface treatment of medical devices
US20080141628A1 (en) * 2006-12-15 2008-06-19 Bausch & Lomb Incorporated Packaging Solutions
US20080143956A1 (en) * 2006-12-15 2008-06-19 Bausch & Lomb Incorporated Silicone contact lenses with wrinkled surface
US20080143955A1 (en) * 2006-12-15 2008-06-19 Bausch & Lomb Incorporated Silicone Contact Lenses with Silicate Coating
US20080148689A1 (en) * 2006-12-20 2008-06-26 Bausch & Lomb Incorporated Packaging solutions
US20080151181A1 (en) * 2006-12-20 2008-06-26 Bausch & Lomb Incorporated Coatings and Solutions for Contact Lenses
US20080151180A1 (en) * 2006-12-20 2008-06-26 Bausch & Lomb Incorporated Coatings and Solutions for Contact Lenses
US20080152540A1 (en) * 2006-12-22 2008-06-26 Bausch & Lomb Incorporated Packaging solutions
US20080182956A1 (en) * 2007-01-26 2008-07-31 Stanbro Jason K Synthesis of cationic siloxane prepolymers
US20080229213A1 (en) * 2007-03-15 2008-09-18 Accenture Global Services Gmbh Establishment of message context in a collaboration system
WO2008116131A2 (en) * 2007-03-22 2008-09-25 Novartis Ag Prepolymers with dangling polysiloxane-containing polymer chains
US20080241225A1 (en) * 2007-03-31 2008-10-02 Hill Gregory A Basic processes to prepare antimicrobial contact lenses
US20080251958A1 (en) * 2006-10-31 2008-10-16 Molock Frank F Light absorbing prepolymers for use in tinted contact lenses and methods for their production
US7461937B2 (en) 2001-09-10 2008-12-09 Johnson & Johnson Vision Care, Inc. Soft contact lenses displaying superior on-eye comfort
EP2014724A1 (en) 2004-03-05 2009-01-14 Johson & Johnson Vision Care Inc. Wettable hydrogels comprising acyclic polyamides
US20090018233A1 (en) * 2007-07-10 2009-01-15 Nunez Ivan M Crosslink Agents and Dual Radical Cure Polymer
US20090023876A1 (en) * 2007-07-20 2009-01-22 Nunez Ivan M Crosslink Agents and Dual Radical Cure Polymer
US20090051060A1 (en) * 2007-03-30 2009-02-26 Yongcheng Li Preparation of antimicrobial contact lenses with reduced haze using swelling agents
US20090093596A1 (en) * 2007-10-03 2009-04-09 Salamone Joseph C Use of silylated sulfonate monomers to improve contact lens wettability
US20090092655A1 (en) * 2007-10-03 2009-04-09 Weihong Lang Novel prepolymerizable surface active monomers with both fluorine-containing groups and hydrophilic groups
US20090100801A1 (en) * 2007-10-23 2009-04-23 Bausch & Lomb Incorporated Packaging Solutions
US20090103045A1 (en) * 2007-10-23 2009-04-23 Yu-Chin Lai Silicone hydrogels with amino surface groups
US20090108479A1 (en) * 2007-10-26 2009-04-30 Bausch & Lomb Incorporated Method for Making Biomedical Devices
US20090122260A1 (en) * 2007-11-14 2009-05-14 Salamone Joseph C Biomedical Devices
US20090142387A1 (en) * 2007-12-03 2009-06-04 Blackwell Richard I Method For Inhibiting Attachment Of Microorganisms To Biomedical Devices
US20090141234A1 (en) * 2007-12-03 2009-06-04 Blackwell Richard I High Water Content Silicone Hydrogels
US20090142485A1 (en) * 2007-11-29 2009-06-04 Yu-Chin Lai Process for Making Biomedical Devices
US20090142292A1 (en) * 2007-12-03 2009-06-04 Blackwell Richard I Method For The Mitigation of Symptoms of Dry Eye
US20090145091A1 (en) * 2007-12-11 2009-06-11 Richard Connolly Method for treating ophthalmic lenses
US20090156745A1 (en) * 2007-12-14 2009-06-18 Yu-Chin Lai Surface modified biomedical devices
US20090156708A1 (en) * 2007-12-14 2009-06-18 Yu-Chin Lai Biomedical devices
US20090171027A1 (en) * 2007-12-27 2009-07-02 Linhardt Jeffrey G Segmented interactive block copolymers
US20090168013A1 (en) * 2007-12-27 2009-07-02 Kunzler Jay F Trimethylsilyl-Capped Polysiloxane Macromonomers Containing Polar Fluorinated Side-Chains
US20090173044A1 (en) * 2008-01-09 2009-07-09 Linhardt Jeffrey G Packaging Solutions
WO2009085756A1 (en) 2007-12-27 2009-07-09 Bausch & Lomb Incorporated Coating solutions comprising segmented interactive block copolymers
US20090173045A1 (en) * 2008-01-09 2009-07-09 Yu-Chin Lai Packaging Solutions
US20090173643A1 (en) * 2008-01-09 2009-07-09 Yu-Chin Lai Packaging Solutions
US20090191256A1 (en) * 2008-01-25 2009-07-30 Blackwell Richard I High water content ophthalmic devices
US20090192275A1 (en) * 2008-01-25 2009-07-30 Salamone Joseph C Multi-armed macromonomers
US20090295004A1 (en) * 2008-06-02 2009-12-03 Pinsly Jeremy B Silicone hydrogel contact lenses displaying reduced protein uptake
US20100069522A1 (en) * 2008-03-17 2010-03-18 Linhardt Jeffrey G Lenses comprising amphiphilic multiblock copolymers
US20100081772A1 (en) * 2008-09-30 2010-04-01 Diana Zanini Process for forming silicone hydrogel articles having improved optical properties
US7691917B2 (en) 2007-06-14 2010-04-06 Bausch & Lomb Incorporated Silcone-containing prepolymers
US20100149482A1 (en) * 2008-12-12 2010-06-17 Ammon Jr Daniel M Contact lens
US20100162661A1 (en) * 2008-12-30 2010-07-01 David Paul Vanderbilt Packaging Solutions
US20100168851A1 (en) * 2008-12-30 2010-07-01 David Paul Vanderbilt Surface Modified Biomedical Devices
US20100168356A1 (en) * 2008-12-30 2010-07-01 Yu-Chin Lai Biomedical Devices
US20100168852A1 (en) * 2008-12-30 2010-07-01 David Paul Vanderbilt Brush Copolymers
US20100168855A1 (en) * 2008-12-30 2010-07-01 Mcgee Joseph A Method of Applying Renewable Polymeric Lens Coating
US20100162663A1 (en) * 2008-12-30 2010-07-01 Mcgee Joseph A Packaging Solutions
US20100168850A1 (en) * 2008-12-30 2010-07-01 David Paul Vanderbilt Brush CoPolymers
JP2010159248A (en) * 2008-12-10 2010-07-22 Rohto Pharmaceut Co Ltd Ophthalmic solution for silicone hydrogel contact lenses
US7781554B2 (en) 2008-03-05 2010-08-24 Bausch & Lomb Incorporated Polysiloxanes and polysiloxane prepolymers with vinyl or epoxy functionality
US20100249356A1 (en) * 2008-09-30 2010-09-30 Osman Rathore Ionic silicone hydrogels having improved hydrolytic stability
US20100280146A1 (en) * 2002-09-06 2010-11-04 Vanderlaan Douglas C Forming clear, wettable silicone hydrogel articles without surface treatments
US7828432B2 (en) 2007-05-25 2010-11-09 Synergeyes, Inc. Hybrid contact lenses prepared with expansion controlled polymeric materials
EP2258736A1 (en) 2000-03-22 2010-12-08 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US20100310622A1 (en) * 2007-12-17 2010-12-09 University Of Florida Research Foundation, Inc. Dry eye treatment by puncta plugs
US20100317816A1 (en) * 2009-06-16 2010-12-16 Bausch & Lomb Incorporated Biomedical devices
US20100315588A1 (en) * 2009-06-16 2010-12-16 Bausch & Lomb Incorporated Biomedical devices
US20100317809A1 (en) * 2009-06-16 2010-12-16 Bausch & Lomb Incorporated Biomedical devices
US20100317817A1 (en) * 2009-06-16 2010-12-16 Bausch & Lomb Incorporated Biomedical devices
WO2010147865A1 (en) 2009-06-16 2010-12-23 Bausch & Lomb Incorporated Multi-armed macromonomers, polymeric materials and contact lenses comprising same
US20110009519A1 (en) * 2009-07-09 2011-01-13 Alok Kumar Awasthi Mono ethylenically unsaturated polymerizable group containing polycarbosiloxane monomers
US20110009658A1 (en) * 2009-07-09 2011-01-13 Alok Kumar Awasthi Mono Ethylenically Unsaturated Polycarbosiloxane Monomers
US20110009587A1 (en) * 2009-07-09 2011-01-13 Alok Kumar Awasthi Mono ethylenically unsaturated polycarbosiloxane monomers
US7879267B2 (en) 2001-08-02 2011-02-01 J&J Vision Care, Inc. Method for coating articles by mold transfer
US7919136B2 (en) 2006-12-15 2011-04-05 Bausch & Lomb Incorporated Surface treatment of biomedical devices
US20110092659A1 (en) * 2007-09-13 2011-04-21 Cognis Ip Management Gmbh Improved Method For Making Tinted Polymers
US7935770B2 (en) 2007-07-03 2011-05-03 Bausch & Lomb Incorporated Surface active prepolymers with both fluorine-containing groups and hydrophilic groups
US7939579B1 (en) 2008-07-09 2011-05-10 Contamac Limited Hydrogels and methods of manufacture
US20110125260A1 (en) * 2008-04-30 2011-05-26 University Of Washington Artificial cornea
US7960465B2 (en) 2006-06-30 2011-06-14 Johnson & Johnson Vision Care, Inc. Antimicrobial lenses, processes to prepare them and methods of their use
WO2011130138A1 (en) 2010-04-13 2011-10-20 Johnson & Johnson Vision Care, Inc. Contact lenses displaying reduced indoor glare
EP2384772A2 (en) 2002-11-22 2011-11-09 Johnson & Johnson Vision Care, Inc. Antimicrobial lenses, processes to prepare them and methods of their use
WO2011140318A1 (en) 2010-05-06 2011-11-10 Johnson & Johnson Vision Care, Inc. Non-reactive, hydrophilic polymers having terminal siloxanes and uses of the same
US8071660B2 (en) 2007-12-14 2011-12-06 Bausch & Lomb Incorporated Surface modified biomedical devices
WO2012006485A2 (en) 2010-07-09 2012-01-12 Lee Darren Norris Polar thermoplastic opthalmic lens molds, opthalmic lenses molded therein, and related methods
WO2012013946A1 (en) 2010-07-30 2012-02-02 Neil Goodenough Vinyl alcohol ophthalmic lens molds, ophthalmic lenses molded therein, and related methods
WO2012047969A1 (en) 2010-10-06 2012-04-12 Novartis Ag Water-processable silicone-containing prepolymers and uses thereof
US8158037B2 (en) 2005-04-08 2012-04-17 Johnson & Johnson Vision Care, Inc. Photochromic materials having extended pi-conjugated systems and compositions and articles including the same
WO2012099555A2 (en) 2007-12-20 2012-07-26 Johnson & Johnson Vision Care, Inc. Cosmetic contact lenses having a sparkle effect
EP2492720A1 (en) 2011-02-28 2012-08-29 CooperVision International Holding Company, LP Wettable Silicone Hydrogel Contact Lenses
EP2492719A1 (en) 2011-02-28 2012-08-29 CooperVision International Holding Company, LP Dimensionally stable silicone hydrogel contact lenses
WO2012118672A2 (en) 2011-02-28 2012-09-07 Coopervision International Holding Company, Lp Silicone hydrogel contact lenses
WO2012118671A1 (en) 2011-02-28 2012-09-07 Coopervision International Holding Company, Lp Phosphine-containing hydrogel contact lenses
WO2012118681A2 (en) 2011-02-28 2012-09-07 Coopervision International Holding Company, Lp Silicone hydrogel contact lenses having acceptable levels of energy loss
WO2012151135A1 (en) 2011-05-04 2012-11-08 Johnson & Johnson Vision Care, Inc. Medical devices having homogeneous charge density and methods for making same
WO2012154268A1 (en) 2011-02-28 2012-11-15 Coopervision International Holding Company, Lp Silicone hydrogel contact lenses
WO2013033554A1 (en) 2011-09-01 2013-03-07 Vertellus Specialties Inc. Biocompatible material
WO2013033553A1 (en) 2011-09-01 2013-03-07 Vertellus Specialties Inc. Methods for producing biocompatible materials
WO2013048990A1 (en) 2011-09-30 2013-04-04 Johnson & Johnson Vision Care, Inc. Silicone hydrogels having improved curing speed and other properties
WO2013048993A1 (en) 2011-09-30 2013-04-04 Johnson & Johnson Vision Care, Inc. Method of creating a visible mark on lens using a leuco dye
WO2013048991A1 (en) 2011-09-30 2013-04-04 Johnson & Johnson Vision Care, Inc. Method of creating a visible mark on lens using a leuco dye
US8415404B2 (en) 1994-09-06 2013-04-09 Ciba Vision Corporation Extended wear ophthalmic lens
US8440738B2 (en) 2008-07-09 2013-05-14 Timothy Higgs Silicone hydrogels and methods of manufacture
EP2597113A1 (en) 2007-12-27 2013-05-29 Bausch & Lomb Incorporated Coating solutions comprising segmented reactive block copolymers
WO2013085814A2 (en) 2011-12-08 2013-06-13 Johnson & Johnson Vision Care, Inc. Monomer systems with dispersed silicone-based engineered particles
WO2013109482A1 (en) 2012-01-17 2013-07-25 Johnson & Johnson Vision Care, Inc. Silicone polymers comprising sulfonic acid groups
US8557940B2 (en) 2010-07-30 2013-10-15 Novartis Ag Amphiphilic polysiloxane prepolymers and uses thereof
US8568626B2 (en) 1994-09-06 2013-10-29 Ciba Vision Corporation Extended wear ophthalmic lens
WO2013176886A2 (en) 2012-05-25 2013-11-28 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
WO2013177523A2 (en) 2012-05-25 2013-11-28 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
WO2013176957A1 (en) 2012-05-25 2013-11-28 Bausch & Lomb Incorporated Method of making a fully polymerized uv blocking silicone hydrogel lens
WO2013177008A1 (en) 2012-05-25 2013-11-28 Bausch & Lomb Incorporated Fully polymerized uv blocking silicone hydrogel lens
JP2013256477A (en) * 2012-06-14 2013-12-26 Shin-Etsu Chemical Co Ltd Method for producing organoxysilane compound having piperazinyl group and piperazine compound
WO2014004107A1 (en) 2012-06-25 2014-01-03 Johnson & Johnson Vision Care, Inc. Lens comprising low and high molecular weight polyamides
WO2014004106A1 (en) 2012-06-25 2014-01-03 Johnson & Johnson Vision Care, Inc. Method of making silicone containing contact lens with reduced amount of diluents
US8696115B2 (en) 2005-02-14 2014-04-15 Johnson & Johnson Vision Care, Inc. Comfortable ophthalmic device and methods of its production
WO2014093751A2 (en) 2012-12-14 2014-06-19 Novartis Ag Amphiphilic siloxane-containing vinylic monomers and uses thereof
WO2014093764A1 (en) 2012-12-14 2014-06-19 Novartis Ag Amphiphilic siloxane-containing (meth)acrylamides and uses thereof
WO2014100171A1 (en) 2012-12-20 2014-06-26 Bausch & Lomb Incorporated Method of preparing water extractable silicon-containing biomedical devices
US8798332B2 (en) 2012-05-15 2014-08-05 Google Inc. Contact lenses
US8807745B2 (en) 2012-05-25 2014-08-19 Bausch & Lomb Incorporated Fully polymerized UV blocking silicone hydrogel lens
US8821811B2 (en) 2012-09-26 2014-09-02 Google Inc. In-vitro contact lens testing
US8820934B1 (en) 2012-09-05 2014-09-02 Google Inc. Passive surface acoustic wave communication
US8827447B2 (en) 2009-07-09 2014-09-09 Bausch & Lomb Incorporated Mono ethylenically unsaturated polymerizable group containing polycarbosiloxane monomers
US8835525B2 (en) 2010-10-06 2014-09-16 Novartis Ag Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains
WO2014143926A1 (en) 2013-03-15 2014-09-18 Bausch & Lomb Incorporated Ethylenically unsaturated polymerizable groups comprising polycarbosiloxane monomers
WO2014149546A1 (en) 2013-03-15 2014-09-25 Johnson & Johnson Vision Care, Inc. Silicone-containing contact lens having clay treatment applied thereto
WO2014149544A1 (en) 2013-03-15 2014-09-25 Johnson & Johnson Vision Care, Inc. Silicone-containing contact lens having reduced amount of silicon on the surface
WO2014151254A1 (en) 2013-03-15 2014-09-25 Bausch & Lomb Incorporated Method and apparatus for delaying polymerisation
US8857981B2 (en) 2012-07-26 2014-10-14 Google Inc. Facilitation of contact lenses with capacitive sensors
US8870370B1 (en) 2012-09-24 2014-10-28 Google Inc. Contact lens that facilitates antenna communication via sensor impedance modulation
US8874182B2 (en) 2013-01-15 2014-10-28 Google Inc. Encapsulated electronics
US8870372B2 (en) 2011-12-14 2014-10-28 Semprus Biosciences Corporation Silicone hydrogel contact lens modified using lanthanide or transition metal oxidants
US8880139B1 (en) 2013-06-17 2014-11-04 Google Inc. Symmetrically arranged sensor electrodes in an ophthalmic electrochemical sensor
US8919953B1 (en) 2012-08-02 2014-12-30 Google Inc. Actuatable contact lenses
US8926809B2 (en) 2013-01-25 2015-01-06 Google Inc. Standby biasing of electrochemical sensor to reduce sensor stabilization time during measurement
WO2015017191A1 (en) 2013-08-02 2015-02-05 Bausch & Lomb Incorporated Hydrogel monomer mix containing added water
US8950068B2 (en) 2013-03-26 2015-02-10 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US8960899B2 (en) 2012-09-26 2015-02-24 Google Inc. Assembling thin silicon chips on a contact lens
US8960898B1 (en) 2012-09-24 2015-02-24 Google Inc. Contact lens that restricts incoming light to the eye
US8965478B2 (en) 2012-10-12 2015-02-24 Google Inc. Microelectrodes in an ophthalmic electrochemical sensor
US8979271B2 (en) 2012-09-25 2015-03-17 Google Inc. Facilitation of temperature compensation for contact lens sensors and temperature sensing
US8980972B2 (en) 2011-11-10 2015-03-17 Vertellus Specialties Inc. Polymerisable material
US8985763B1 (en) 2012-09-26 2015-03-24 Google Inc. Contact lens having an uneven embedded substrate and method of manufacture
US8989834B2 (en) 2012-09-25 2015-03-24 Google Inc. Wearable device
CN104447843A (en) * 2013-09-25 2015-03-25 信越化学工业株式会社 Silicone compound having a radical-polymerizable group and a method for the preparation thereof
US8993651B2 (en) 2010-10-06 2015-03-31 Novartis Ag Polymerizable chain-extended polysiloxanes with pendant hydrophilic groups
US9000063B2 (en) 2011-12-14 2015-04-07 Semprus Biosciences Corporation Multistep UV process to create surface modified contact lenses
US9004682B2 (en) 2011-12-14 2015-04-14 Semprus Biosciences Corporation Surface modified contact lenses
US9006359B2 (en) 2011-12-14 2015-04-14 Semprus Biosciences Corporation Imbibing process for contact lens surface modification
US9009958B2 (en) 2013-03-27 2015-04-21 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US9028772B2 (en) 2013-06-28 2015-05-12 Google Inc. Methods for forming a channel through a polymer layer using one or more photoresist layers
US9039174B2 (en) 2009-07-09 2015-05-26 Bausch & Lomb Incorporated Ethylenically unsaturated polymerizable groups comprising polycarbosiloxane monomers
US9052529B2 (en) 2006-02-10 2015-06-09 Johnson & Johnson Vision Care, Inc. Comfortable ophthalmic device and methods of its production
US9063351B1 (en) 2012-09-28 2015-06-23 Google Inc. Input detection system
US9075187B2 (en) 2012-05-25 2015-07-07 Bausch & Lomb Incorporated Fully polymerized UV blocking silicone hydrogel lens
WO2015108722A1 (en) 2014-01-15 2015-07-23 Johnson & Johnson Vision Care, Inc. Polymers comprising sulfonic acid groups
US9101667B2 (en) 2008-09-30 2015-08-11 Johnson & Johnson Vision Care, Inc. Ionic silicone hydrogels comprising pharmaceutical and/or neuticeutical components and having improved hydrolytic stability
US9111473B1 (en) 2012-08-24 2015-08-18 Google Inc. Input system
US9120119B2 (en) 2011-12-14 2015-09-01 Semprus Biosciences Corporation Redox processes for contact lens modification
US9158133B1 (en) 2012-07-26 2015-10-13 Google Inc. Contact lens employing optical signals for power and/or communication
US9176332B1 (en) 2012-10-24 2015-11-03 Google Inc. Contact lens and method of manufacture to improve sensor sensitivity
US9184698B1 (en) 2014-03-11 2015-11-10 Google Inc. Reference frequency from ambient light signal
US9244196B2 (en) 2012-05-25 2016-01-26 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
US9289954B2 (en) 2013-01-17 2016-03-22 Verily Life Sciences Llc Method of ring-shaped structure placement in an eye-mountable device
US9298020B1 (en) 2012-07-26 2016-03-29 Verily Life Sciences Llc Input system
US9297929B2 (en) 2012-05-25 2016-03-29 Johnson & Johnson Vision Care, Inc. Contact lenses comprising water soluble N-(2 hydroxyalkyl) (meth)acrylamide polymers or copolymers
US9307901B1 (en) 2013-06-28 2016-04-12 Verily Life Sciences Llc Methods for leaving a channel in a polymer layer using a cross-linked polymer plug
US9320460B2 (en) 2012-09-07 2016-04-26 Verily Life Sciences Llc In-situ tear sample collection and testing using a contact lens
US9326710B1 (en) 2012-09-20 2016-05-03 Verily Life Sciences Llc Contact lenses having sensors with adjustable sensitivity
US9332935B2 (en) 2013-06-14 2016-05-10 Verily Life Sciences Llc Device having embedded antenna
US9366570B1 (en) 2014-03-10 2016-06-14 Verily Life Sciences Llc Photodiode operable in photoconductive mode and photovoltaic mode
US9398868B1 (en) 2012-09-11 2016-07-26 Verily Life Sciences Llc Cancellation of a baseline current signal via current subtraction within a linear relaxation oscillator-based current-to-frequency converter circuit
US9492118B1 (en) 2013-06-28 2016-11-15 Life Sciences Llc Pre-treatment process for electrochemical amperometric sensor
US9523865B2 (en) 2012-07-26 2016-12-20 Verily Life Sciences Llc Contact lenses with hybrid power sources
US9572522B2 (en) 2013-12-20 2017-02-21 Verily Life Sciences Llc Tear fluid conductivity sensor
US9594188B2 (en) 2011-12-06 2017-03-14 University Of Florida Research Foundation, Inc. UV blocker loaded contact lenses
US9612364B2 (en) 2011-05-04 2017-04-04 Johnson & Johnson Vision Care, Inc. Medical devices having homogeneous charge density and methods for making same
US9636016B1 (en) 2013-01-25 2017-05-02 Verily Life Sciences Llc Eye-mountable devices and methods for accurately placing a flexible ring containing electronics in eye-mountable devices
US9654674B1 (en) 2013-12-20 2017-05-16 Verily Life Sciences Llc Image sensor with a plurality of light channels
US9685689B1 (en) 2013-06-27 2017-06-20 Verily Life Sciences Llc Fabrication methods for bio-compatible devices
US9696564B1 (en) 2012-08-21 2017-07-04 Verily Life Sciences Llc Contact lens with metal portion and polymer layer having indentations
US9757056B1 (en) 2012-10-26 2017-09-12 Verily Life Sciences Llc Over-molding of sensor apparatus in eye-mountable device
US9789655B1 (en) 2014-03-14 2017-10-17 Verily Life Sciences Llc Methods for mold release of body-mountable devices including microelectronics
US9814387B2 (en) 2013-06-28 2017-11-14 Verily Life Sciences, LLC Device identification
WO2018009309A1 (en) 2016-07-06 2018-01-11 Johnson & Johnson Vision Care, Inc. Increased stiffness center optic in soft contact lenses for astigmatism correction
WO2018009310A1 (en) 2016-07-06 2018-01-11 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising high levels of polyamides
WO2018009311A1 (en) 2016-07-06 2018-01-11 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising polyamides
WO2018009312A1 (en) 2016-07-06 2018-01-11 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising n-alkyl methacrylamides and contact lenses made thereof
US9880324B2 (en) 2004-04-01 2018-01-30 Novartis Ag Colored ink for pad transfer printing of silicone hydrogel lenses
US9884180B1 (en) 2012-09-26 2018-02-06 Verily Life Sciences Llc Power transducer for a retinal implant using a contact lens
WO2018026822A1 (en) 2016-08-05 2018-02-08 Johnson & Johnson Vision Care, Inc. Polymer compositions containing grafted polymeric networks and processes for their preparation and use
WO2018067284A1 (en) 2016-10-06 2018-04-12 Johnson & Johnson Vision Care, Inc. Tri-block prepolymers and their use in silicone hydrogels
US9948895B1 (en) 2013-06-18 2018-04-17 Verily Life Sciences Llc Fully integrated pinhole camera for eye-mountable imaging system
US9965583B2 (en) 2012-09-25 2018-05-08 Verily Life Sciences, LLC Information processing method
US10010270B2 (en) 2012-09-17 2018-07-03 Verily Life Sciences Llc Sensing system
WO2019003064A1 (en) 2017-06-30 2019-01-03 Johnson & Johnson Vision Care, Inc. Hydroxyphenyl phenanthrolines as polymerizable blockers of high energy light for preparing ophthalmic devices, such as e.g. contact lenses
WO2019002971A1 (en) 2017-06-26 2019-01-03 Johnson & Johnson Vision Care, Inc. Polymerizable blockers of high energy light
US10209534B2 (en) 2012-03-27 2019-02-19 Johnson & Johnson Vision Care, Inc. Increased stiffness center optic in soft contact lenses for astigmatism correction
EP3456758A1 (en) 2011-02-28 2019-03-20 CooperVision International Holding Company, LP Silicone hydrogel contact lenses and related compositions and methods
WO2019147425A1 (en) 2018-01-26 2019-08-01 Bausch & Lomb Incorporated Method for end-capping a polysiloxane prepolymer
WO2019150216A1 (en) 2018-01-30 2019-08-08 Johnson & Johnson Vision Care, Inc. Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use
WO2019150217A1 (en) 2018-01-30 2019-08-08 Johnson & Johnson Vision Care, Inc. Ophthalmic devices containing localized grafted networks and processes for their preparation and use
WO2019162881A1 (en) 2018-02-26 2019-08-29 Novartis Ag Silicone hydrogel contact lenses
WO2019166971A1 (en) 2018-03-02 2019-09-06 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of uv and high energy visible light
WO2019186426A1 (en) 2018-03-28 2019-10-03 Alcon Inc. Method for making silicone hydrogel contact lenses
US10445313B1 (en) 2007-09-21 2019-10-15 United Services Automobile Association (Usaa) Systems, methods, and computer readable media for managing a hosts file
EP3557290A1 (en) 2006-06-15 2019-10-23 CooperVision International Holding Company, LP Wettable silicone hydrogel contact lenses and related compositions and methods
WO2019212657A1 (en) 2018-05-01 2019-11-07 Bausch & Lomb Incorporated Ophthalmic devices containing uv blocker and methods for their preparation
WO2019221838A1 (en) 2018-05-15 2019-11-21 Bausch & Lomb Incorporated Water extractable ophthalmic devices
EP3572028A1 (en) 2012-07-06 2019-11-27 Peter J. Zegarelli An oral appliance for delivery of medicaments and/or other substances
WO2019234593A1 (en) 2018-06-04 2019-12-12 Alcon Inc. Method for producing silicone hydrogel contact lenses
WO2019234591A1 (en) 2018-06-04 2019-12-12 Alcon Inc. Method for producing silicone hydrogel contact lenses
WO2019234590A1 (en) 2018-06-04 2019-12-12 Alcon Inc. Method for making silicone hydrogel contact lenses
WO2020003022A1 (en) 2018-06-29 2020-01-02 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of uv and high energy visible light
US10526296B2 (en) 2017-06-30 2020-01-07 Johnson & Johnson Vision Care, Inc. Hydroxyphenyl naphthotriazoles as polymerizable blockers of high energy light
WO2020009747A1 (en) 2018-07-03 2020-01-09 Bausch & Lomb Incorporated Water extractable ophthalmic devices
WO2020032973A1 (en) 2018-08-10 2020-02-13 Bausch & Lomb Incorporated Ophthalmic devices
WO2020032972A1 (en) 2018-08-10 2020-02-13 Bausch & Lomb Incorporated High water content ophthalmic devices
WO2020065430A1 (en) 2018-09-26 2020-04-02 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of uv and high energy visible light
WO2020159915A1 (en) 2019-01-29 2020-08-06 Bausch & Lomb Incorporated Packaging solutions for contact lenses
WO2020159690A1 (en) 2019-01-30 2020-08-06 Bausch & Lomb Incorporated Crosslinked polymeric network and use thereof
US10816822B2 (en) 2010-04-13 2020-10-27 Johnson & Johnson Vision Care, Inc. Pupil-only photochromic contact lenses displaying desirable optics and comfort
WO2020222914A1 (en) 2019-04-29 2020-11-05 Bausch & Lomb Incorporated Glycophospholipid polymeric network and use thereof
WO2020230016A1 (en) 2019-05-13 2020-11-19 Alcon Inc. Method for producing photochromic contact lenses
WO2020240440A1 (en) 2019-05-28 2020-12-03 Alcon Inc. Method for making opaque colored silicone hydrogel contact lenses
WO2020261091A1 (en) 2019-06-28 2020-12-30 Johnson & Johnson Vision Care, Inc. Photostable mimics of macular pigment
WO2020261001A1 (en) 2019-06-24 2020-12-30 Johnson & Johnson Vision Care, Inc. Silicone hydrogel contact lenses having non-uniform morphology
WO2020261021A1 (en) 2019-06-28 2020-12-30 Johnson & Johnson Vision Care, Inc. Polymerizable fused tricyclic compounds as absorbers of uv and visible light
WO2021001706A1 (en) 2019-07-02 2021-01-07 Johnson & Johnson Vision Care, Inc. Core-shell particles and methods of making and using thereof
US10894374B2 (en) 2010-04-13 2021-01-19 Johnson & Johnson Vision Care, Inc. Process for manufacture of a thermochromic contact lens material
WO2021038369A1 (en) 2019-08-30 2021-03-04 Johnson & Johnson Vision Care, Inc. Multifocal contact lens displaying improved vision attributes
WO2021038368A1 (en) 2019-08-30 2021-03-04 Johnson & Johnson Vision Care, Inc. Contact lens displaying improved vision attributes
WO2021053057A1 (en) 2019-09-20 2021-03-25 Bausch Health Ireland Limited Grafted polymer and use thereof
US10996491B2 (en) 2018-03-23 2021-05-04 Johnson & Johnson Vision Care, Inc. Ink composition for cosmetic contact lenses
WO2021090169A1 (en) 2019-11-04 2021-05-14 Alcon Inc. Contact lenses with surfaces having different softness
WO2021124099A1 (en) 2019-12-16 2021-06-24 Alcon Inc. Wettable silicone hydrogel contact lenses
WO2021124001A1 (en) 2019-12-19 2021-06-24 Johnson & Johnson Vision Care, Inc. Contact lens containing photosensitive chromophore and package therefor
WO2021181307A1 (en) 2020-03-11 2021-09-16 Alcon Inc. Photochromic polydiorganosiloxane vinylic crosslinkers
WO2021186383A1 (en) 2020-03-19 2021-09-23 Alcon Inc. Embedded silicone hydrogel contact lenses
WO2021186381A1 (en) 2020-03-19 2021-09-23 Alcon Inc. Insert materials with high oxygen permeability and high refractive index
WO2021186296A1 (en) 2020-03-18 2021-09-23 Johnson & Johnson Vision Care, Inc. Ophthalmic devices containing transition metal complexes as high energy visible light filters
WO2021186382A1 (en) 2020-03-19 2021-09-23 Alcon Inc. High refractive index siloxane insert materials for embedded contact lenses
WO2021224855A1 (en) 2020-05-07 2021-11-11 Alcon Inc. Method for producing silicone hydrogel contact lenses
WO2021245551A1 (en) 2020-06-02 2021-12-09 Alcon Inc. Method for making photochromic contact lenses
WO2021255552A1 (en) 2020-06-16 2021-12-23 Johnson & Johnson Vision Care, Inc. Amino acid-based polymerizable compounds and ophthalmic devices prepared therefrom
WO2021255536A1 (en) 2020-06-15 2021-12-23 Johnson & Johnson Vision Care, Inc. Systems and methods for indicating the time elapsed since the occurrence of a triggering event
WO2021255551A1 (en) 2020-06-16 2021-12-23 Johnson & Johnson Vision Care, Inc. Imidazolium zwitterion polymerizable compounds and ophthalmic devices incorporating them
WO2022023966A1 (en) 2020-07-28 2022-02-03 Alcon Inc. Contact lenses with softer lens surfaces
WO2022034010A1 (en) 2020-08-10 2022-02-17 Bausch + Lomb Ireland Limited Packaging solutions
WO2022079630A1 (en) 2020-10-13 2022-04-21 Johnson & Johnson Vision Care, Inc. Contact lens position and rotation control using the pressure of the eyelid margin
WO2022090967A1 (en) 2020-10-28 2022-05-05 Alcon Inc. Method for making photochromic contact lenses
WO2022097049A1 (en) 2020-11-04 2022-05-12 Alcon Inc. Method for making photochromic contact lenses
WO2022097048A1 (en) 2020-11-04 2022-05-12 Alcon Inc. Method for making photochromic contact lenses
WO2022130089A1 (en) 2020-12-18 2022-06-23 Johnson & Johnson Vision Care, Inc. Photostable mimics of macular pigment
WO2022172154A1 (en) 2021-02-09 2022-08-18 Alcon Inc. Hydrophilized polydiorganosiloxane vinylic crosslinkers
WO2022184542A1 (en) 2021-03-05 2022-09-09 Bausch + Lomb Ireland Limited Molds for production of ophthalmic devices
WO2022189941A1 (en) 2021-03-08 2022-09-15 Alcon Inc. Method for making photochromic contact lenses
WO2022189517A1 (en) 2021-03-11 2022-09-15 Bausch + Lomb Ireland Limited Packaging solutions
WO2022201013A1 (en) 2021-03-23 2022-09-29 Alcon Inc. Polysiloxane vinylic crosslinkers with high refractive index
WO2022201072A1 (en) 2021-03-24 2022-09-29 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2022208448A1 (en) 2021-04-01 2022-10-06 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2022208450A1 (en) 2021-04-01 2022-10-06 Alcon Inc. Method for making photochromic contact lenses
WO2022208447A1 (en) 2021-04-01 2022-10-06 Alcon Inc. Embedded hydrogel contact lenses
WO2022248127A2 (en) 2021-05-26 2022-12-01 Bausch + Lomb Ireland Limited Packaging solutions
WO2022263994A1 (en) 2021-06-14 2022-12-22 Alcon Inc. Multifocal diffractive silicone hydrogel contact lenses
WO2023275683A1 (en) 2021-06-30 2023-01-05 Johnson & Johnson Vision Care, Inc. Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use
WO2023274748A1 (en) 2021-06-30 2023-01-05 Bausch + Lomb Ireland Limited High water content biomedical devices
WO2023275685A1 (en) 2021-06-30 2023-01-05 Johnson & Johnson Vision Care, Inc. Transition metal complexes as visible light absorbers
WO2023030715A1 (en) 2021-08-31 2023-03-09 Bausch + Lomb Ireland Limited Ophthalmic devices and method of manufacturing
WO2023030717A1 (en) 2021-08-31 2023-03-09 Bausch + Lomb Ireland Limited Ophthalmic devices and method of manufacturing
WO2023030716A1 (en) 2021-08-31 2023-03-09 Bausch + Lomb Ireland Limited Ophthalmic devices
WO2023052890A1 (en) 2021-09-29 2023-04-06 Johnson & Johnson Vision Care, Inc. Anthraquinone-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses
WO2023052888A1 (en) 2021-09-29 2023-04-06 Johnson & Johnson Vision Care, Inc. Ophthalmic lenses and their manufacture by in-mold modification
WO2023052889A1 (en) 2021-09-29 2023-04-06 Johnson & Johnson Vision Care, Inc. Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses
WO2023094265A1 (en) 2021-11-23 2023-06-01 Bausch + Lomb Ireland Limited Method for making a preservative-free packaged ophthalmic device product
WO2023119021A1 (en) 2021-12-20 2023-06-29 Johnson & Johnson Vision Care, Inc. Contact lenses containing light absorbing regions and methods for their preparation
WO2023148171A1 (en) 2022-02-02 2023-08-10 Bausch + Lomb Ireland Limited Multifunctional crosslinking agents and ophthalmic devices formed therefrom
US11724471B2 (en) 2019-03-28 2023-08-15 Johnson & Johnson Vision Care, Inc. Methods for the manufacture of photoabsorbing contact lenses and photoabsorbing contact lenses produced thereby
US11733440B1 (en) 2022-04-28 2023-08-22 Johnson & Johnson Vision Care, Inc. Thermally stable nanoparticles and methods thereof
WO2023161325A1 (en) 2022-02-24 2023-08-31 Bausch + Lomb Ireland Limited Ophthalmic devices
WO2023209631A1 (en) 2022-04-28 2023-11-02 Alcon Inc. Method for making uv and hevl-absorbing ophthalmic lenses
WO2023209449A1 (en) 2022-04-28 2023-11-02 Johnson & Johnson Vision Care, Inc. Light-filtering materials for biomaterial integration and methods thereof
WO2023209447A1 (en) 2022-04-28 2023-11-02 Johnson & Johnson Vision Care, Inc. Particle surface modification to increase compatibility and stability in hydrogels
WO2023209450A1 (en) 2022-04-28 2023-11-02 Johnson & Johnson Vision Care, Inc. Using particles for light filtering
WO2023209630A1 (en) 2022-04-29 2023-11-02 Alcon Inc. Method for making silicone hydrogel contact lenses
WO2023209570A1 (en) 2022-04-26 2023-11-02 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2023209446A1 (en) 2022-04-28 2023-11-02 Johnson & Johnson Vision Care, Inc. Shape engineering of particles to create a narrow spectral filter against a specific portion of the light spectrum
WO2023209569A1 (en) 2022-04-26 2023-11-02 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2023218324A1 (en) 2022-05-09 2023-11-16 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2023228055A1 (en) 2022-05-23 2023-11-30 Alcon Inc. Uv/hevl-filtering contact lenses
WO2023228106A1 (en) 2022-05-25 2023-11-30 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2023228054A1 (en) 2022-05-23 2023-11-30 Alcon Inc. Method for making hevl-filtering contact lenses
WO2023242688A1 (en) 2022-06-16 2023-12-21 Johnson & Johnson Vision Care, Inc. Ophthalmic devices containing photostable mimics of macular pigment and other visible light filters
US11891526B2 (en) 2019-09-12 2024-02-06 Johnson & Johnson Vision Care, Inc. Ink composition for cosmetic contact lenses
WO2024038390A1 (en) 2022-08-17 2024-02-22 Alcon Inc. A contact lens with a hydrogel coating thereon
US11912800B2 (en) 2021-09-29 2024-02-27 Johnson & Johnson Vision Care, Inc. Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses
US11993037B1 (en) 2018-03-02 2024-05-28 Johnson & Johnson Vision Care, Inc. Contact lens displaying improved vision attributes
WO2024127114A1 (en) 2022-12-15 2024-06-20 Johnson & Johnson Vision Care, Inc. Transition metal complexes as visible light absorbers
WO2024134382A1 (en) 2022-12-21 2024-06-27 Johnson & Johnson Vision Care, Inc. Compositions for ophthalmologic devices
WO2024146878A1 (en) 2023-01-04 2024-07-11 Bausch + Lomb Ireland Limited Biomedical devices having a surface coating
WO2024156667A1 (en) 2023-01-24 2024-08-02 Bausch + Lomb Ireland Limited Ophthalmic devices having a high refractive index and abbe number
WO2024161344A1 (en) 2023-02-02 2024-08-08 Alcon Inc. Water gradient silicone hydrogel contact lenses
WO2024180452A1 (en) 2023-02-27 2024-09-06 Alcon Inc. A method for producing wettable silicone hydrogel contact lenses
WO2024183985A1 (en) 2023-03-08 2024-09-12 Bausch + Lomb Ireland Limited Contact lens containing deprotected ultraviolet blockers
WO2024194826A1 (en) 2023-03-22 2024-09-26 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2024193881A1 (en) 2023-03-22 2024-09-26 Bausch + Lomb Ireland Limited Silicone hydrogels
WO2024194792A1 (en) 2023-03-20 2024-09-26 Johnson & Johnson Vision Care, Inc. Ophthalmic lenses and their manufacture by in-mold modification
WO2024193880A1 (en) 2023-03-22 2024-09-26 Bausch + Lomb Ireland Limited Monofunctional silicone monomers and silicone hydrogels formed therefrom
WO2024201156A1 (en) 2023-03-28 2024-10-03 Johnson & Johnson Vision Care, Inc. Grafted opthalmic devices containing deactivated regions and processes for their preparation and use
US12128641B2 (en) 2023-05-19 2024-10-29 Johnson & Johnson Vision Care, Inc. Methods for the manufacture of photoabsorbing contact lenses and photoabsorbing contact lenses produced thereby

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2514455B2 (en) * 1990-05-17 1996-07-10 日本ペイント株式会社 Carbonate compounds containing double and triple bonds in the molecule
US5358995A (en) * 1992-05-15 1994-10-25 Bausch & Lomb Incorporated Surface wettable silicone hydrogels
US5777032A (en) * 1996-03-04 1998-07-07 Menicon Co., Ltd. Ocular lens and a method for its production
JP4330268B2 (en) * 1997-09-03 2009-09-16 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Novel biomimetic hydrogel materials
US5981617A (en) * 1998-01-20 1999-11-09 Kim; Hee Jung Irradiation of gas permeable contact lenses by far infrared light
US5945465A (en) * 1998-05-15 1999-08-31 Bausch & Lomb Incorporated Method for polymerizing contact lenses having UV absorbing properties
US6359024B2 (en) 1998-05-15 2002-03-19 Bausch & Lomb Incorporated Method for polymerizing contact lenses
US5914355A (en) * 1998-05-15 1999-06-22 Bausch & Lomb Incorporated Method for making contact lenses having UV absorbing properties
US6649722B2 (en) * 1999-12-10 2003-11-18 Novartis Ag Contact lens
US6559260B1 (en) * 2000-03-27 2003-05-06 Sartomer Technology Company, Inc. Allyl urethane resin compositions
US6428839B1 (en) 2000-06-02 2002-08-06 Bausch & Lomb Incorporated Surface treatment of medical device
JP4622071B2 (en) * 2000-09-14 2011-02-02 東レ株式会社 Monomers, polymers, ophthalmic lenses and contact lenses
US6555596B1 (en) * 2000-11-06 2003-04-29 Arco Chemical Technology, L.P. Multifunctional allyl carbamates and coatings therefrom
US6759496B2 (en) 2000-12-18 2004-07-06 Bausch & Lomb Incorporated Poly(2-oxazoline) biomedical devices
US6815074B2 (en) 2001-05-30 2004-11-09 Novartis Ag Polymeric materials for making contact lenses
US6908978B2 (en) 2001-11-02 2005-06-21 Bausch & Lomb Incorporated High refractive index polymeric siloxysilane compositions
US7169874B2 (en) * 2001-11-02 2007-01-30 Bausch & Lomb Incorporated High refractive index polymeric siloxysilane compositions
US6776934B2 (en) 2001-11-02 2004-08-17 Bausch & Lomb Incorporated Method for polymerizing lenses
DE10215962A1 (en) * 2002-04-11 2003-10-30 Wacker Polymer Systems Gmbh Organopolymers of silicone and their saponification products
US20050245753A1 (en) * 2004-05-03 2005-11-03 Cruse Richard W Cyclic diol-derived blocked mercaptofunctional silane compositions
WO2005123653A1 (en) * 2004-06-16 2005-12-29 Asahi Glass Company, Limited Fluoroadamantane derivative
US7531588B2 (en) 2004-07-30 2009-05-12 Momentive Performance Materials Inc. Silane compositions, processes for their preparation and rubber compositions containing same
US7928258B2 (en) 2004-08-20 2011-04-19 Momentive Performance Materials Inc. Cyclic diol-derived blocked mercaptofunctional silane compositions
US20060069178A1 (en) * 2004-09-24 2006-03-30 Bausch & Lomb Incorporated Method for polymerizing ophthalmic devices
US20060071356A1 (en) * 2004-10-04 2006-04-06 Kevin Beebe Method for separating excess material from a lens mold
US7694822B2 (en) * 2005-05-02 2010-04-13 Covidien Ag Medical implement disposal and collection device
TW200704641A (en) * 2005-06-21 2007-02-01 Bausch & Lomb Novel method for the preparation of vinyl carbonate capped polydimethylsiloxanes
US7423108B2 (en) * 2005-12-16 2008-09-09 Bausch & Lomb Incorporated High refractive-index siloxy-containing monomers and polymers, and ophthalmic devices comprising such polymers
US7544371B2 (en) * 2005-12-20 2009-06-09 Bausch + Lomb Incorporated Drug delivery systems
US20070148244A1 (en) * 2005-12-22 2007-06-28 Kunzler Jay F Drug delivery systems
US7718819B2 (en) 2006-02-21 2010-05-18 Momentive Performance Materials Inc. Process for making organofunctional silanes and mixtures thereof
US7510670B2 (en) 2006-02-21 2009-03-31 Momentive Performance Materials Inc. Free flowing filler composition based on organofunctional silane
US7919650B2 (en) 2006-02-21 2011-04-05 Momentive Performance Materials Inc. Organofunctional silanes and their mixtures
US7504456B2 (en) 2006-02-21 2009-03-17 Momentive Performance Materials Inc. Rubber composition containing organofunctional silane
US7572841B2 (en) * 2006-06-15 2009-08-11 Coopervision International Holding Company, Lp Wettable silicone hydrogel contact lenses and related compositions and methods
US7540609B2 (en) * 2006-06-15 2009-06-02 Coopervision International Holding Company, Lp Wettable silicone hydrogel contact lenses and related compositions and methods
US8569538B2 (en) * 2006-06-30 2013-10-29 Johnson & Johnson Vision Care, Inc. Acryloyl materials for molded plastics
US8053539B2 (en) * 2006-06-30 2011-11-08 Johnson & Johnson Vision Care Inc. Siloxanyl materials for molded plastics
US8097744B2 (en) 2006-08-14 2012-01-17 Momentive Performance Materials Inc. Free flowing filler composition comprising mercapto-functional silane
US7368584B2 (en) 2006-08-14 2008-05-06 Momentive Performance Materials Inc. Mercapto-functional silane
US7550540B2 (en) 2006-08-14 2009-06-23 Momentive Performance Materials Inc. Rubber composition and articles therefrom both comprising mercapto-functional silane
US8008519B2 (en) 2006-08-14 2011-08-30 Momentive Performance Materials Inc. Process for making mercapto-functional silane
US9056880B2 (en) 2006-09-29 2015-06-16 Johnson & Johnson Vision Care, Inc. Process for producing hydrolysis-resistant silicone compounds
US7838698B2 (en) * 2006-09-29 2010-11-23 Johnson & Johnson Vision Care, Inc. Hydrolysis-resistant silicone compounds
US20080119627A1 (en) * 2006-11-22 2008-05-22 Masataka Nakamura Methods for purifying siloxanyl monomers
WO2008084086A1 (en) * 2007-01-12 2008-07-17 Basf Se Method for the production of o-vinylcarbamates and vinylcarbonates
US20100178316A1 (en) * 2007-05-30 2010-07-15 Anuj Chauhan Extended release of bioactive molecules from silicone hydrogels
US8080622B2 (en) 2007-06-29 2011-12-20 Johnson & Johnson Vision Care, Inc. Soluble silicone prepolymers
US8075909B2 (en) * 2007-09-04 2011-12-13 University Of Florida Research Foundation, Incorporated Contact lens based bioactive agent delivery system
US7816435B2 (en) 2007-10-31 2010-10-19 Momentive Performance Materials Inc. Halo-functional silane, process for its preparation, rubber composition containing same and articles manufactured therefrom
JP2011505179A (en) * 2007-11-23 2011-02-24 テヒニーシェ ウニヴェルジテート ウィーン Polymeric curable compositions for the preparation of polyvinyl alcohol-based biodegradable, biocompatible, crosslinked polymers
AT506726B1 (en) * 2008-03-25 2012-03-15 Univ Wien Tech USE OF POLYMERIZATION CURABLE COMPOSITIONS FOR THE MANUFACTURE OF BIODEGRADABLE, BIOVEROUS, NETWORKED POLYMERS BASED ON POLYVINYL ALCOHOL
US7897654B2 (en) * 2007-12-27 2011-03-01 Johnson & Johnson Vision Care Inc. Silicone prepolymer solutions
US9144642B2 (en) 2009-09-18 2015-09-29 Becton, Dickinson And Company Shipping container integrating a sharps disposal container with a new product storage container
US9650335B2 (en) * 2011-01-17 2017-05-16 Isp Investments Llc Compounds, monomers, and polymers containing a carbonate linkage
US8273914B1 (en) 2011-06-27 2012-09-25 Bausch & Lomb Incorporated Process for preparing vinyl chloroformate
WO2013024799A1 (en) * 2011-08-17 2013-02-21 東レ株式会社 Medical treatment device, composition for coating solution, and method for manufacturing medical treatment device
WO2014116996A1 (en) * 2013-01-25 2014-07-31 Washington State University Research Foundation Derivatives of fatty esters, fatty acids and rosins
JP6939706B2 (en) * 2018-05-30 2021-09-22 信越化学工業株式会社 Carbonate group-containing silane compound and its production method
EP3914635A4 (en) * 2020-01-23 2022-10-19 ISP Investments LLC Dihydroxy lactam based polymers, compositions and applications thereof
US11905351B2 (en) 2020-04-10 2024-02-20 Envision Biomedical LLC Silicone hydrogel materials

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153641A (en) * 1977-07-25 1979-05-08 Bausch & Lomb Incorporated Polysiloxane composition and contact lens
US4189546A (en) * 1977-07-25 1980-02-19 Bausch & Lomb Incorporated Polysiloxane shaped article for use in biomedical applications
US4195030A (en) * 1979-01-10 1980-03-25 Bausch & Lomb Incorporated Preparation of monomeric organosilicon esters
EP0079814A2 (en) * 1981-11-13 1983-05-25 Societe Nationale Des Poudres Et Explosifs Polymerisable composition of an organic resin and a diluent at least partly composed of vinyl carbonate
US4837349A (en) * 1985-09-19 1989-06-06 Suntory Limited Tertiary-butyldimethylsilyl carbamate derivative and process for producing the same
US4861908A (en) * 1987-07-08 1989-08-29 Shin-Etsu Chemical Co., Ltd. Organosilicon compound

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2532011A (en) * 1946-09-07 1950-11-28 Minnesota Mining & Mfg Liners and adhesive tapes having low adhesion polyvinyl carbamate coatings
GB1116005A (en) 1966-02-21 1968-06-06 Dow Chemical Co Vinyl n-heterocyclic carbamates, process for their production and polymers thereof
DE1670515A1 (en) * 1966-03-15 1970-11-12 Dow Chemical Co Process for the preparation of N-heterocyclic vinyl carbamates
US3622482A (en) * 1969-07-16 1971-11-23 Union Carbide Corp Polymeric compositions stabilized & photosensitized by substituted & unsubstituted acylarylesters of organic monocarboxylic acids
US4119106A (en) * 1975-10-22 1978-10-10 Philip Morris, Incorporated Flavorant-release resin compositions
US4212310A (en) * 1977-12-12 1980-07-15 Philip Morris Incorporated Unitary pack of smoking tobacco products containing polymeric alcohol flavorant-release compositions
JPS55115849A (en) * 1979-02-28 1980-09-06 Yasumitsu Tamura Isopropenyl carbonate, its preparation, and protection of hydroxyl, amino, or imino group with it
JPS5936105A (en) * 1982-08-24 1984-02-28 Nippon Oil & Fats Co Ltd Manufacture of plastic lenz
FR2533561B1 (en) * 1982-09-24 1986-07-25 Poudres & Explosifs Ste Nale PROCESS FOR THE PREPARATION OF VINYL CARBAMATES AND NOVEL VINYL CARBAMATES
US4625007A (en) * 1982-09-30 1986-11-25 Polymer Technology Corporation Silicone-containing contact lens material and contact lenses made thereof
IT1160172B (en) * 1983-01-13 1987-03-04 Anic Spa POLYMERIZABLE LIQUID COMPOSITION, SUITABLE FOR PRODUCING POLYMERS WITH HIGH OPTICAL AND MECHANICAL CHARACTERISTICS AND POLYMERS AND MANUFACTURES OBTAINED FROM THAT COMPOSITION
JPS60103304A (en) * 1983-11-11 1985-06-07 Seiko Epson Corp Plastic lens having high-refractive index
JPS60104041A (en) * 1983-11-11 1985-06-08 Tokuyama Soda Co Ltd Production of allyl carbonate
FR2566401B1 (en) * 1984-06-20 1986-09-12 Atochem PROCESS FOR THE PREPARATION OF FLUORINATED OLEFINS AND NEW OLEFINS THEREFROM
DE3524519A1 (en) * 1984-07-11 1986-01-16 Mitsubishi Chemical Industries Ltd., Tokio/Tokyo Dyes for heat-sensitive sublimation transfer recording
JPH0676558B2 (en) * 1984-12-21 1994-09-28 三菱化成株式会社 Indoaniline compounds and dyes for thermal transfer recording
IT1183525B (en) * 1985-03-29 1987-10-22 Enichem Sintesi PROCEDURE FOR THE PRODUCTION OF THERMOFORMED ITEMS
US5173552A (en) * 1985-03-29 1992-12-22 Enichem Sintesi S.P.A. Process for the production of thermoformed articles by polymerizing compositions comprising diethylene glycol bis (allylcarbonate)
US4746716A (en) * 1985-12-27 1988-05-24 Ppg Industries, Inc. Compositions for producing polymers of high refractive index and low yellowness
FR2603886B1 (en) * 1986-09-12 1988-12-16 Poudres & Explosifs Ste Nale PROCESS FOR THE PREPARATION OF ALKENYL-1 CARBONATES
JPS63145310A (en) * 1986-12-06 1988-06-17 Agency Of Ind Science & Technol Optical plastic material
FR2611729B1 (en) * 1987-02-24 1989-06-16 Rhone Poulenc Chimie PROCESS FOR THE PREPARATION OF AN ACRYLATE AND / OR METHACRYLATE ORGANOPOLYSILOXANE
IT1223527B (en) * 1987-12-18 1990-09-19 Enichem Sintesi POLYMERIZABLE LIQUID COMPOSITION IN ORGANIC GLASSES EQUIPPED WITH LOW WATER ABSORPTION AND HIGH THERMAL STABILITY
US5070215A (en) 1989-05-02 1991-12-03 Bausch & Lomb Incorporated Novel vinyl carbonate and vinyl carbamate contact lens material monomers
US5220047A (en) * 1990-09-17 1993-06-15 Union Carbide Chemicals & Plastics Technology Corporation Carbamate silicon compounds as latent coupling agents and process for preparation and use
US5177165A (en) * 1990-11-27 1993-01-05 Bausch & Lomb Incorporated Surface-active macromonomers
US5274008A (en) * 1990-11-27 1993-12-28 Bausch & Lomb Incorporated Mold materials for silicone containing lens materials
US5219965A (en) * 1990-11-27 1993-06-15 Bausch & Lomb Incorporated Surface modification of polymer objects
US5391677A (en) * 1991-07-23 1995-02-21 Shin-Etsu Chemical Co., Ltd. Acrylic-functional organopolysiloxane and method for the preparation thereof
US5336797A (en) * 1992-12-30 1994-08-09 Bausch & Lomb Incorporated Siloxane macromonomers
US5352816A (en) * 1993-12-28 1994-10-04 Three Bond Co., Ltd. Organosilicon compound

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153641A (en) * 1977-07-25 1979-05-08 Bausch & Lomb Incorporated Polysiloxane composition and contact lens
US4189546A (en) * 1977-07-25 1980-02-19 Bausch & Lomb Incorporated Polysiloxane shaped article for use in biomedical applications
US4195030A (en) * 1979-01-10 1980-03-25 Bausch & Lomb Incorporated Preparation of monomeric organosilicon esters
EP0079814A2 (en) * 1981-11-13 1983-05-25 Societe Nationale Des Poudres Et Explosifs Polymerisable composition of an organic resin and a diluent at least partly composed of vinyl carbonate
US4837349A (en) * 1985-09-19 1989-06-06 Suntory Limited Tertiary-butyldimethylsilyl carbamate derivative and process for producing the same
US4861908A (en) * 1987-07-08 1989-08-29 Shin-Etsu Chemical Co., Ltd. Organosilicon compound

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Vol. 16, Polymer Bulletin 16, pp. 391 394 (1986), Bernard Boutevin et al., Polymerization Synthesis & Polymerization of Fluorinated, Chlorinated & Deuterated Vinyl Carbonates . *
Vol. 16, Polymer Bulletin 16, pp. 391-394 (1986), Bernard Boutevin et al., "Polymerization--Synthesis & Polymerization of Fluorinated, Chlorinated & Deuterated Vinyl Carbonates".
Vol. 24, Journal of Polymer Science, Part C, pp. 75 88 (1968) Poly(vinyl Chloroformate) & Derivatives: Preparation & Properties , J. R. Schaefgen. *
Vol. 24, Journal of Polymer Science, Part C, pp. 75-88 (1968) "Poly(vinyl Chloroformate) & Derivatives: Preparation & Properties", J. R. Schaefgen.
Vol. 4, Polymer Bulletin 4, pp. 705 710 (1981), Gilles Meunier et al., Polymerization & Copolymerization of Vinyl Carbamates & Vinyl Carbonates . *
Vol. 4, Polymer Bulletin 4, pp. 705-710 (1981), Gilles Meunier et al., "Polymerization & Copolymerization of Vinyl Carbamates & Vinyl Carbonates".

Cited By (829)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610252A (en) * 1989-05-02 1997-03-11 Bausch & Lomb Incorporated Vinyl carbonate and vinyl carbamate contact lens material monomers
US5364918A (en) * 1990-11-27 1994-11-15 Bausch & Lomb Incorporated Surface modification of polymer objects
US5177165A (en) * 1990-11-27 1993-01-05 Bausch & Lomb Incorporated Surface-active macromonomers
US5274008A (en) * 1990-11-27 1993-12-28 Bausch & Lomb Incorporated Mold materials for silicone containing lens materials
US5525691A (en) * 1990-11-27 1996-06-11 Bausch & Lomb Incorporated Surface modification of polymeric objects
US5486579A (en) * 1991-11-05 1996-01-23 Bausch & Lomb Incorporated Wettable silicone hydrogel compositions and methods for their manufacture
US5310779A (en) * 1991-11-05 1994-05-10 Bausch & Lomb Incorporated UV curable crosslinking agents useful in copolymerization
US5449729A (en) * 1991-11-05 1995-09-12 Bausch & Lomb Incorporated UV curable crosslinking agents useful in copolymerization
US5512205A (en) * 1991-11-05 1996-04-30 Bausch & Lomb Incorporated UV curable crosslinking agents useful in copolymerization
US5288890A (en) * 1992-02-28 1994-02-22 Shin-Etsu Chemical Co., Ltd. Fluorine-containing organosilicon compound and process of producing the same
US5260000A (en) * 1992-08-03 1993-11-09 Bausch & Lomb Incorporated Process for making silicone containing hydrogel lenses
US5260001A (en) * 1992-08-03 1993-11-09 Bausch & Lomb Incorporated Spincasting process for producing a series of contact lenses having desired shapes
US5539016A (en) * 1993-02-12 1996-07-23 Bausch & Lomb Incorporated Fluorosilicone hydrogels
US5321108A (en) * 1993-02-12 1994-06-14 Bausch & Lomb Incorporated Fluorosilicone hydrogels
US5387662A (en) * 1993-02-12 1995-02-07 Bausch & Lomb Incorporated Fluorosilicone hydrogels
US5616757A (en) * 1993-04-08 1997-04-01 Bausch & Lomb Incorporated Organosilicon-containing materials useful for biomedical devices
US5510442A (en) * 1993-04-08 1996-04-23 Bausch & Lomb Incorporated Organosilicon-containing materials useful for biomedical devices
US5639908A (en) * 1993-12-17 1997-06-17 Bausch & Lomb Incorporated Urea and urethane monomers for contact lens materials
US5648515A (en) * 1993-12-17 1997-07-15 Bausch & Lomb Incorporated Urea and urethane monomers for contact lens materials
US5594085A (en) * 1993-12-17 1997-01-14 Bausch & Lomb Incorporated Urea and urethane monomers for contact lens materials
US5352816A (en) * 1993-12-28 1994-10-04 Three Bond Co., Ltd. Organosilicon compound
US6610221B2 (en) 1994-01-31 2003-08-26 Bausch & Lomb Incorporated Treatment of contact lenses with supercritical fluid
US6180031B1 (en) 1994-01-31 2001-01-30 Bausch & Lomb Incorporated Treatment of contact lenses with supercritical fluid
US6071439A (en) * 1994-01-31 2000-06-06 Bausch & Lomb Incorporated Treatment of contact lenses with supercritical fluid
US8568626B2 (en) 1994-09-06 2013-10-29 Ciba Vision Corporation Extended wear ophthalmic lens
US8415404B2 (en) 1994-09-06 2013-04-09 Ciba Vision Corporation Extended wear ophthalmic lens
US9612455B2 (en) 1995-04-04 2017-04-04 Novartis Ag Extended wear ophthalmic lens
US5908906A (en) * 1995-12-07 1999-06-01 Bausch & Lomb Incorporated Monomeric units useful for reducing the modulus of silicone hydrogels
US5714557A (en) * 1995-12-07 1998-02-03 Bausch & Lomb Incorporated Monomeric units useful for reducing the modulus of low water polymeric silicone compositions
US5710302A (en) * 1995-12-07 1998-01-20 Bausch & Lomb Incorporated Monomeric units useful for reducing the modules of silicone hydrogels
US5959014A (en) * 1996-05-07 1999-09-28 Emory University Water-stabilized organosilane compounds and methods for using the same
WO1997041876A1 (en) * 1996-05-07 1997-11-13 Emory University Water-stabilized organosilanes and methods for use
US6221944B1 (en) 1996-05-07 2001-04-24 Emory University Water-stabilized organosilane compounds and methods for using the same
US5708094A (en) * 1996-12-17 1998-01-13 Bausch & Lomb Incorporated Polybutadiene-based compositions for contact lenses
US7074876B2 (en) * 1997-08-21 2006-07-11 General Electric Company Blocked mercaptosilane coupling agents for filled rubbers
US8741981B2 (en) 1998-03-02 2014-06-03 Johnson & Johnson Vision Care, Inc. Contact lenses
US6943203B2 (en) 1998-03-02 2005-09-13 Johnson & Johnson Vision Care, Inc. Soft contact lenses
US8399538B2 (en) 1998-03-02 2013-03-19 Johnson & Johnson Vision Care, Inc. Contact lenses
US20050159502A1 (en) * 1998-03-02 2005-07-21 Steffen Robert B. Contact Lenses
US9507172B2 (en) 1998-03-02 2016-11-29 Johnson & Johnson Vision Care, Inc. Contact lenses
US6849671B2 (en) 1998-03-02 2005-02-01 Johnson & Johnson Vision Care, Inc. Contact lenses
US20040209973A1 (en) * 1998-03-02 2004-10-21 Steffen Robert B. Contact lenses
US20040186248A1 (en) * 1998-03-02 2004-09-23 Vanderlaan Douglas G. Soft contact lenses
US7825170B2 (en) 1998-03-02 2010-11-02 Johnson & Johnson Vision Care, Inc. Contact lenses
US20090091704A1 (en) * 1998-03-02 2009-04-09 Steffen Robert B Contact lenses
US7521488B2 (en) 1998-03-02 2009-04-21 Johnson & Johnson Vision Care, Inc. Contact lenses
US6362363B1 (en) 1999-06-29 2002-03-26 Wright Chemical Corporation Synthesis of vinyl carbonates for use in producing vinyl carbamates
US6284911B1 (en) 1999-06-29 2001-09-04 Wright Chemical Corporation Synthesis of vinyl carbonates for use in producing vinyl carbamates
US20020151740A1 (en) * 1999-06-29 2002-10-17 Allen David Lewis Synthesis of vinyl carbonates for use in producing vinyl carbamates
US6423862B1 (en) 1999-06-29 2002-07-23 Wright Chemical Corporation Synthesis of vinyl carbonates for use in producing vinyl carbamates
US6762264B2 (en) 1999-07-27 2004-07-13 Bausch & Lomb Incorporated Contact lens material
US6921802B2 (en) 1999-07-27 2005-07-26 Bausch & Lomb, Inc. Contact lens materials
US6423820B1 (en) 1999-09-24 2002-07-23 Bausch & Lomb Incorporated Process for purifying and reusing solvent used to remove extractables
US7022813B2 (en) 1999-09-24 2006-04-04 Bausch & Lomb Incorporated Process for purifying and reusing solvent used to remove extractables
US20020132971A1 (en) * 1999-09-24 2002-09-19 Madhu Ayyagari Process for purifying and reusing solvent used to remove extractables
US6998073B2 (en) 1999-12-21 2006-02-14 Bausch & Lomb Incorporated Pulse extraction of ocular medical devices
US6514438B1 (en) 1999-12-21 2003-02-04 Bausch & Lomb Incorporated Pulse extraction of ocular medical devices
US20030116873A1 (en) * 1999-12-21 2003-06-26 Bausch & Lomb Incorporated Pulse extraction of ocular medical devices
US6602930B2 (en) 2000-02-24 2003-08-05 Hoya Healthcare Corporation Materials for contact lenses comprising a macromer having the polysiloxane structure in the side chain
EP2258736A1 (en) 2000-03-22 2010-12-08 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US6414049B1 (en) * 2000-03-22 2002-07-02 Johnson & Johnson Vision Care, Inc. Stable initiator system
US6827885B2 (en) 2000-03-31 2004-12-07 Bausch & Lomb Incorporated Methods and devices to control polymerization
US6772988B2 (en) 2000-03-31 2004-08-10 Bausch & Lomb Incorporated Method and mold to control optical device polymerization
US7144528B2 (en) 2000-03-31 2006-12-05 Bausch & Lomb Incorporated Method and mold to control optical device polymerization
US20040207105A1 (en) * 2000-03-31 2004-10-21 Altmann Griffith E. Method and mold to control optical device polymerization
US20050104239A1 (en) * 2000-03-31 2005-05-19 Altmann Griffith E. Methods and devices to control polymerization
US6364934B1 (en) 2000-07-31 2002-04-02 Bausch & Lomb Incorporated Method of making ocular devices
US6638563B2 (en) 2000-09-19 2003-10-28 Bausch & Lomb Incorporated Method for applying renewable polymeric lens coating
US20040214735A1 (en) * 2000-10-06 2004-10-28 Groemminger Suzanne F. Cleaner for contact lens
US6872695B1 (en) 2000-10-06 2005-03-29 Bausch & Lomb Incorporated Method for in-eye cleaning of contact lens comprising polymeric beads
US20030087022A1 (en) * 2000-10-24 2003-05-08 Bausch & Lomb Incorporated Prevention of bacterial attachment to biomaterials by cationic polysaccharides
US7731148B2 (en) 2000-12-01 2010-06-08 Johnson & Johnson Vision Care, Inc. High optical quality molds for use in contact lens production
US20050167864A1 (en) * 2000-12-01 2005-08-04 Turner David C. Method for manufacturing a contact lens
US6861123B2 (en) 2000-12-01 2005-03-01 Johnson & Johnson Vision Care, Inc. Silicone hydrogel contact lens
US20090020683A1 (en) * 2000-12-01 2009-01-22 Turner David C High optical quality molds for use in contact lens production
US7422710B2 (en) 2000-12-01 2008-09-09 Johnson & Johnson Vision Care, Inc. Method for manufacturing a contact lens
US6805836B2 (en) 2000-12-15 2004-10-19 Bausch & Lomb Incorporated Prevention of preservative uptake into biomaterials
US20040258558A1 (en) * 2000-12-15 2004-12-23 Salamone Joseph C. Prevention of preservative uptake into biomaterials
US7087222B2 (en) 2000-12-19 2006-08-08 Bausch & Lomb Incorporated Method for enhancing integrity of epithelium using retinoic acid
US20040151755A1 (en) * 2000-12-21 2004-08-05 Osman Rathore Antimicrobial lenses displaying extended efficacy, processes to prepare them and methods of their use
US20040213827A1 (en) * 2000-12-21 2004-10-28 Enns John B. Antimicrobial contact lenses and methods for their production
US20030000028A1 (en) * 2001-02-23 2003-01-02 Molock Frank F. Colorants for use in tinted contact lenses and methods for their production
US6702983B2 (en) 2001-05-15 2004-03-09 Bausch & Lomb Incorporated Low ionic strength method and composition for reducing bacterial attachment to biomaterials
US7879267B2 (en) 2001-08-02 2011-02-01 J&J Vision Care, Inc. Method for coating articles by mold transfer
US7485672B2 (en) 2001-08-02 2009-02-03 Johnson & Johnson Vision Care, Inc. Process for the synthesis of soluble, high molecular weight polymers
US20050054745A1 (en) * 2001-08-02 2005-03-10 Frank Molock Process for the synthesis of soluble, high molecular weight polymers
US6528464B1 (en) 2001-08-17 2003-03-04 Bausch & Lomb Incorporated Composition and method for inhibiting uptake of biguanide antimicrobials by hydrogels
US7666921B2 (en) 2001-09-10 2010-02-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US10641926B2 (en) 2001-09-10 2020-05-05 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
EP2258411A1 (en) 2001-09-10 2010-12-08 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US8168720B2 (en) 2001-09-10 2012-05-01 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US20030125498A1 (en) * 2001-09-10 2003-07-03 Mccabe Kevin P. Biomedical devices containing internal wetting agents
US10935696B2 (en) 2001-09-10 2021-03-02 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US8895687B2 (en) 2001-09-10 2014-11-25 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US7461937B2 (en) 2001-09-10 2008-12-09 Johnson & Johnson Vision Care, Inc. Soft contact lenses displaying superior on-eye comfort
US7649058B2 (en) 2001-09-10 2010-01-19 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
EP3053605A1 (en) 2001-09-10 2016-08-10 Johnson & Johnson Vision Care Inc. Biomedical devices containing internal wetting agents
US20060007391A1 (en) * 2001-09-10 2006-01-12 Mccabe Kevin P Biomedical devices containing internal wetting agents
US9097914B2 (en) 2001-09-10 2015-08-04 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US9958577B2 (en) 2001-09-10 2018-05-01 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US8450387B2 (en) 2001-09-10 2013-05-28 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US7691916B2 (en) 2001-09-10 2010-04-06 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US10254443B2 (en) 2001-09-10 2019-04-09 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US8431669B2 (en) 2001-09-10 2013-04-30 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
EP2258412A1 (en) 2001-09-10 2010-12-08 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US20030162862A1 (en) * 2001-09-10 2003-08-28 Mccabe Kevin P. Biomedical devices containing internal wetting agents
US8796353B2 (en) 2001-09-10 2014-08-05 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US11360241B2 (en) 2001-09-10 2022-06-14 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US7052131B2 (en) 2001-09-10 2006-05-30 J&J Vision Care, Inc. Biomedical devices containing internal wetting agents
US6822016B2 (en) 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US20110115110A1 (en) * 2001-10-29 2011-05-19 Kunzler Jay F Method of Making Silicone Hydrogels with Fluorinated Side Chain Polysiloxanes
US20050165187A1 (en) * 2001-10-29 2005-07-28 Kunzler Jay F. Silicone hydrogels based on vinyl carbonate endcapped fluorinated side chain polysiloxanes
US7268198B2 (en) 2001-10-29 2007-09-11 Bausch & Lomb Incorporated Silicone hydrogel contact lenses
US7875687B2 (en) 2001-10-29 2011-01-25 Bausch & Lomb Incorporated Silicone hydrogels based on fluorinated polysiloxanes
US6891010B2 (en) 2001-10-29 2005-05-10 Bausch & Lomb Incorporated Silicone hydrogels based on vinyl carbonate endcapped fluorinated side chain polysiloxanes
US20030236376A1 (en) * 2002-03-11 2003-12-25 Ture Kindt-Larsen Low polydispersity poly-HEMA compositions
US20080015322A1 (en) * 2002-03-11 2008-01-17 Ture Kindt-Larsen Low polydispersity poly-hema compositions
US6846892B2 (en) 2002-03-11 2005-01-25 Johnson & Johnson Vision Care, Inc. Low polydispersity poly-HEMA compositions
US7816460B2 (en) 2002-03-11 2010-10-19 Johnson & Johnson Vision Care, Inc. Low polydispersity poly-HEMA compositions
US20060100408A1 (en) * 2002-03-11 2006-05-11 Powell P M Method for forming contact lenses comprising therapeutic agents
US20030222362A1 (en) * 2002-03-28 2003-12-04 Bausch & Lomb Incorporated Process for extracting biomedical devices
WO2003089506A1 (en) * 2002-04-22 2003-10-30 Purdue Research Foundation Hydrogels having enhanced elasticity and mechanical strength properties
US20060004119A1 (en) * 2002-06-25 2006-01-05 Molock Frank F Macromer forming catalysts
US7429623B2 (en) 2002-06-25 2008-09-30 Johnson & Johnson Vision Care, Inc. Macromer forming catalysts
US20040002556A1 (en) * 2002-06-25 2004-01-01 Molock Frank F. Macromer forming catalysts
US6936641B2 (en) 2002-06-25 2005-08-30 Johnson & Johnson Vision Care, Inc. Macromer forming catalysts
US7833443B2 (en) 2002-08-16 2010-11-16 Johnson & Johnson Vision Care, Inc. Molds for producing contact lenses
US20040075039A1 (en) * 2002-08-16 2004-04-22 Dubey Dharmesh K. Molds for producing contact lenses
US20090091047A1 (en) * 2002-08-16 2009-04-09 Changhong Yin Molds for producing contact lenses
US8292256B2 (en) 2002-08-16 2012-10-23 Johnson & Johnson Vision Care, Inc. Molds for producing contact lenses
US20090121368A1 (en) * 2002-08-16 2009-05-14 Changhong Yin Molds for producing contact lenses
US20080299179A1 (en) * 2002-09-06 2008-12-04 Osman Rathore Solutions for ophthalmic lenses containing at least one silicone containing component
US20100280146A1 (en) * 2002-09-06 2010-11-04 Vanderlaan Douglas C Forming clear, wettable silicone hydrogel articles without surface treatments
US8158695B2 (en) 2002-09-06 2012-04-17 Johnson & Johnson Vision Care, Inc. Forming clear, wettable silicone hydrogel articles without surface treatments
EP2384773A1 (en) 2002-11-22 2011-11-09 Johnson & Johnson Vision Care, Inc. Antimicrobial lenses, processes to prepare them and methods of their use
EP2384772A2 (en) 2002-11-22 2011-11-09 Johnson & Johnson Vision Care, Inc. Antimicrobial lenses, processes to prepare them and methods of their use
US20090263278A1 (en) * 2002-11-27 2009-10-22 Brian Gerrard Devlin Stabilization of poly(oxyalkylene) containing polymeric materials
US8318059B2 (en) 2002-11-27 2012-11-27 Novartis Ag Stabilization of poly(oxyalkylene) containing polymeric materials
US20040116564A1 (en) * 2002-11-27 2004-06-17 Devlin Brian Gerrard Stabilization of poly(oxyalkylene) containing polymeric materials
US20040116310A1 (en) * 2002-12-17 2004-06-17 Bausch & Lomb Incorporated Surface treatment of medical device
US6958169B2 (en) 2002-12-17 2005-10-25 Bausch & Lomb Incorporated Surface treatment of medical device
US20040121939A1 (en) * 2002-12-19 2004-06-24 Zanini Diana Biomedical devices with peptide containing coatings
US20040120982A1 (en) * 2002-12-19 2004-06-24 Zanini Diana Biomedical devices with coatings attached via latent reactive components
US7368127B2 (en) 2002-12-19 2008-05-06 Johnson & Johnson Vision Care, Inc. Biomedical devices with peptide containing coatings
US20040166232A1 (en) * 2002-12-23 2004-08-26 Bausch & Lomb Incorporated Surface treatment utilizing microwave radiation
US8097565B2 (en) 2003-06-30 2012-01-17 Johnson & Johnson Vision Care, Inc. Silicone hydrogels having consistent concentrations of multi-functional polysiloxanes
US20050255231A1 (en) * 2003-06-30 2005-11-17 Hill Gregory A Silicone hydrogels having consistent concentrations of multi-functional polysiloxanes
US20050070661A1 (en) * 2003-09-30 2005-03-31 Frank Molock Methods of preparing ophthalmic devices
US20050092680A1 (en) * 2003-10-31 2005-05-05 Shivkumar Mahadevan Purification of silicone containing compounds by supercritical fluid extraction
US7368589B2 (en) * 2003-10-31 2008-05-06 Johnson & Johnson Vision Care, Inc. Purification of silicone containing compounds by supercritical fluid extraction
US7981440B2 (en) 2003-11-18 2011-07-19 Johnson & Johnson Vision Care, Inc. Antimicrobial lenses, processes to prepare them and methods of their use
US20050117112A1 (en) * 2003-11-18 2005-06-02 Alvarez-Carrigan Nayiby Antimicrobial lenses, processes to prepare them and methods of their use
US7416737B2 (en) 2003-11-18 2008-08-26 Johnson & Johnson Vision Care, Inc. Antimicrobial lenses, processes to prepare them and methods of their use
US20080274207A1 (en) * 2003-11-18 2008-11-06 Alvarez-Carrigan Nayiby Antimicrobial lenses, processes to prepare them and methods of their use
US20110232231A1 (en) * 2003-11-18 2011-09-29 Alvarez-Carrigan Nayiby Antimicrobial lenses, processes to prepare them and methods of their use
US20050124776A1 (en) * 2003-12-05 2005-06-09 Yu-Chin Lai Novel prepolymers for improved surface modification of contact lenses
US7176268B2 (en) 2003-12-05 2007-02-13 Bausch & Lomb Incorporated Prepolymers for improved surface modification of contact lenses
US20070129521A1 (en) * 2003-12-05 2007-06-07 Yu-Chin Lai Novel Prepolymers for Improved Surface Modification of Contact Lenses
US7084188B2 (en) 2003-12-05 2006-08-01 Bausch & Lomb Incorporated Surface modification of contact lenses
US20050124719A1 (en) * 2003-12-05 2005-06-09 Yu-Chin Lai Surface modification of contact lenses
US7399795B2 (en) 2003-12-05 2008-07-15 Bausch & Lomb Incorporated Surface modification of contact lenses
US20050153055A1 (en) * 2003-12-22 2005-07-14 Bausch & Lomb Incorporated Surface treatment utilizing supercritical fluid
US7402689B2 (en) 2004-01-28 2008-07-22 Bausch & Lomb Incorporated Vinylchloroformate-free synthesis of vinyl and allyl(thio) carbamates
US20050176980A1 (en) * 2004-01-28 2005-08-11 Bausch & Lomb Incorporated Vinylchloroformate-free synthesis of vinyl and allyl(thio) carbamates
US7396890B2 (en) 2004-02-11 2008-07-08 Johnson & Johnson Vision Care, Inc. (Meth)acrylamide monomers containing hydroxy and silicone functionalities
US20050176911A1 (en) * 2004-02-11 2005-08-11 Diana Zanini (Meth)acrylamide monomers containing hydroxy and silicone functionalities
US7214809B2 (en) 2004-02-11 2007-05-08 Johnson & Johnson Vision Care, Inc. (Meth)acrylamide monomers containing hydroxy and silicone functionalities
US8222353B2 (en) 2004-03-05 2012-07-17 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising acyclic polyamides
EP2014724A1 (en) 2004-03-05 2009-01-14 Johson & Johnson Vision Care Inc. Wettable hydrogels comprising acyclic polyamides
US7786185B2 (en) 2004-03-05 2010-08-31 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising acyclic polyamides
US8022158B2 (en) 2004-03-05 2011-09-20 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising acyclic polyamides
US9880324B2 (en) 2004-04-01 2018-01-30 Novartis Ag Colored ink for pad transfer printing of silicone hydrogel lenses
US20050258096A1 (en) * 2004-05-21 2005-11-24 Bausch & Lomb Incorporated Process for extracting biomedical devices
US7411029B2 (en) 2004-06-25 2008-08-12 Bausch & Lomb Incorporated Prepolymers for improved surface modification of contact lenses
US7482416B2 (en) 2004-06-25 2009-01-27 Bausch & Lomb Incorporated Prepolymers for improved surface modification of contact lenses
US20080097002A1 (en) * 2004-06-25 2008-04-24 Yu-Chin Lai Novel prepolymers for improved surface modification of contact lenses
US20050288466A1 (en) * 2004-06-25 2005-12-29 Yu-Chin Lai Novel prepolymers for improved surface modification of contact lenses
WO2006011999A1 (en) 2004-06-30 2006-02-02 Johnson & Johnson Vision Care, Inc. Solutions for ophthalmic lenses containing at least one silicone containing component
US20060067981A1 (en) * 2004-09-29 2006-03-30 Bausch & Lomb Incorporated Contact lens with improved biocidal activity and related methods and materials
US20060069235A1 (en) * 2004-09-30 2006-03-30 Arnold Stephen C Lactam polymer derivatives
US7247692B2 (en) 2004-09-30 2007-07-24 Johnson & Johnson Vision Care, Inc. Biomedical devices containing amphiphilic block copolymers
US20060074208A1 (en) * 2004-09-30 2006-04-06 Laredo Walter R Biomedical devices containing amphiphilic block copolymers
US20060072069A1 (en) * 2004-09-30 2006-04-06 Laredo Walter R Wettable hydrogels comprising reactive, hydrophilic, polymeric internal wetting agents
US20070290174A1 (en) * 2004-09-30 2007-12-20 Arnold Stephen C Lactam polymer derivatives
US20080275156A1 (en) * 2004-09-30 2008-11-06 Laredo Walter R Wettable hydrogels comprising reactive, hydrophilic, polymeric internal wetting agents
US7249848B2 (en) 2004-09-30 2007-07-31 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising reactive, hydrophilic, polymeric internal wetting agents
US7956131B2 (en) 2004-09-30 2011-06-07 Johnson & Johnson Vision Care, Inc. Lactam polymer derivatives
EP1890171A2 (en) 2004-09-30 2008-02-20 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising reactive, hydrophilic, polymeric internal wetting agents
US8273802B2 (en) 2004-09-30 2012-09-25 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising reactive, hydrophilic, polymeric internal wetting agents
US7473738B2 (en) 2004-09-30 2009-01-06 Johnson & Johnson Vision Care, Inc. Lactam polymer derivatives
US20100171923A1 (en) * 2004-09-30 2010-07-08 Arnold Stephen C Lactam polymer derivatives
US20060078592A1 (en) * 2004-10-12 2006-04-13 Bausch & Lomb Incorporated Drug delivery systems
US20060093728A1 (en) * 2004-11-01 2006-05-04 Bausch & Lomb Incorporated Process for hydrating lenses
US20060275342A1 (en) * 2004-12-01 2006-12-07 Lindhardt Jeffrey G Polymerizable surfactants and their use as device forming comonomers
US20060130881A1 (en) * 2004-12-21 2006-06-22 Sanjay Rastogi Method of cleaning optical tools for making contact lens molds using super-cooled fluids
US8197841B2 (en) 2004-12-22 2012-06-12 Bausch & Lomb Incorporated Polymerizable surfactants and their use as device forming comonomers
US20060131769A1 (en) * 2004-12-22 2006-06-22 Bausch & Lomb Incorporated Pre-polymer extraction using a super-cooled fluid
US20060134169A1 (en) * 2004-12-22 2006-06-22 Linhardt Jeffrey G Polymerizable surfactants and their use as device forming comonomers
US8377464B2 (en) 2004-12-22 2013-02-19 Bausch & Lomb Incorporated Polymerizable surfactants and their use as device forming comonomers
US11953651B2 (en) 2005-02-14 2024-04-09 Johnson & Johnson Vision Care, Inc. Comfortable ophthalmic device and methods of its production
US11150383B2 (en) 2005-02-14 2021-10-19 Johnson & Johnson Vision Care, Inc. Comfortable ophthalmic device and methods of its production
US8696115B2 (en) 2005-02-14 2014-04-15 Johnson & Johnson Vision Care, Inc. Comfortable ophthalmic device and methods of its production
US9395559B2 (en) 2005-02-14 2016-07-19 Johnson & Johnson Vision Care, Inc. Comfortable ophthalmic device and methods of its production
US10267952B2 (en) 2005-02-14 2019-04-23 Johnson & Johnson Vision Care, Inc. Comfortable ophthalmic device and methods of its production
US9097916B2 (en) 2005-04-08 2015-08-04 Johnson & Johnson Vision Care, Inc. Photochromic materials having extended pi-conjugated systems and compositions and articles including the same
US11256002B2 (en) 2005-04-08 2022-02-22 Johnson & Johnson Vision Care, Inc. Ophthalmic devices comprising photochromic materials with reactive substituents
US20060226402A1 (en) * 2005-04-08 2006-10-12 Beon-Kyu Kim Ophthalmic devices comprising photochromic materials having extended PI-conjugated systems
US20060226401A1 (en) * 2005-04-08 2006-10-12 Wenjing Xiao Ophthalmic devices comprising photochromic materials with reactive substituents
US20060227287A1 (en) * 2005-04-08 2006-10-12 Frank Molock Photochromic ophthalmic devices made with dual initiator system
US10197707B2 (en) 2005-04-08 2019-02-05 Johnson & Johnson Vision Care, Inc. Ophthalmic devices comprising photochromic materials with reactive sub substituents
EP2270559A2 (en) 2005-04-08 2011-01-05 Johnson and Johnson Vision Care, Inc. Ophthalmic devices comprising photochromic materials with reactive substituents
US11874434B2 (en) 2005-04-08 2024-01-16 Johnson & Johnson Vision Care, Inc. Ophthalmic devices comprising photochromic materials with reactive substituents
US8158037B2 (en) 2005-04-08 2012-04-17 Johnson & Johnson Vision Care, Inc. Photochromic materials having extended pi-conjugated systems and compositions and articles including the same
EP3633423A1 (en) 2005-04-08 2020-04-08 Johnson & Johnson Vision Care, Inc. Ophthalmic devices comprising photochromic materials with reactive substituents
US20090072206A1 (en) * 2005-04-08 2009-03-19 Beon-Kyu Kim Ophthalmic devices comprising photochromic materials having extended pi-conjugated systems
US9465234B2 (en) 2005-04-08 2016-10-11 Johnson & Johnson Vision Care, Inc. Photochromic materials having extended pi-conjugated systems and compositions and articles including the same
US8741188B2 (en) 2005-04-08 2014-06-03 Johnson & Johnson Vision Care, Inc. Ophthalmic devices comprising photochromic materials having extended pi-conjugated systems
US9052438B2 (en) 2005-04-08 2015-06-09 Johnson & Johnson Vision Care, Inc. Ophthalmic devices comprising photochromic materials with reactive substituents
US20060292202A1 (en) * 2005-06-27 2006-12-28 Bausch & Lomb Incorporated Drug delivery device
US20060292101A1 (en) * 2005-06-28 2006-12-28 Roya Borazjani In-eye method of cleaning and/or disinfecting silicone hydrogel contact lenses
US20060293476A1 (en) * 2005-06-28 2006-12-28 Mahendra Nandu Novel system for synthesis of device forming monomers
US7745564B2 (en) 2005-06-28 2010-06-29 Bausch & Lomb Incorporated System for synthesis of device forming monomers
US20070035693A1 (en) * 2005-08-11 2007-02-15 Coopervision Inc. Contact lenses and methods for reducing conjunctival pressure in contact lens wearers
US7360890B2 (en) 2005-08-11 2008-04-22 Coopervision, Inc Contact lenses and methods for reducing conjunctival pressure in contact lens wearers
US20070048349A1 (en) * 2005-08-29 2007-03-01 Bausch & Lomb Incorporated Surface-modified medical devices and methods of making
US20070049713A1 (en) * 2005-08-30 2007-03-01 Bausch & Lomb Incorporated Polymeric materials having enhanced ion and water transport property and medical devices comprising same
US7390863B2 (en) 2005-08-30 2008-06-24 Bausch & Lomb Incorporated Polymeric materials having enhanced ion and water transport property and medical devices comprising same
US20070087113A1 (en) * 2005-10-19 2007-04-19 Bausch & Lomb Incorporated Surface-modified medical devices and method of making
US20070092830A1 (en) * 2005-10-24 2007-04-26 Bausch & Lomb Incorporated Polymeric radiation-absorbing materials and ophthalmic devices comprising same
US20070104611A1 (en) * 2005-11-09 2007-05-10 Coopervision Inc. Methods for sterilizing silicone hydrogel contact lenses
US20070116741A1 (en) * 2005-11-21 2007-05-24 Bausch & Lomb Incorporated Contact lenses with mucin affinity
US20070116740A1 (en) * 2005-11-21 2007-05-24 Bausch & Lomb Incorporated Contact lenses with mucin affinity
US7988988B2 (en) 2005-11-21 2011-08-02 Bausch & Lomb Incorporated Contact lenses with mucin affinity
US20070122540A1 (en) * 2005-11-29 2007-05-31 Bausch & Lomb Incorporated Coatings on ophthalmic lenses
US20070123602A1 (en) * 2005-11-29 2007-05-31 Bausch & Lomb Incorporated Use of thermal reversible associations for enhanced polymer interactions
US20070120279A1 (en) * 2005-11-29 2007-05-31 Bausch & Lomb Incorporated Method for coating lens material
US20070132120A1 (en) * 2005-12-08 2007-06-14 Bausch & Lomb Incorporated Preferential release of an ophthalmic lens using a super-cooled fluid
US20070132125A1 (en) * 2005-12-08 2007-06-14 Bausch & Lomb Incorporated Use of a super-cooled fluid in lens processing
US20070132119A1 (en) * 2005-12-08 2007-06-14 Bausch & Lomb Incorporated Use of a super-cooled fluid in the manufacture of contact lenses
US20070132121A1 (en) * 2005-12-08 2007-06-14 Bausch & Lomb Incorporated Method of cleaning molds using super-cooled fluids
US20070132118A1 (en) * 2005-12-09 2007-06-14 Bausch And Lomb Incorporated Method and Apparatus for Treatment of a Device-in-Mold Assembly with a Supercritical Fluid
US20070138668A1 (en) * 2005-12-21 2007-06-21 Yu-Chin Lai Process for Extracting Biomedical Devices
US20070142583A1 (en) * 2005-12-21 2007-06-21 Derek Schorzman Cationic hydrophilic siloxanyl monomers
US20070138669A1 (en) * 2005-12-21 2007-06-21 Yu-Chin Lai Process for Casting and Extracting Biomedical Devices
US20070142584A1 (en) * 2005-12-21 2007-06-21 Derek Schorzman Silicon-containing monomers end-capped with polymerizable cationic hydrophilic groups
US7622512B2 (en) 2005-12-21 2009-11-24 Bausch & Lomb Incorporated Cationic hydrophilic siloxanyl monomers
US7759408B2 (en) 2005-12-21 2010-07-20 Bausch & Lomb Incorporated Silicon-containing monomers end-capped with polymerizable cationic hydrophilic groups
US20070155851A1 (en) * 2005-12-30 2007-07-05 Azaam Alli Silicone containing polymers formed from non-reactive silicone containing prepolymers
US7825273B2 (en) 2006-01-06 2010-11-02 Bausch & Lomb Incorporated Process for making cationic hydrophilic siloxanyl monomers
US20070160649A1 (en) * 2006-01-06 2007-07-12 Schorzman Derek A Siloxane prepolymer containing pendant and end-capping cationic and polymerizable groups
EP2287169A1 (en) * 2006-01-06 2011-02-23 Bausch & Lomb Incorporated Process for making cationic hydrophilic siloxanyl monomers
US20110015298A1 (en) * 2006-01-06 2011-01-20 Schorzman Derek A Process for making cationic hydrophilic siloxanyl monomers
WO2007082119A2 (en) 2006-01-06 2007-07-19 Bausch & Lomb Incorporated Siloxane prepolymer containing pendant and end-capping cationic and polymerizable groups
WO2007082121A1 (en) * 2006-01-06 2007-07-19 Bausch & Lomb Incorporated Process for making cationic hydrophilic siloxanyl monomers
US20070161810A1 (en) * 2006-01-06 2007-07-12 Schorzman Derek A Process for making cationic hydrophilic siloxanyl monomers
US8877829B2 (en) 2006-01-06 2014-11-04 Bausch & Lomb Incorporated Process for making cationic hydrophilic siloxanyl monomers
US7528208B2 (en) 2006-01-06 2009-05-05 Bausch & Lomb Incorporated Siloxane prepolymer containing pendant and end-capping cationic and polymerizable groups
US8828420B2 (en) 2006-01-06 2014-09-09 Bausch & Lomb Incorporated Siloxane prepolymer containing pendant cationic and polymerizable groups
US20070161769A1 (en) * 2006-01-06 2007-07-12 Schorzman Derek A Polymerizable silicon-containing monomer bearing pendant cationic hydrophilic groups
US20070160643A1 (en) * 2006-01-06 2007-07-12 Schorzman Derek A Siloxane prepolymer containing pendant cationic and polymerizable groups
US20070185014A1 (en) * 2006-02-09 2007-08-09 The Schepens Eye Research Institute, Inc. Methods and compositions for modulating conjunctival goblet cells
US9052529B2 (en) 2006-02-10 2015-06-09 Johnson & Johnson Vision Care, Inc. Comfortable ophthalmic device and methods of its production
US20070197733A1 (en) * 2006-02-22 2007-08-23 Bausch & Lomb Incorporated Star macromonomers and polymeric materials and medical devices comprising same
US7727545B2 (en) 2006-02-22 2010-06-01 Bausch & Lomb Incorporated Polymeric fluorinated dioxole and medical devices comprising same
US20070196431A1 (en) * 2006-02-22 2007-08-23 Bausch & Lomb Incorporated Polymeric fluorinated dioxole and medical devices comprising same
US8714738B2 (en) 2006-03-23 2014-05-06 Johnson & Johnson Vision Care, Inc. Process for making ophthalmic lenses
US20070222095A1 (en) * 2006-03-23 2007-09-27 Diana Zanini Process for making ophthalmic lenses
US20070222094A1 (en) * 2006-03-23 2007-09-27 Azaam Alli Process for making ophthalmic lenses
US8414804B2 (en) 2006-03-23 2013-04-09 Johnson & Johnson Vision Care, Inc. Process for making ophthalmic lenses
US20070242215A1 (en) * 2006-04-13 2007-10-18 Bausch & Lomb Incorporated Cationic end-capped siloxane prepolymer for reduced cross-link density
US7960447B2 (en) 2006-04-13 2011-06-14 Bausch & Lomb Incorporated Cationic end-capped siloxane prepolymer for reduced cross-link density
US7576159B2 (en) 2006-04-28 2009-08-18 Bausch & Lomb Incorporated Gas-permeable materials and medical devices
US20070255014A1 (en) * 2006-04-28 2007-11-01 Salamone Joseph C Gas-permeable materials and medical devices
US20070264503A1 (en) * 2006-05-11 2007-11-15 Yu-Chin Lai Polymers comprising polyhydric alcohols, medical devices modified with same, and method of making
EP3557290A1 (en) 2006-06-15 2019-10-23 CooperVision International Holding Company, LP Wettable silicone hydrogel contact lenses and related compositions and methods
US20080002146A1 (en) * 2006-06-28 2008-01-03 Stachowski Mark J Biocompatible, surface modified materials
EP2404951A1 (en) 2006-06-30 2012-01-11 Bausch & Lomb Incorporated Polymerizable siloxane-quaternary amine copolymers
US20080003259A1 (en) * 2006-06-30 2008-01-03 Salamone Joseph C Modification of surfaces of polymeric articles by Michael addition reaction
US20080004410A1 (en) * 2006-06-30 2008-01-03 Yu-Chin Lai Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
US20080000201A1 (en) * 2006-06-30 2008-01-03 Derek Schorzman Carboxylic tris-like siloxanyl monomers
US20080004414A1 (en) * 2006-06-30 2008-01-03 Derek Schorzman Carboxylic siloxanyl monomers with pendant polymerizable groups
US7960465B2 (en) 2006-06-30 2011-06-14 Johnson & Johnson Vision Care, Inc. Antimicrobial lenses, processes to prepare them and methods of their use
US20090143556A1 (en) * 2006-06-30 2009-06-04 Bausch & Lomb Incorporated Polymerizable siloxane-quaternary amine copolymers
US7601766B2 (en) 2006-06-30 2009-10-13 Bausch & Lomb Incorporated Carboxylic siloxanyl monomers with pendant polymerizable groups
US20080001318A1 (en) * 2006-06-30 2008-01-03 Derek Schorzman Polymerizable siloxane-quaternary amine copolymers
WO2008005642A1 (en) * 2006-06-30 2008-01-10 Bausch & Lomb Incorporated Carboxylic tris-like siloxanyl monomers
US20080004413A1 (en) * 2006-06-30 2008-01-03 Derek Schorzman Carboxylic M2Dx-like siloxanyl monomers
US20080003252A1 (en) * 2006-06-30 2008-01-03 Yu-Chin Lai Functionalized hydrophilic macromonomers and medical devices incorporating same
US20080003261A1 (en) * 2006-06-30 2008-01-03 Derek Schorzman Fluorinated poly(ether)s end-capped with polymerizable cationic hydrophilic groups
US7468397B2 (en) 2006-06-30 2008-12-23 Bausch & Lomb Incorporated Polymerizable siloxane-quaternary amine copolymers
US8105623B2 (en) 2006-06-30 2012-01-31 Bausch & Lomb Incorporated Fluorinated poly(ether)s end-capped with polymerizable cationic hydrophilic groups
WO2008005644A1 (en) 2006-06-30 2008-01-10 Bausch & Lomb Incorporated Polymerizable siloxane-quaternary amine copolymers
US7557231B2 (en) 2006-06-30 2009-07-07 Bausch & Lomb Incorporated Carboxylic tris-like siloxanyl monomers
US7781558B2 (en) 2006-09-27 2010-08-24 Bausch & Lomb Incorporated Hydrophilic siloxanyl monomers with pendant polymerizable groups
US20080076898A1 (en) * 2006-09-27 2008-03-27 Salamone Joseph C Water soluble silicone macromonomers for ophthalmic materials
US20080076893A1 (en) * 2006-09-27 2008-03-27 Schorzman Derek A Hydrophilic siloxanyl monomers with pendant polymerizable groups
US20080100797A1 (en) * 2006-10-31 2008-05-01 Nayiby Alvarez-Carrigan Antimicrobial contact lenses with reduced haze and preparation thereof
EP2484703A2 (en) 2006-10-31 2012-08-08 Johnson & Johnson Vision Care, Inc. Polymeric compositions comprising at least one volume excluding polymer
US8883874B2 (en) 2006-10-31 2014-11-11 Johnson & Johnson Vision Care, Inc. Polymeric compositions comprising at least one volume excluding polymer
US20080102100A1 (en) * 2006-10-31 2008-05-01 Osman Rathore Processes to prepare antimicrobial contact lenses
US8507577B2 (en) 2006-10-31 2013-08-13 Johnson & Johnson Vision Care, Inc. Process for forming clear, wettable silicone hydrogel articles
US20080103231A1 (en) * 2006-10-31 2008-05-01 Diana Zanini Process for forming clear, wettable silicone hydrogel articles
US9358317B2 (en) 2006-10-31 2016-06-07 Johnson & Johnson Vision Care, Inc. Acidic processes to prepare antimicrobial contact lenses
US20080102095A1 (en) * 2006-10-31 2008-05-01 Kent Young Acidic processes to prepare antimicrobial contact lenses
US8501832B2 (en) 2006-10-31 2013-08-06 Johnson & Johnson Vision Care, Inc. Polymeric compositions comprising at least one volume excluding polymer
EP2484704A2 (en) 2006-10-31 2012-08-08 Johnson & Johnson Vision Care, Inc. Polymeric compositions comprising at least one volume excluding polymer
EP1918310A1 (en) 2006-10-31 2008-05-07 Johnson & Johnson Vision Care, Inc. Polymeric compositions comprising at least one volume excluding polymer
US7968650B2 (en) 2006-10-31 2011-06-28 Johnson & Johnson Vision Care, Inc. Polymeric compositions comprising at least one volume excluding polymer
US20080251958A1 (en) * 2006-10-31 2008-10-16 Molock Frank F Light absorbing prepolymers for use in tinted contact lenses and methods for their production
US20080114123A1 (en) * 2006-10-31 2008-05-15 Tighe Brian J Polymeric compositions comprising at least one volume excluding polymer
EP2484705A2 (en) 2006-10-31 2012-08-08 Johnson & Johnson Vision Care, Inc. Polymeric compositions comprising at least one volume excluding polymer
WO2008073593A2 (en) 2006-10-31 2008-06-19 Johnson & Johnson Vision Care, Inc. Processes to prepare antimicrobial contact lenses
US20080110770A1 (en) * 2006-11-10 2008-05-15 Bausch & Lomb Incorporated Packaging solutions
US20080143956A1 (en) * 2006-12-15 2008-06-19 Bausch & Lomb Incorporated Silicone contact lenses with wrinkled surface
US20080141628A1 (en) * 2006-12-15 2008-06-19 Bausch & Lomb Incorporated Packaging Solutions
US7919136B2 (en) 2006-12-15 2011-04-05 Bausch & Lomb Incorporated Surface treatment of biomedical devices
US20080142038A1 (en) * 2006-12-15 2008-06-19 Bausch & Lomb Incorporated Surface treatment of medical devices
US20080143955A1 (en) * 2006-12-15 2008-06-19 Bausch & Lomb Incorporated Silicone Contact Lenses with Silicate Coating
US20100039613A1 (en) * 2006-12-15 2010-02-18 Bausch & Lomb Incorporated Silicone contact lenses with wrinkled surface
US7625598B2 (en) 2006-12-15 2009-12-01 Bausch & Lomb Incorporated Silicone contact lenses with wrinkled surface
US20110152399A1 (en) * 2006-12-15 2011-06-23 Linhardt Jeffrey G Surface treatment of biomedical devices
US20080151181A1 (en) * 2006-12-20 2008-06-26 Bausch & Lomb Incorporated Coatings and Solutions for Contact Lenses
US7832856B2 (en) 2006-12-20 2010-11-16 Bausch & Lomb Incorporated Coatings and solutions for contact lenses
US20080148689A1 (en) * 2006-12-20 2008-06-26 Bausch & Lomb Incorporated Packaging solutions
EP2409717A2 (en) 2006-12-20 2012-01-25 Bausch & Lomb Incorporated Packaging solutions
US20080151180A1 (en) * 2006-12-20 2008-06-26 Bausch & Lomb Incorporated Coatings and Solutions for Contact Lenses
WO2008079522A1 (en) 2006-12-20 2008-07-03 Bausch & Lomb Incorporated Packaging solutions
US20080152540A1 (en) * 2006-12-22 2008-06-26 Bausch & Lomb Incorporated Packaging solutions
US20110146206A1 (en) * 2007-01-26 2011-06-23 Stanbro Jason K Synthesis of cationic siloxane prepolymers
US20080182956A1 (en) * 2007-01-26 2008-07-31 Stanbro Jason K Synthesis of cationic siloxane prepolymers
US7951897B2 (en) 2007-01-26 2011-05-31 Bausch & Lomb Incorporated Synthesis of cationic siloxane prepolymers
US8138288B2 (en) 2007-01-26 2012-03-20 Bausch & Lomb Incorporated Synthesis of cationic siloxane prepolymers
US20080229213A1 (en) * 2007-03-15 2008-09-18 Accenture Global Services Gmbh Establishment of message context in a collaboration system
CN101641206B (en) * 2007-03-22 2013-03-20 诺瓦提斯公司 Prepolymers with dangling polysiloxane-containing polymer chains
US8071658B2 (en) 2007-03-22 2011-12-06 Novartis Ag Prepolymers with dangling polysiloxane-containing polymer chains
US8263679B2 (en) * 2007-03-22 2012-09-11 Novartis Ag Prepolymers with dangling polysiloxane-containing polymer chains
US20120046382A1 (en) * 2007-03-22 2012-02-23 Zhou Jian S Prepolymers with dangling polysiloxane-containing polymer chains
WO2008116131A3 (en) * 2007-03-22 2009-05-14 Novartis Ag Prepolymers with dangling polysiloxane-containing polymer chains
US20080231798A1 (en) * 2007-03-22 2008-09-25 Zhou Jian S Prepolymers with dangling polysiloxane-containing polymer chains
AU2008228760B2 (en) * 2007-03-22 2010-09-23 Novartis Ag Prepolymers with dangling polysiloxane-containing polymer chains
WO2008116131A2 (en) * 2007-03-22 2008-09-25 Novartis Ag Prepolymers with dangling polysiloxane-containing polymer chains
US20110111120A1 (en) * 2007-03-30 2011-05-12 Yongcheng Li Preparation of antimicrobial contact lenses with reduced haze using swelling agents
US8361355B2 (en) 2007-03-30 2013-01-29 Johnson & Johnson Vision Care, Inc. Preparation of antimicrobial contact lenses with reduced haze using swelling agents
US20090051060A1 (en) * 2007-03-30 2009-02-26 Yongcheng Li Preparation of antimicrobial contact lenses with reduced haze using swelling agents
US20080241225A1 (en) * 2007-03-31 2008-10-02 Hill Gregory A Basic processes to prepare antimicrobial contact lenses
US7828432B2 (en) 2007-05-25 2010-11-09 Synergeyes, Inc. Hybrid contact lenses prepared with expansion controlled polymeric materials
US7691917B2 (en) 2007-06-14 2010-04-06 Bausch & Lomb Incorporated Silcone-containing prepolymers
US7935770B2 (en) 2007-07-03 2011-05-03 Bausch & Lomb Incorporated Surface active prepolymers with both fluorine-containing groups and hydrophilic groups
US8101698B2 (en) 2007-07-03 2012-01-24 Bausch & Lomb Incorporated Surface active prepolymers with both fluorine-containing groups and hydrophilic groups
US8252850B2 (en) 2007-07-10 2012-08-28 Bausch & Lomb Incorporated Crosslink agents
US7901073B2 (en) 2007-07-10 2011-03-08 Bausch & Lomb Incorporated Silicone hydrogel with composite hydrophilic and silicone polymers prepared with selective crosslink agents
EP3424965A1 (en) 2007-07-10 2019-01-09 Bausch & Lomb Incorporated Crosslink agents and dual radical cure polymer
US20090018233A1 (en) * 2007-07-10 2009-01-15 Nunez Ivan M Crosslink Agents and Dual Radical Cure Polymer
US8053489B2 (en) 2007-07-20 2011-11-08 Bausch & Lomb Incorporated Crosslink agents and dual radical cure polymer
WO2009014923A1 (en) 2007-07-20 2009-01-29 Bausch & Lomb Incorporated Crosslink agents and dual radical cure polymer
US20090023876A1 (en) * 2007-07-20 2009-01-22 Nunez Ivan M Crosslink Agents and Dual Radical Cure Polymer
US8349912B2 (en) 2007-07-20 2013-01-08 Bausch & Lomb Incorporated Crosslink agents and dual radical cure polymer
US20110092659A1 (en) * 2007-09-13 2011-04-21 Cognis Ip Management Gmbh Improved Method For Making Tinted Polymers
US10445313B1 (en) 2007-09-21 2019-10-15 United Services Automobile Association (Usaa) Systems, methods, and computer readable media for managing a hosts file
US20090093596A1 (en) * 2007-10-03 2009-04-09 Salamone Joseph C Use of silylated sulfonate monomers to improve contact lens wettability
US8071704B2 (en) 2007-10-03 2011-12-06 Bausch & Lomb Incorporated Prepolymerizable surface active monomers with both fluorine-containing groups and hydrophilic groups
US20090092655A1 (en) * 2007-10-03 2009-04-09 Weihong Lang Novel prepolymerizable surface active monomers with both fluorine-containing groups and hydrophilic groups
US7732546B2 (en) 2007-10-03 2010-06-08 Bausch & Lomb Incorporated Use of silylated sulfonate monomers to improve contact lens wettability
US8490782B2 (en) 2007-10-23 2013-07-23 Bausch & Lomb Incorporated Packaging solutions
US20090100801A1 (en) * 2007-10-23 2009-04-23 Bausch & Lomb Incorporated Packaging Solutions
US8119753B2 (en) 2007-10-23 2012-02-21 Bausch & Lomb Incorporated Silicone hydrogels with amino surface groups
US9527617B2 (en) 2007-10-23 2016-12-27 Bausch & Lomb Incorporated Packaging solutions
US20090103045A1 (en) * 2007-10-23 2009-04-23 Yu-Chin Lai Silicone hydrogels with amino surface groups
US20090108479A1 (en) * 2007-10-26 2009-04-30 Bausch & Lomb Incorporated Method for Making Biomedical Devices
US20090122260A1 (en) * 2007-11-14 2009-05-14 Salamone Joseph C Biomedical Devices
US7884141B2 (en) 2007-11-14 2011-02-08 Bausch & Lomb Incorporated Biomedical devices
US20090142485A1 (en) * 2007-11-29 2009-06-04 Yu-Chin Lai Process for Making Biomedical Devices
EP2397505A1 (en) 2007-12-03 2011-12-21 Bausch & Lomb Incorporated High water content silicone hydrogels
US20090142292A1 (en) * 2007-12-03 2009-06-04 Blackwell Richard I Method For The Mitigation of Symptoms of Dry Eye
US7934830B2 (en) * 2007-12-03 2011-05-03 Bausch & Lomb Incorporated High water content silicone hydrogels
US20090142387A1 (en) * 2007-12-03 2009-06-04 Blackwell Richard I Method For Inhibiting Attachment Of Microorganisms To Biomedical Devices
US20090141234A1 (en) * 2007-12-03 2009-06-04 Blackwell Richard I High Water Content Silicone Hydrogels
US20090145091A1 (en) * 2007-12-11 2009-06-11 Richard Connolly Method for treating ophthalmic lenses
US20090156708A1 (en) * 2007-12-14 2009-06-18 Yu-Chin Lai Biomedical devices
US8071660B2 (en) 2007-12-14 2011-12-06 Bausch & Lomb Incorporated Surface modified biomedical devices
US8071661B2 (en) 2007-12-14 2011-12-06 Bausch & Lomb Incorporated Biomedical devices
US20090156745A1 (en) * 2007-12-14 2009-06-18 Yu-Chin Lai Surface modified biomedical devices
US20100310622A1 (en) * 2007-12-17 2010-12-09 University Of Florida Research Foundation, Inc. Dry eye treatment by puncta plugs
WO2012099555A2 (en) 2007-12-20 2012-07-26 Johnson & Johnson Vision Care, Inc. Cosmetic contact lenses having a sparkle effect
US20090171049A1 (en) * 2007-12-27 2009-07-02 Linhardt Jeffrey G Segmented reactive block copolymers
US20090169716A1 (en) * 2007-12-27 2009-07-02 Linhardt Jeffrey G Coating solutions comprising surface active segmented block copolymers
US8100528B2 (en) 2007-12-27 2012-01-24 Bausch & Lomb Incorporated Coating solutions comprising segmented interactive block copolymers
WO2009085756A1 (en) 2007-12-27 2009-07-09 Bausch & Lomb Incorporated Coating solutions comprising segmented interactive block copolymers
US20090168013A1 (en) * 2007-12-27 2009-07-02 Kunzler Jay F Trimethylsilyl-Capped Polysiloxane Macromonomers Containing Polar Fluorinated Side-Chains
US20090171050A1 (en) * 2007-12-27 2009-07-02 Linhardt Jeffrey G Surface active segmented block copolymers
US20090171459A1 (en) * 2007-12-27 2009-07-02 Linhardt Jeffrey G Coating solutions comprising segmented reactive block copolymers
US7942929B2 (en) 2007-12-27 2011-05-17 Bausch & Lomb Incorporated Coating solutions comprising segmented reactive block copolymers
EP2597113A1 (en) 2007-12-27 2013-05-29 Bausch & Lomb Incorporated Coating solutions comprising segmented reactive block copolymers
US20090171027A1 (en) * 2007-12-27 2009-07-02 Linhardt Jeffrey G Segmented interactive block copolymers
US7837934B2 (en) 2008-01-09 2010-11-23 Bausch & Lomb Incorporated Packaging solutions
US20090173643A1 (en) * 2008-01-09 2009-07-09 Yu-Chin Lai Packaging Solutions
US20090173045A1 (en) * 2008-01-09 2009-07-09 Yu-Chin Lai Packaging Solutions
US20090173044A1 (en) * 2008-01-09 2009-07-09 Linhardt Jeffrey G Packaging Solutions
US20090192275A1 (en) * 2008-01-25 2009-07-30 Salamone Joseph C Multi-armed macromonomers
US8389597B2 (en) 2008-01-25 2013-03-05 Bausch & Lomb Incorporated High water content ophthalmic devices
US20090191256A1 (en) * 2008-01-25 2009-07-30 Blackwell Richard I High water content ophthalmic devices
US8030423B2 (en) 2008-01-25 2011-10-04 Salamone Joseph C Multi-armed macromonomers
US8138290B2 (en) 2008-01-25 2012-03-20 Bausch & Lomb Incorporated High water content ophthalmic devices
US7781554B2 (en) 2008-03-05 2010-08-24 Bausch & Lomb Incorporated Polysiloxanes and polysiloxane prepolymers with vinyl or epoxy functionality
US20100069522A1 (en) * 2008-03-17 2010-03-18 Linhardt Jeffrey G Lenses comprising amphiphilic multiblock copolymers
US20110125260A1 (en) * 2008-04-30 2011-05-26 University Of Washington Artificial cornea
EP2365360A2 (en) 2008-06-02 2011-09-14 Johnson & Johnson Vision Care, Inc. Silicone Hydrogel Contact Lenses Displaying Reduced Protein Uptake
US20090295004A1 (en) * 2008-06-02 2009-12-03 Pinsly Jeremy B Silicone hydrogel contact lenses displaying reduced protein uptake
US8440738B2 (en) 2008-07-09 2013-05-14 Timothy Higgs Silicone hydrogels and methods of manufacture
US7939579B1 (en) 2008-07-09 2011-05-10 Contamac Limited Hydrogels and methods of manufacture
US9260544B2 (en) 2008-09-30 2016-02-16 Johnson & Johnson Vision Care, Inc. Ionic silicone hydrogels having improved hydrolytic stability
US8470906B2 (en) 2008-09-30 2013-06-25 Johnson & Johnson Vision Care, Inc. Ionic silicone hydrogels having improved hydrolytic stability
US20100081772A1 (en) * 2008-09-30 2010-04-01 Diana Zanini Process for forming silicone hydrogel articles having improved optical properties
US20100249356A1 (en) * 2008-09-30 2010-09-30 Osman Rathore Ionic silicone hydrogels having improved hydrolytic stability
US8815972B2 (en) 2008-09-30 2014-08-26 Johnson & Johnson Vision Care, Inc. Ionic silicone hydrogels having improved hydrolytic stability
US9101667B2 (en) 2008-09-30 2015-08-11 Johnson & Johnson Vision Care, Inc. Ionic silicone hydrogels comprising pharmaceutical and/or neuticeutical components and having improved hydrolytic stability
JP2010159248A (en) * 2008-12-10 2010-07-22 Rohto Pharmaceut Co Ltd Ophthalmic solution for silicone hydrogel contact lenses
JP2016216519A (en) * 2008-12-10 2016-12-22 ロート製薬株式会社 Eye drops for silicone hydrogel contact lenses
JP2020169211A (en) * 2008-12-10 2020-10-15 ロート製薬株式会社 Eye drops for silicone hydrogel contact lenses
JP2015078235A (en) * 2008-12-10 2015-04-23 ロート製薬株式会社 Eye drop for silicone hydrogel contact lens
US20100149482A1 (en) * 2008-12-12 2010-06-17 Ammon Jr Daniel M Contact lens
WO2010077709A2 (en) 2008-12-30 2010-07-08 Bausch & Lomb Incorporated Biomedical devices
US8377126B2 (en) 2008-12-30 2013-02-19 Bausch & Lomb Incorporated Renewable polymeric lens coating
US20100168850A1 (en) * 2008-12-30 2010-07-01 David Paul Vanderbilt Brush CoPolymers
US20100162661A1 (en) * 2008-12-30 2010-07-01 David Paul Vanderbilt Packaging Solutions
US20100168851A1 (en) * 2008-12-30 2010-07-01 David Paul Vanderbilt Surface Modified Biomedical Devices
US20100168356A1 (en) * 2008-12-30 2010-07-01 Yu-Chin Lai Biomedical Devices
US8454689B2 (en) 2008-12-30 2013-06-04 Bausch & Lomb Incorporated Brush copolymers
WO2010078150A1 (en) 2008-12-30 2010-07-08 Bausch & Lomb Incorporated Packaging solutions
US20100168852A1 (en) * 2008-12-30 2010-07-01 David Paul Vanderbilt Brush Copolymers
US20100168855A1 (en) * 2008-12-30 2010-07-01 Mcgee Joseph A Method of Applying Renewable Polymeric Lens Coating
US8631631B2 (en) 2008-12-30 2014-01-21 Bausch & Lomb Incorporated Packaging solutions
WO2010077708A1 (en) 2008-12-30 2010-07-08 Bausch & Lomb Incorporated Packaging solutions
WO2010078107A1 (en) 2008-12-30 2010-07-08 Bausch & Lomb Incorporated Brush copolymers
US8534031B2 (en) 2008-12-30 2013-09-17 Bausch & Lomb Incorporated Packaging solutions
US20100162663A1 (en) * 2008-12-30 2010-07-01 Mcgee Joseph A Packaging Solutions
US8419792B2 (en) 2008-12-30 2013-04-16 Bausch & Lomb Incorporated Brush copolymers
WO2010077646A2 (en) 2008-12-30 2010-07-08 Bausch & Lomb Incorporated Method of applying renewable polymeric lens coating
US8337551B2 (en) 2009-06-16 2012-12-25 Bausch & Lomb Incorporated Biomedical devices
WO2010147864A2 (en) 2009-06-16 2010-12-23 Bausch & Lomb Incorporated Biomedical devices
WO2010147875A2 (en) 2009-06-16 2010-12-23 Bausch & Lomb Incorporated Biomedical devices
WO2010147865A1 (en) 2009-06-16 2010-12-23 Bausch & Lomb Incorporated Multi-armed macromonomers, polymeric materials and contact lenses comprising same
US20100317816A1 (en) * 2009-06-16 2010-12-16 Bausch & Lomb Incorporated Biomedical devices
US8083348B2 (en) 2009-06-16 2011-12-27 Bausch & Lomb Incorporated Biomedical devices
WO2010147874A1 (en) 2009-06-16 2010-12-23 Bausch & Lomb Incorporated Biomedical devices, polymeric materials and contact lenses comprising same
US9285508B2 (en) 2009-06-16 2016-03-15 Bausch & Lomb Incorporated Biomedical devices
US8133960B2 (en) 2009-06-16 2012-03-13 Bausch & Lomb Incorporated Biomedical devices
US20100315588A1 (en) * 2009-06-16 2010-12-16 Bausch & Lomb Incorporated Biomedical devices
US20100317817A1 (en) * 2009-06-16 2010-12-16 Bausch & Lomb Incorporated Biomedical devices
WO2010147876A2 (en) 2009-06-16 2010-12-23 Bausch & Lomb Incorporated Biomedical devices
US20100317809A1 (en) * 2009-06-16 2010-12-16 Bausch & Lomb Incorporated Biomedical devices
US8043369B2 (en) 2009-06-16 2011-10-25 Bausch & Lomb Incorporated Biomedical devices
US8827447B2 (en) 2009-07-09 2014-09-09 Bausch & Lomb Incorporated Mono ethylenically unsaturated polymerizable group containing polycarbosiloxane monomers
US7994356B2 (en) 2009-07-09 2011-08-09 Bausch & Lomb Incorporated Mono ethylenically unsaturated polycarbosiloxane monomers
US20110009519A1 (en) * 2009-07-09 2011-01-13 Alok Kumar Awasthi Mono ethylenically unsaturated polymerizable group containing polycarbosiloxane monomers
WO2011005937A2 (en) 2009-07-09 2011-01-13 Bausch & Lomb Incorporated Mono ethylenically unsaturated polymerizable group containing polycarbosiloxane monomers
US7915323B2 (en) 2009-07-09 2011-03-29 Bausch & Lamb Incorporated Mono ethylenically unsaturated polycarbosiloxane monomers
US8420711B2 (en) 2009-07-09 2013-04-16 Bausch & Lomb Incorporated Mono ethylenically unsaturated polymerizable group containing polycarbosiloxane monomers
US9039174B2 (en) 2009-07-09 2015-05-26 Bausch & Lomb Incorporated Ethylenically unsaturated polymerizable groups comprising polycarbosiloxane monomers
US20110009658A1 (en) * 2009-07-09 2011-01-13 Alok Kumar Awasthi Mono Ethylenically Unsaturated Polycarbosiloxane Monomers
US20110009587A1 (en) * 2009-07-09 2011-01-13 Alok Kumar Awasthi Mono ethylenically unsaturated polycarbosiloxane monomers
US11724472B2 (en) 2010-04-13 2023-08-15 Johnson & Johnson Vision Care, Inc. Process for manufacture of a thermochromic contact lens material
US11391965B2 (en) 2010-04-13 2022-07-19 Johnson & Johnson Vision Care, Inc. Pupil-only photochromic contact lenses displaying desirable optics and comfort
US11789291B2 (en) 2010-04-13 2023-10-17 Johnson & Johnson Vision Care, Inc. Pupil-only photochromic contact lenses displaying desirable optics and comfort
US10894374B2 (en) 2010-04-13 2021-01-19 Johnson & Johnson Vision Care, Inc. Process for manufacture of a thermochromic contact lens material
WO2011130138A1 (en) 2010-04-13 2011-10-20 Johnson & Johnson Vision Care, Inc. Contact lenses displaying reduced indoor glare
US10816822B2 (en) 2010-04-13 2020-10-27 Johnson & Johnson Vision Care, Inc. Pupil-only photochromic contact lenses displaying desirable optics and comfort
US9690115B2 (en) 2010-04-13 2017-06-27 Johnson & Johnson Vision Care, Inc. Contact lenses displaying reduced indoor glare
US9815979B2 (en) 2010-05-06 2017-11-14 Johnson & Johnson Vision Care, Inc. Non-reactive, hydrophilic polymers having terminal siloxanes and methods for making and using the same
US10301465B2 (en) 2010-05-06 2019-05-28 Johnson & Johnson Vision Care, Inc. Non-reactive, hydrophilic polymers having terminal siloxanes and methods for making and using the same
US9522980B2 (en) 2010-05-06 2016-12-20 Johnson & Johnson Vision Care, Inc. Non-reactive, hydrophilic polymers having terminal siloxanes and methods for making and using the same
WO2011140318A1 (en) 2010-05-06 2011-11-10 Johnson & Johnson Vision Care, Inc. Non-reactive, hydrophilic polymers having terminal siloxanes and uses of the same
WO2012006485A2 (en) 2010-07-09 2012-01-12 Lee Darren Norris Polar thermoplastic opthalmic lens molds, opthalmic lenses molded therein, and related methods
WO2012006488A2 (en) 2010-07-09 2012-01-12 Lee Darren Norris Ophthalmic lens molds with low levels of uv light transmittance, ophthalmic lenses molded therein, and related methods
WO2012013946A1 (en) 2010-07-30 2012-02-02 Neil Goodenough Vinyl alcohol ophthalmic lens molds, ophthalmic lenses molded therein, and related methods
US8557940B2 (en) 2010-07-30 2013-10-15 Novartis Ag Amphiphilic polysiloxane prepolymers and uses thereof
US9341744B2 (en) 2010-07-30 2016-05-17 Novartis Ag Amphiphilic polysiloxane prepolymers and uses thereof
WO2012013947A1 (en) 2010-07-30 2012-02-02 Neil Goodenough Silicone hydrogel ophthalmic devices molded in vinyl alcohol copolymer molds and related methods
US8987403B2 (en) 2010-07-30 2015-03-24 Novartis Ag Amphiphilic polysiloxane prepolymers and uses thereof
WO2012047969A1 (en) 2010-10-06 2012-04-12 Novartis Ag Water-processable silicone-containing prepolymers and uses thereof
US9109091B2 (en) 2010-10-06 2015-08-18 Novartis Ag Polymerizable chain-extended polysiloxanes with pendant hydrophilic groups
US9187601B2 (en) 2010-10-06 2015-11-17 Novartis Ag Water-processable silicone-containing prepolymers and uses thereof
US8835525B2 (en) 2010-10-06 2014-09-16 Novartis Ag Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains
US9052440B2 (en) 2010-10-06 2015-06-09 Novartis Ag Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains
US9921340B2 (en) 2010-10-06 2018-03-20 Novartis Ag Water-processable silicone-containing prepolymers and uses thereof
US8993651B2 (en) 2010-10-06 2015-03-31 Novartis Ag Polymerizable chain-extended polysiloxanes with pendant hydrophilic groups
US9864103B2 (en) 2011-02-28 2018-01-09 Coopervision International Holding Company, Lp Phosphine-containing hydrogel contact lenses
US8642677B2 (en) 2011-02-28 2014-02-04 Coopervision International Holding Company, Lp Phosphine-containing hydrogel contact lenses
WO2012154268A1 (en) 2011-02-28 2012-11-15 Coopervision International Holding Company, Lp Silicone hydrogel contact lenses
WO2012118681A2 (en) 2011-02-28 2012-09-07 Coopervision International Holding Company, Lp Silicone hydrogel contact lenses having acceptable levels of energy loss
EP2492720A1 (en) 2011-02-28 2012-08-29 CooperVision International Holding Company, LP Wettable Silicone Hydrogel Contact Lenses
WO2012118671A1 (en) 2011-02-28 2012-09-07 Coopervision International Holding Company, Lp Phosphine-containing hydrogel contact lenses
EP2492719A1 (en) 2011-02-28 2012-08-29 CooperVision International Holding Company, LP Dimensionally stable silicone hydrogel contact lenses
EP3456758A1 (en) 2011-02-28 2019-03-20 CooperVision International Holding Company, LP Silicone hydrogel contact lenses and related compositions and methods
WO2012118672A2 (en) 2011-02-28 2012-09-07 Coopervision International Holding Company, Lp Silicone hydrogel contact lenses
EP3581973A1 (en) 2011-05-04 2019-12-18 Johnson & Johnson Vision Care Inc. Medical devices having homogeneous charge density and methods for making same
US9170349B2 (en) 2011-05-04 2015-10-27 Johnson & Johnson Vision Care, Inc. Medical devices having homogeneous charge density and methods for making same
US11067720B2 (en) 2011-05-04 2021-07-20 Johnson & Johnson Vision Care, Inc. Medical devices having homogeneous charge density and methods for making same
EP3141933A1 (en) 2011-05-04 2017-03-15 Johnson & Johnson Vision Care Inc. Medical devices having homogeneous charge density and methods for making same
US9612364B2 (en) 2011-05-04 2017-04-04 Johnson & Johnson Vision Care, Inc. Medical devices having homogeneous charge density and methods for making same
WO2012151135A1 (en) 2011-05-04 2012-11-08 Johnson & Johnson Vision Care, Inc. Medical devices having homogeneous charge density and methods for making same
US10386545B2 (en) 2011-05-04 2019-08-20 Johnson & Johnson Vision Care, Inc. Medical devices having homogeneous charge density and methods for making same
US9599751B2 (en) 2011-05-04 2017-03-21 Johnson & Johnson Vision Care, Inc. Medical devices having homogeneous charge density and methods for making same
US9006305B2 (en) 2011-09-01 2015-04-14 Vertellus Specialties Inc. Biocompatible material
US8980956B2 (en) 2011-09-01 2015-03-17 Vertellus Specialities Inc. Methods for producing biocompatible materials
WO2013033553A1 (en) 2011-09-01 2013-03-07 Vertellus Specialties Inc. Methods for producing biocompatible materials
WO2013033554A1 (en) 2011-09-01 2013-03-07 Vertellus Specialties Inc. Biocompatible material
WO2013048991A1 (en) 2011-09-30 2013-04-04 Johnson & Johnson Vision Care, Inc. Method of creating a visible mark on lens using a leuco dye
US9188702B2 (en) 2011-09-30 2015-11-17 Johnson & Johnson Vision Care, Inc. Silicone hydrogels having improved curing speed and other properties
WO2013048990A1 (en) 2011-09-30 2013-04-04 Johnson & Johnson Vision Care, Inc. Silicone hydrogels having improved curing speed and other properties
WO2013048993A1 (en) 2011-09-30 2013-04-04 Johnson & Johnson Vision Care, Inc. Method of creating a visible mark on lens using a leuco dye
US8980972B2 (en) 2011-11-10 2015-03-17 Vertellus Specialties Inc. Polymerisable material
US9885886B2 (en) 2011-12-06 2018-02-06 University Of Florida Research Foundation, Inc. UV blocker loaded contact lenses
US9594188B2 (en) 2011-12-06 2017-03-14 University Of Florida Research Foundation, Inc. UV blocker loaded contact lenses
WO2013085814A2 (en) 2011-12-08 2013-06-13 Johnson & Johnson Vision Care, Inc. Monomer systems with dispersed silicone-based engineered particles
US9000063B2 (en) 2011-12-14 2015-04-07 Semprus Biosciences Corporation Multistep UV process to create surface modified contact lenses
US9004682B2 (en) 2011-12-14 2015-04-14 Semprus Biosciences Corporation Surface modified contact lenses
US9006359B2 (en) 2011-12-14 2015-04-14 Semprus Biosciences Corporation Imbibing process for contact lens surface modification
US9120119B2 (en) 2011-12-14 2015-09-01 Semprus Biosciences Corporation Redox processes for contact lens modification
US8870372B2 (en) 2011-12-14 2014-10-28 Semprus Biosciences Corporation Silicone hydrogel contact lens modified using lanthanide or transition metal oxidants
WO2013109482A1 (en) 2012-01-17 2013-07-25 Johnson & Johnson Vision Care, Inc. Silicone polymers comprising sulfonic acid groups
US8940812B2 (en) 2012-01-17 2015-01-27 Johnson & Johnson Vision Care, Inc. Silicone polymers comprising sulfonic acid groups
US10209534B2 (en) 2012-03-27 2019-02-19 Johnson & Johnson Vision Care, Inc. Increased stiffness center optic in soft contact lenses for astigmatism correction
US10620456B2 (en) 2012-03-27 2020-04-14 Johnson & Johnson Vision Care, Inc. Increased stiffness center optic in soft contact lenses for astigmatism correction
US11829008B2 (en) 2012-03-27 2023-11-28 Johnson & Johnson Vision Care, Inc. Increased stiffness center optic in soft contact lenses for astigmatism correction
US11187920B2 (en) 2012-03-27 2021-11-30 Johnson & Johnson Vision Care, Inc. Increased stiffness center optic in soft contact lenses for astigmatism correction
US9047512B2 (en) 2012-05-15 2015-06-02 Google Inc. Contact lenses
US8798332B2 (en) 2012-05-15 2014-08-05 Google Inc. Contact lenses
US10502978B2 (en) 2012-05-25 2019-12-10 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
WO2013177506A2 (en) 2012-05-25 2013-11-28 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
US9244196B2 (en) 2012-05-25 2016-01-26 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
US9625617B2 (en) 2012-05-25 2017-04-18 Johnson & Johnson Vision Care, Inc. Contact lenses comprising water soluble N-(2 hydroxyalkyl) (meth)acrylamide polymers or copolymers
WO2013176886A2 (en) 2012-05-25 2013-11-28 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
WO2013177523A2 (en) 2012-05-25 2013-11-28 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
US9726906B2 (en) 2012-05-25 2017-08-08 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
WO2013177513A1 (en) 2012-05-25 2013-11-28 Johnson & Johnson Vision Care, Inc. Contact lenses comprising water soluble n-(2 hydroxyalkyl) (meth)acrylamide polymers or copolymers
US11782296B2 (en) 2012-05-25 2023-10-10 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
US9297929B2 (en) 2012-05-25 2016-03-29 Johnson & Johnson Vision Care, Inc. Contact lenses comprising water soluble N-(2 hydroxyalkyl) (meth)acrylamide polymers or copolymers
US10502867B2 (en) 2012-05-25 2019-12-10 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
EP3401342A1 (en) 2012-05-25 2018-11-14 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
WO2013176957A1 (en) 2012-05-25 2013-11-28 Bausch & Lomb Incorporated Method of making a fully polymerized uv blocking silicone hydrogel lens
US11029539B2 (en) 2012-05-25 2021-06-08 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
US9075187B2 (en) 2012-05-25 2015-07-07 Bausch & Lomb Incorporated Fully polymerized UV blocking silicone hydrogel lens
US10871595B2 (en) 2012-05-25 2020-12-22 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
US8807745B2 (en) 2012-05-25 2014-08-19 Bausch & Lomb Incorporated Fully polymerized UV blocking silicone hydrogel lens
EP3296334A1 (en) 2012-05-25 2018-03-21 Johnson & Johnson Vision Care Inc. Polymers and nanogel materials and methods for making and using the same
WO2013177008A1 (en) 2012-05-25 2013-11-28 Bausch & Lomb Incorporated Fully polymerized uv blocking silicone hydrogel lens
US10073192B2 (en) 2012-05-25 2018-09-11 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
JP2013256477A (en) * 2012-06-14 2013-12-26 Shin-Etsu Chemical Co Ltd Method for producing organoxysilane compound having piperazinyl group and piperazine compound
US10265916B2 (en) 2012-06-25 2019-04-23 Johnson & Johnson Vision Care, Inc. Method of making silicone containing contact lens with reduced amount of diluents
US11945180B2 (en) 2012-06-25 2024-04-02 Johnson & Johnson Vision Care, Inc. Method of making silicone containing contact lens with reduced amount of diluents
US9423528B2 (en) 2012-06-25 2016-08-23 Johnson & Johnson Vision Care, Inc. Method of making silicone containing contact lens with reduced amount of diluents
US9981434B2 (en) 2012-06-25 2018-05-29 Johnson & Johnson Vision Care, Inc. Method of making silicone containing contact lens with reduced amount of diluents
WO2014004107A1 (en) 2012-06-25 2014-01-03 Johnson & Johnson Vision Care, Inc. Lens comprising low and high molecular weight polyamides
US10792874B2 (en) 2012-06-25 2020-10-06 Johnson & Johnson Vision Care, Inc. Method of making silicone containing contact lens with reduced amount of diluents
WO2014004106A1 (en) 2012-06-25 2014-01-03 Johnson & Johnson Vision Care, Inc. Method of making silicone containing contact lens with reduced amount of diluents
EP3572028A1 (en) 2012-07-06 2019-11-27 Peter J. Zegarelli An oral appliance for delivery of medicaments and/or other substances
US10256919B1 (en) 2012-07-26 2019-04-09 Verily Life Sciences Llc Employing optical signals for power and/or communication
US8857981B2 (en) 2012-07-26 2014-10-14 Google Inc. Facilitation of contact lenses with capacitive sensors
US10873401B1 (en) 2012-07-26 2020-12-22 Verily Life Sciences Llc Employing optical signals for power and/or communication
US8864305B2 (en) 2012-07-26 2014-10-21 Google Inc. Facilitation of contact lenses with capacitive sensors
US10120203B2 (en) 2012-07-26 2018-11-06 Verliy Life Sciences LLC Contact lenses with hybrid power sources
US9298020B1 (en) 2012-07-26 2016-03-29 Verily Life Sciences Llc Input system
US9158133B1 (en) 2012-07-26 2015-10-13 Google Inc. Contact lens employing optical signals for power and/or communication
US9523865B2 (en) 2012-07-26 2016-12-20 Verily Life Sciences Llc Contact lenses with hybrid power sources
US9735892B1 (en) 2012-07-26 2017-08-15 Verily Life Sciences Llc Employing optical signals for power and/or communication
US8919953B1 (en) 2012-08-02 2014-12-30 Google Inc. Actuatable contact lenses
US9696564B1 (en) 2012-08-21 2017-07-04 Verily Life Sciences Llc Contact lens with metal portion and polymer layer having indentations
US9111473B1 (en) 2012-08-24 2015-08-18 Google Inc. Input system
US8820934B1 (en) 2012-09-05 2014-09-02 Google Inc. Passive surface acoustic wave communication
US9320460B2 (en) 2012-09-07 2016-04-26 Verily Life Sciences Llc In-situ tear sample collection and testing using a contact lens
US9398868B1 (en) 2012-09-11 2016-07-26 Verily Life Sciences Llc Cancellation of a baseline current signal via current subtraction within a linear relaxation oscillator-based current-to-frequency converter circuit
US9737248B1 (en) 2012-09-11 2017-08-22 Verily Life Sciences Llc Cancellation of a baseline current signal via current subtraction within a linear relaxation oscillator-based current-to-frequency converter circuit
US10729363B1 (en) 2012-09-11 2020-08-04 Verily Life Sciences Llc Cancellation of a baseline current signal via current subtraction within a linear relaxation oscillator-based current-to-frequency converter circuit
US10010270B2 (en) 2012-09-17 2018-07-03 Verily Life Sciences Llc Sensing system
US10932695B2 (en) 2012-09-17 2021-03-02 Verily Life Sciences Llc Sensing system
US9326710B1 (en) 2012-09-20 2016-05-03 Verily Life Sciences Llc Contact lenses having sensors with adjustable sensitivity
US8870370B1 (en) 2012-09-24 2014-10-28 Google Inc. Contact lens that facilitates antenna communication via sensor impedance modulation
US8960898B1 (en) 2012-09-24 2015-02-24 Google Inc. Contact lens that restricts incoming light to the eye
US8979271B2 (en) 2012-09-25 2015-03-17 Google Inc. Facilitation of temperature compensation for contact lens sensors and temperature sensing
US8989834B2 (en) 2012-09-25 2015-03-24 Google Inc. Wearable device
US9965583B2 (en) 2012-09-25 2018-05-08 Verily Life Sciences, LLC Information processing method
US8821811B2 (en) 2012-09-26 2014-09-02 Google Inc. In-vitro contact lens testing
US9054079B2 (en) 2012-09-26 2015-06-09 Google Inc. Assembling thin silicon chips on a contact lens
US9488853B2 (en) 2012-09-26 2016-11-08 Verily Life Sciences Llc Assembly bonding
US10099049B2 (en) 2012-09-26 2018-10-16 Verily Life Sciences Llc Power transducer for a retinal implant using using a contact lens
US8960899B2 (en) 2012-09-26 2015-02-24 Google Inc. Assembling thin silicon chips on a contact lens
US9884180B1 (en) 2012-09-26 2018-02-06 Verily Life Sciences Llc Power transducer for a retinal implant using a contact lens
US8985763B1 (en) 2012-09-26 2015-03-24 Google Inc. Contact lens having an uneven embedded substrate and method of manufacture
US9775513B1 (en) 2012-09-28 2017-10-03 Verily Life Sciences Llc Input detection system
US9063351B1 (en) 2012-09-28 2015-06-23 Google Inc. Input detection system
US10342424B2 (en) 2012-09-28 2019-07-09 Verily Life Sciences Llc Input detection system
US9724027B2 (en) 2012-10-12 2017-08-08 Verily Life Sciences Llc Microelectrodes in an ophthalmic electrochemical sensor
US8965478B2 (en) 2012-10-12 2015-02-24 Google Inc. Microelectrodes in an ophthalmic electrochemical sensor
US9055902B2 (en) 2012-10-12 2015-06-16 Google Inc. Microelectrodes in an ophthalmic electrochemical sensor
US9176332B1 (en) 2012-10-24 2015-11-03 Google Inc. Contact lens and method of manufacture to improve sensor sensitivity
US9757056B1 (en) 2012-10-26 2017-09-12 Verily Life Sciences Llc Over-molding of sensor apparatus in eye-mountable device
US9541676B2 (en) 2012-12-14 2017-01-10 Novartis Ag Amphiphilic siloxane-containing vinylic monomers and uses thereof
WO2014093751A2 (en) 2012-12-14 2014-06-19 Novartis Ag Amphiphilic siloxane-containing vinylic monomers and uses thereof
US9103965B2 (en) 2012-12-14 2015-08-11 Novartis Ag Amphiphilic siloxane-containing vinylic monomers and uses thereof
WO2014093764A1 (en) 2012-12-14 2014-06-19 Novartis Ag Amphiphilic siloxane-containing (meth)acrylamides and uses thereof
US9268064B2 (en) 2012-12-14 2016-02-23 Novartis Ag Amphiphilic siloxane-containing (meth)acrylamides and uses thereof
US9097840B2 (en) 2012-12-14 2015-08-04 Novartis Ag Amphiphilic siloxane-containing (meth)acrylamides and uses thereof
US8967799B2 (en) 2012-12-20 2015-03-03 Bausch & Lomb Incorporated Method of preparing water extractable silicon-containing biomedical devices
WO2014100171A1 (en) 2012-12-20 2014-06-26 Bausch & Lomb Incorporated Method of preparing water extractable silicon-containing biomedical devices
US8874182B2 (en) 2013-01-15 2014-10-28 Google Inc. Encapsulated electronics
US10004457B2 (en) 2013-01-15 2018-06-26 Verily Life Sciences Llc Encapsulated electronics
US8886275B2 (en) 2013-01-15 2014-11-11 Google Inc. Encapsulated electronics
US9289954B2 (en) 2013-01-17 2016-03-22 Verily Life Sciences Llc Method of ring-shaped structure placement in an eye-mountable device
US8926809B2 (en) 2013-01-25 2015-01-06 Google Inc. Standby biasing of electrochemical sensor to reduce sensor stabilization time during measurement
US9636016B1 (en) 2013-01-25 2017-05-02 Verily Life Sciences Llc Eye-mountable devices and methods for accurately placing a flexible ring containing electronics in eye-mountable devices
WO2014149544A1 (en) 2013-03-15 2014-09-25 Johnson & Johnson Vision Care, Inc. Silicone-containing contact lens having reduced amount of silicon on the surface
US9250357B2 (en) 2013-03-15 2016-02-02 Johnson & Johnson Vision Care, Inc. Silicone-containing contact lens having reduced amount of silicon on the surface
WO2014151254A1 (en) 2013-03-15 2014-09-25 Bausch & Lomb Incorporated Method and apparatus for delaying polymerisation
WO2014143926A1 (en) 2013-03-15 2014-09-18 Bausch & Lomb Incorporated Ethylenically unsaturated polymerizable groups comprising polycarbosiloxane monomers
WO2014149546A1 (en) 2013-03-15 2014-09-25 Johnson & Johnson Vision Care, Inc. Silicone-containing contact lens having clay treatment applied thereto
US9161712B2 (en) 2013-03-26 2015-10-20 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US8950068B2 (en) 2013-03-26 2015-02-10 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US9009958B2 (en) 2013-03-27 2015-04-21 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US9113829B2 (en) 2013-03-27 2015-08-25 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US9332935B2 (en) 2013-06-14 2016-05-10 Verily Life Sciences Llc Device having embedded antenna
US9084561B2 (en) 2013-06-17 2015-07-21 Google Inc. Symmetrically arranged sensor electrodes in an ophthalmic electrochemical sensor
US9662054B2 (en) 2013-06-17 2017-05-30 Verily Life Sciences Llc Symmetrically arranged sensor electrodes in an ophthalmic electrochemical sensor
US8880139B1 (en) 2013-06-17 2014-11-04 Google Inc. Symmetrically arranged sensor electrodes in an ophthalmic electrochemical sensor
US9948895B1 (en) 2013-06-18 2018-04-17 Verily Life Sciences Llc Fully integrated pinhole camera for eye-mountable imaging system
US9685689B1 (en) 2013-06-27 2017-06-20 Verily Life Sciences Llc Fabrication methods for bio-compatible devices
US9307901B1 (en) 2013-06-28 2016-04-12 Verily Life Sciences Llc Methods for leaving a channel in a polymer layer using a cross-linked polymer plug
US9492118B1 (en) 2013-06-28 2016-11-15 Life Sciences Llc Pre-treatment process for electrochemical amperometric sensor
US9814387B2 (en) 2013-06-28 2017-11-14 Verily Life Sciences, LLC Device identification
US9028772B2 (en) 2013-06-28 2015-05-12 Google Inc. Methods for forming a channel through a polymer layer using one or more photoresist layers
WO2015017191A1 (en) 2013-08-02 2015-02-05 Bausch & Lomb Incorporated Hydrogel monomer mix containing added water
KR20150034095A (en) * 2013-09-25 2015-04-02 신에쓰 가가꾸 고교 가부시끼가이샤 Silicone compound containing radical-polymerizable group and method for producing the same
CN104447843A (en) * 2013-09-25 2015-03-25 信越化学工业株式会社 Silicone compound having a radical-polymerizable group and a method for the preparation thereof
US9572522B2 (en) 2013-12-20 2017-02-21 Verily Life Sciences Llc Tear fluid conductivity sensor
US9654674B1 (en) 2013-12-20 2017-05-16 Verily Life Sciences Llc Image sensor with a plurality of light channels
US9459377B2 (en) 2014-01-15 2016-10-04 Johnson & Johnson Vision Care, Inc. Polymers comprising sulfonic acid groups
WO2015108722A1 (en) 2014-01-15 2015-07-23 Johnson & Johnson Vision Care, Inc. Polymers comprising sulfonic acid groups
US9366570B1 (en) 2014-03-10 2016-06-14 Verily Life Sciences Llc Photodiode operable in photoconductive mode and photovoltaic mode
US9184698B1 (en) 2014-03-11 2015-11-10 Google Inc. Reference frequency from ambient light signal
US9789655B1 (en) 2014-03-14 2017-10-17 Verily Life Sciences Llc Methods for mold release of body-mountable devices including microelectronics
WO2018009310A1 (en) 2016-07-06 2018-01-11 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising high levels of polyamides
WO2018009311A1 (en) 2016-07-06 2018-01-11 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising polyamides
US10370476B2 (en) 2016-07-06 2019-08-06 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising high levels of polyamides
WO2018009312A1 (en) 2016-07-06 2018-01-11 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising n-alkyl methacrylamides and contact lenses made thereof
US10371865B2 (en) 2016-07-06 2019-08-06 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising polyamides
US10890689B2 (en) 2016-07-06 2021-01-12 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising polyamides
WO2018009309A1 (en) 2016-07-06 2018-01-11 Johnson & Johnson Vision Care, Inc. Increased stiffness center optic in soft contact lenses for astigmatism correction
US11828913B2 (en) 2016-07-06 2023-11-28 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising polyamides
US11125916B2 (en) 2016-07-06 2021-09-21 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising N-alkyl methacrylamides and contact lenses made thereof
US10738145B2 (en) 2016-07-06 2020-08-11 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising high levels of polyamides
US11754754B2 (en) 2016-07-06 2023-09-12 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising N-alkyl methacrylamides and contact lenses made thereof
EP4043508A1 (en) 2016-07-06 2022-08-17 Johnson & Johnson Vision Care, Inc. Silicone hydrogels comprising n-alkyl methacrylamides and contact lenses made thereof
US11820850B2 (en) 2016-08-05 2023-11-21 Johnson & Johnson Vision Care, Inc. Polymer compositions containing grafted polymeric networks and processes for their preparation and use
WO2018026822A1 (en) 2016-08-05 2018-02-08 Johnson & Johnson Vision Care, Inc. Polymer compositions containing grafted polymeric networks and processes for their preparation and use
US11021558B2 (en) 2016-08-05 2021-06-01 Johnson & Johnson Vision Care, Inc. Polymer compositions containing grafted polymeric networks and processes for their preparation and use
EP3753975A1 (en) 2016-08-05 2020-12-23 Johnson & Johnson Vision Care Inc. Polymer compositions containing grafted polymeric networks and processes for their preparation and use
WO2018067284A1 (en) 2016-10-06 2018-04-12 Johnson & Johnson Vision Care, Inc. Tri-block prepolymers and their use in silicone hydrogels
US10676575B2 (en) 2016-10-06 2020-06-09 Johnson & Johnson Vision Care, Inc. Tri-block prepolymers and their use in silicone hydrogels
US10752720B2 (en) 2017-06-26 2020-08-25 Johnson & Johnson Vision Care, Inc. Polymerizable blockers of high energy light
WO2019002971A1 (en) 2017-06-26 2019-01-03 Johnson & Johnson Vision Care, Inc. Polymerizable blockers of high energy light
US10526296B2 (en) 2017-06-30 2020-01-07 Johnson & Johnson Vision Care, Inc. Hydroxyphenyl naphthotriazoles as polymerizable blockers of high energy light
US10723732B2 (en) 2017-06-30 2020-07-28 Johnson & Johnson Vision Care, Inc. Hydroxyphenyl phenanthrolines as polymerizable blockers of high energy light
WO2019003064A1 (en) 2017-06-30 2019-01-03 Johnson & Johnson Vision Care, Inc. Hydroxyphenyl phenanthrolines as polymerizable blockers of high energy light for preparing ophthalmic devices, such as e.g. contact lenses
US10975040B2 (en) 2017-06-30 2021-04-13 Johnson & Johnson Vision Care, Inc. Hydroxyphenyl naphthotriazoles as polymerizable blockers of high energy light
WO2019147425A1 (en) 2018-01-26 2019-08-01 Bausch & Lomb Incorporated Method for end-capping a polysiloxane prepolymer
WO2019150217A1 (en) 2018-01-30 2019-08-08 Johnson & Johnson Vision Care, Inc. Ophthalmic devices containing localized grafted networks and processes for their preparation and use
US11780953B2 (en) 2018-01-30 2023-10-10 Johnson & Johnson Vision Care, Inc. Ophthalmic devices containing localized grafted networks and processes for their preparation and use
US11034789B2 (en) 2018-01-30 2021-06-15 Johnson & Johnson Vision Care, Inc. Ophthalmic devices containing localized grafted networks and processes for their preparation and use
US11834547B2 (en) 2018-01-30 2023-12-05 Johnson & Johnson Vision Care, Inc. Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use
WO2019150216A1 (en) 2018-01-30 2019-08-08 Johnson & Johnson Vision Care, Inc. Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use
US10961341B2 (en) 2018-01-30 2021-03-30 Johnson & Johnson Vision Care, Inc. Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use
US10968319B2 (en) 2018-02-26 2021-04-06 Alcon Inc. Silicone hydrogel contact lenses
WO2019162881A1 (en) 2018-02-26 2019-08-29 Novartis Ag Silicone hydrogel contact lenses
US11993037B1 (en) 2018-03-02 2024-05-28 Johnson & Johnson Vision Care, Inc. Contact lens displaying improved vision attributes
US11820899B2 (en) 2018-03-02 2023-11-21 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of UV and high energy visible light
WO2019166971A1 (en) 2018-03-02 2019-09-06 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of uv and high energy visible light
US10935695B2 (en) 2018-03-02 2021-03-02 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of UV and high energy visible light
EP4219632A2 (en) 2018-03-02 2023-08-02 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of uv and high energy visible light
US10996491B2 (en) 2018-03-23 2021-05-04 Johnson & Johnson Vision Care, Inc. Ink composition for cosmetic contact lenses
US11427685B2 (en) 2018-03-28 2022-08-30 Alcon Inc. Method for making silicone hydrogel contact lenses
WO2019186426A1 (en) 2018-03-28 2019-10-03 Alcon Inc. Method for making silicone hydrogel contact lenses
WO2019212657A1 (en) 2018-05-01 2019-11-07 Bausch & Lomb Incorporated Ophthalmic devices containing uv blocker and methods for their preparation
US11066530B2 (en) 2018-05-01 2021-07-20 Bausch & Lomb Incorporated Ophthalmic devices containing UV blocker and methods for their preparation
US11345773B2 (en) 2018-05-15 2022-05-31 Bausch & Lomb Incorporated Water extractable ophthalmic devices
WO2019221838A1 (en) 2018-05-15 2019-11-21 Bausch & Lomb Incorporated Water extractable ophthalmic devices
US11897985B2 (en) 2018-05-15 2024-02-13 Bausch & Lomb Incorporated Water extractable ophthalmic devices
WO2019234591A1 (en) 2018-06-04 2019-12-12 Alcon Inc. Method for producing silicone hydrogel contact lenses
WO2019234590A1 (en) 2018-06-04 2019-12-12 Alcon Inc. Method for making silicone hydrogel contact lenses
US11433629B2 (en) 2018-06-04 2022-09-06 Alcon Inc. Method for preparing silicone hydrogels
WO2019234593A1 (en) 2018-06-04 2019-12-12 Alcon Inc. Method for producing silicone hydrogel contact lenses
US11254076B2 (en) 2018-06-04 2022-02-22 Alcon Inc. Method for producing silicone hydrogel contact lenses
US11254075B2 (en) 2018-06-04 2022-02-22 Alcon Inc. Method for producing silicone hydrogel contact lenses
WO2020003022A1 (en) 2018-06-29 2020-01-02 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of uv and high energy visible light
US11970431B2 (en) 2018-06-29 2024-04-30 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of UV and high energy visible light
US11046636B2 (en) 2018-06-29 2021-06-29 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of UV and high energy visible light
WO2020009747A1 (en) 2018-07-03 2020-01-09 Bausch & Lomb Incorporated Water extractable ophthalmic devices
US11022722B2 (en) 2018-07-03 2021-06-01 Bausch & Lomb Incorporated Water extractable ophthalmic devices
WO2020032972A1 (en) 2018-08-10 2020-02-13 Bausch & Lomb Incorporated High water content ophthalmic devices
JP7357055B2 (en) 2018-08-10 2023-10-05 ボシュ・アンド・ロム・インコーポレイテッド High water content ophthalmic device
JP2021535446A (en) * 2018-08-10 2021-12-16 ボシュ・アンド・ロム・インコーポレイテッドBausch & Lomb Incorporated High water content ophthalmic device
WO2020032973A1 (en) 2018-08-10 2020-02-13 Bausch & Lomb Incorporated Ophthalmic devices
US11493668B2 (en) 2018-09-26 2022-11-08 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of UV and high energy visible light
WO2020065430A1 (en) 2018-09-26 2020-04-02 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of uv and high energy visible light
WO2020159915A1 (en) 2019-01-29 2020-08-06 Bausch & Lomb Incorporated Packaging solutions for contact lenses
US11492189B2 (en) 2019-01-29 2022-11-08 Bausch & Lomb Incorporated Contact lens packaging solutions containing hydrophilic polymers endcapped with a hydrophilic and a hydrophobic group
US11421047B2 (en) 2019-01-30 2022-08-23 Bausch & Lomb Incorporated Crosslinked polymeric network and use thereof
WO2020159690A1 (en) 2019-01-30 2020-08-06 Bausch & Lomb Incorporated Crosslinked polymeric network and use thereof
US11845813B2 (en) 2019-01-30 2023-12-19 Bausch & Lomb Incorporated Crosslinked polymeric network and use thereof
US11732060B2 (en) 2019-01-30 2023-08-22 Bausch & Lomb Incorporated Crosslinked polymeric network and use thereof
US11724471B2 (en) 2019-03-28 2023-08-15 Johnson & Johnson Vision Care, Inc. Methods for the manufacture of photoabsorbing contact lenses and photoabsorbing contact lenses produced thereby
US11673974B2 (en) 2019-04-29 2023-06-13 Bausch & Lomb Incorporated Glycophospholipid polymeric network and use thereof
WO2020222914A1 (en) 2019-04-29 2020-11-05 Bausch & Lomb Incorporated Glycophospholipid polymeric network and use thereof
US11542353B2 (en) 2019-05-13 2023-01-03 Alcon Inc. Method for producing photochromic contact lenses
WO2020230016A1 (en) 2019-05-13 2020-11-19 Alcon Inc. Method for producing photochromic contact lenses
US11584097B2 (en) 2019-05-28 2023-02-21 Alcon Inc. Method for making opaque colored silicone hydrogel contact lenses
WO2020240440A1 (en) 2019-05-28 2020-12-03 Alcon Inc. Method for making opaque colored silicone hydrogel contact lenses
EP4283345A2 (en) 2019-06-24 2023-11-29 Johnson & Johnson Vision Care, Inc. Silicone hydrogel contact lenses having non-uniform morphology
US11827755B2 (en) 2019-06-24 2023-11-28 Johnson & Johnson Vision Care, Inc. Silicone hydrogel contact lenses having non-uniform morphology
WO2020261001A1 (en) 2019-06-24 2020-12-30 Johnson & Johnson Vision Care, Inc. Silicone hydrogel contact lenses having non-uniform morphology
US11578176B2 (en) 2019-06-24 2023-02-14 Johnson & Johnson Vision Care, Inc. Silicone hydrogel contact lenses having non-uniform morphology
WO2020261021A1 (en) 2019-06-28 2020-12-30 Johnson & Johnson Vision Care, Inc. Polymerizable fused tricyclic compounds as absorbers of uv and visible light
US11958824B2 (en) 2019-06-28 2024-04-16 Johnson & Johnson Vision Care, Inc. Photostable mimics of macular pigment
WO2020261091A1 (en) 2019-06-28 2020-12-30 Johnson & Johnson Vision Care, Inc. Photostable mimics of macular pigment
WO2021001706A1 (en) 2019-07-02 2021-01-07 Johnson & Johnson Vision Care, Inc. Core-shell particles and methods of making and using thereof
WO2021038369A1 (en) 2019-08-30 2021-03-04 Johnson & Johnson Vision Care, Inc. Multifocal contact lens displaying improved vision attributes
WO2021038368A1 (en) 2019-08-30 2021-03-04 Johnson & Johnson Vision Care, Inc. Contact lens displaying improved vision attributes
US11543683B2 (en) 2019-08-30 2023-01-03 Johnson & Johnson Vision Care, Inc. Multifocal contact lens displaying improved vision attributes
US11891526B2 (en) 2019-09-12 2024-02-06 Johnson & Johnson Vision Care, Inc. Ink composition for cosmetic contact lenses
WO2021053057A1 (en) 2019-09-20 2021-03-25 Bausch Health Ireland Limited Grafted polymer and use thereof
US11795320B2 (en) 2019-09-20 2023-10-24 Bausch + Lomb Ireland Limited Grafted polymer and use thereof
WO2021090169A1 (en) 2019-11-04 2021-05-14 Alcon Inc. Contact lenses with surfaces having different softness
US12072556B2 (en) 2019-11-04 2024-08-27 Alcon Inc. Contact lenses with surfaces having different softness
EP4369081A2 (en) 2019-12-16 2024-05-15 Alcon Inc. Method for producing an ophthalmic product
WO2021124099A1 (en) 2019-12-16 2021-06-24 Alcon Inc. Wettable silicone hydrogel contact lenses
US11513257B2 (en) 2019-12-16 2022-11-29 Alcon Inc. Wettable silicone hydrogel contact lenses
US11360240B2 (en) 2019-12-19 2022-06-14 Johnson & Johnson Vision Care, Inc. Contact lens containing photosensitive chromophore and package therefor
EP4411429A1 (en) 2019-12-19 2024-08-07 Johnson & Johnson Vision Care, Inc. Contact lens containing photosensitive chromophore and package therefor
WO2021124001A1 (en) 2019-12-19 2021-06-24 Johnson & Johnson Vision Care, Inc. Contact lens containing photosensitive chromophore and package therefor
WO2021181341A1 (en) 2020-03-11 2021-09-16 Alcon Inc. Photochromic polydiorganosiloxane vinylic crosslinkers
US11945895B2 (en) 2020-03-11 2024-04-02 Alcon Inc. Photochromic polydiorganosiloxane vinylic crosslinkers
WO2021181307A1 (en) 2020-03-11 2021-09-16 Alcon Inc. Photochromic polydiorganosiloxane vinylic crosslinkers
WO2021186296A1 (en) 2020-03-18 2021-09-23 Johnson & Johnson Vision Care, Inc. Ophthalmic devices containing transition metal complexes as high energy visible light filters
US11629255B2 (en) 2020-03-19 2023-04-18 Alcon Inc. Embedded silicone hydrogel contact lenses
WO2021186382A1 (en) 2020-03-19 2021-09-23 Alcon Inc. High refractive index siloxane insert materials for embedded contact lenses
US11618823B2 (en) 2020-03-19 2023-04-04 Alcon Inc. High refractive index siloxane insert materials for embedded contact lenses
WO2021186383A1 (en) 2020-03-19 2021-09-23 Alcon Inc. Embedded silicone hydrogel contact lenses
US11867874B2 (en) 2020-03-19 2024-01-09 Alcon Inc. Insert materials with high oxygen permeability and high refractive index
WO2021186381A1 (en) 2020-03-19 2021-09-23 Alcon Inc. Insert materials with high oxygen permeability and high refractive index
WO2021224855A1 (en) 2020-05-07 2021-11-11 Alcon Inc. Method for producing silicone hydrogel contact lenses
US12116442B2 (en) 2020-05-07 2024-10-15 Alcon Inc. Method for producing silicone hydrogel contact lenses
US11999908B2 (en) 2020-06-02 2024-06-04 Alcon Inc. Method for making photochromic contact lenses
WO2021245551A1 (en) 2020-06-02 2021-12-09 Alcon Inc. Method for making photochromic contact lenses
US11853013B2 (en) 2020-06-15 2023-12-26 Johnson & Johnson Vision Care, Inc. Systems and methods for indicating the time elapsed since the occurrence of a triggering event
WO2021255536A1 (en) 2020-06-15 2021-12-23 Johnson & Johnson Vision Care, Inc. Systems and methods for indicating the time elapsed since the occurrence of a triggering event
US12116443B2 (en) 2020-06-16 2024-10-15 Johnson & Johnson Vision Care, Inc. Amino acid-based polymerizable compounds and ophthalmic devices prepared therefrom
WO2021255551A1 (en) 2020-06-16 2021-12-23 Johnson & Johnson Vision Care, Inc. Imidazolium zwitterion polymerizable compounds and ophthalmic devices incorporating them
WO2021255552A1 (en) 2020-06-16 2021-12-23 Johnson & Johnson Vision Care, Inc. Amino acid-based polymerizable compounds and ophthalmic devices prepared therefrom
WO2022023966A1 (en) 2020-07-28 2022-02-03 Alcon Inc. Contact lenses with softer lens surfaces
WO2022034010A1 (en) 2020-08-10 2022-02-17 Bausch + Lomb Ireland Limited Packaging solutions
US12097295B2 (en) 2020-08-10 2024-09-24 Bausch + Lomb Ireland Limited Packaging solutions
WO2022079630A1 (en) 2020-10-13 2022-04-21 Johnson & Johnson Vision Care, Inc. Contact lens position and rotation control using the pressure of the eyelid margin
WO2022090967A1 (en) 2020-10-28 2022-05-05 Alcon Inc. Method for making photochromic contact lenses
US11945181B2 (en) 2020-10-28 2024-04-02 Alcon Inc. Method for making photochromic contact lenses
WO2022097049A1 (en) 2020-11-04 2022-05-12 Alcon Inc. Method for making photochromic contact lenses
WO2022097048A1 (en) 2020-11-04 2022-05-12 Alcon Inc. Method for making photochromic contact lenses
US11886045B2 (en) 2020-11-04 2024-01-30 Alcon Inc. Method for making photochromic contact lenses
US11975499B2 (en) 2020-11-04 2024-05-07 Alcon Inc. Method for making photochromic contact lenses
WO2022130089A1 (en) 2020-12-18 2022-06-23 Johnson & Johnson Vision Care, Inc. Photostable mimics of macular pigment
WO2022172154A1 (en) 2021-02-09 2022-08-18 Alcon Inc. Hydrophilized polydiorganosiloxane vinylic crosslinkers
WO2022184542A1 (en) 2021-03-05 2022-09-09 Bausch + Lomb Ireland Limited Molds for production of ophthalmic devices
WO2022189940A1 (en) 2021-03-08 2022-09-15 Alcon Inc. Method for making photofunctional contact lenses
WO2022189941A1 (en) 2021-03-08 2022-09-15 Alcon Inc. Method for making photochromic contact lenses
US12111443B2 (en) 2021-03-08 2024-10-08 Alcon Inc. Method for making photochromic contact lenses
WO2022189517A1 (en) 2021-03-11 2022-09-15 Bausch + Lomb Ireland Limited Packaging solutions
WO2022201013A1 (en) 2021-03-23 2022-09-29 Alcon Inc. Polysiloxane vinylic crosslinkers with high refractive index
WO2022201072A1 (en) 2021-03-24 2022-09-29 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2022208450A1 (en) 2021-04-01 2022-10-06 Alcon Inc. Method for making photochromic contact lenses
WO2022208448A1 (en) 2021-04-01 2022-10-06 Alcon Inc. Method for making embedded hydrogel contact lenses
US11833771B2 (en) 2021-04-01 2023-12-05 Alcon Inc. Method for making photochromic contact lenses
WO2022208447A1 (en) 2021-04-01 2022-10-06 Alcon Inc. Embedded hydrogel contact lenses
US12012238B2 (en) 2021-05-26 2024-06-18 Bausch + Lomb Ireland Limited Packaging solutions
WO2022248127A2 (en) 2021-05-26 2022-12-01 Bausch + Lomb Ireland Limited Packaging solutions
WO2022263994A1 (en) 2021-06-14 2022-12-22 Alcon Inc. Multifocal diffractive silicone hydrogel contact lenses
WO2023275685A1 (en) 2021-06-30 2023-01-05 Johnson & Johnson Vision Care, Inc. Transition metal complexes as visible light absorbers
US12054499B2 (en) 2021-06-30 2024-08-06 Johnson & Johnson Vision Care, Inc. Transition metal complexes as visible light absorbers
WO2023275683A1 (en) 2021-06-30 2023-01-05 Johnson & Johnson Vision Care, Inc. Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use
WO2023274748A1 (en) 2021-06-30 2023-01-05 Bausch + Lomb Ireland Limited High water content biomedical devices
WO2023030717A1 (en) 2021-08-31 2023-03-09 Bausch + Lomb Ireland Limited Ophthalmic devices and method of manufacturing
WO2023030716A1 (en) 2021-08-31 2023-03-09 Bausch + Lomb Ireland Limited Ophthalmic devices
WO2023030715A1 (en) 2021-08-31 2023-03-09 Bausch + Lomb Ireland Limited Ophthalmic devices and method of manufacturing
US11873361B2 (en) 2021-08-31 2024-01-16 Bausch + Lomb Ireland Limited Ophthalmic devices
WO2023052889A1 (en) 2021-09-29 2023-04-06 Johnson & Johnson Vision Care, Inc. Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses
WO2023052888A1 (en) 2021-09-29 2023-04-06 Johnson & Johnson Vision Care, Inc. Ophthalmic lenses and their manufacture by in-mold modification
WO2023052890A1 (en) 2021-09-29 2023-04-06 Johnson & Johnson Vision Care, Inc. Anthraquinone-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses
US11912800B2 (en) 2021-09-29 2024-02-27 Johnson & Johnson Vision Care, Inc. Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses
WO2023094265A1 (en) 2021-11-23 2023-06-01 Bausch + Lomb Ireland Limited Method for making a preservative-free packaged ophthalmic device product
WO2023119021A1 (en) 2021-12-20 2023-06-29 Johnson & Johnson Vision Care, Inc. Contact lenses containing light absorbing regions and methods for their preparation
WO2023148171A1 (en) 2022-02-02 2023-08-10 Bausch + Lomb Ireland Limited Multifunctional crosslinking agents and ophthalmic devices formed therefrom
WO2023161325A1 (en) 2022-02-24 2023-08-31 Bausch + Lomb Ireland Limited Ophthalmic devices
WO2023209569A1 (en) 2022-04-26 2023-11-02 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2023209570A1 (en) 2022-04-26 2023-11-02 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2023209449A1 (en) 2022-04-28 2023-11-02 Johnson & Johnson Vision Care, Inc. Light-filtering materials for biomaterial integration and methods thereof
WO2023209450A1 (en) 2022-04-28 2023-11-02 Johnson & Johnson Vision Care, Inc. Using particles for light filtering
US11733440B1 (en) 2022-04-28 2023-08-22 Johnson & Johnson Vision Care, Inc. Thermally stable nanoparticles and methods thereof
WO2023209631A1 (en) 2022-04-28 2023-11-02 Alcon Inc. Method for making uv and hevl-absorbing ophthalmic lenses
US11971518B2 (en) 2022-04-28 2024-04-30 Johnson & Johnson Vision Care, Inc. Shape engineering of particles to create a narrow spectral filter against a specific portion of the light spectrum
WO2023209446A1 (en) 2022-04-28 2023-11-02 Johnson & Johnson Vision Care, Inc. Shape engineering of particles to create a narrow spectral filter against a specific portion of the light spectrum
WO2023209448A1 (en) 2022-04-28 2023-11-02 Johnson & Johnson Vision Care, Inc. Thermally stable nanoparticles and methods of making them
WO2023209447A1 (en) 2022-04-28 2023-11-02 Johnson & Johnson Vision Care, Inc. Particle surface modification to increase compatibility and stability in hydrogels
WO2023209630A1 (en) 2022-04-29 2023-11-02 Alcon Inc. Method for making silicone hydrogel contact lenses
WO2023218324A1 (en) 2022-05-09 2023-11-16 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2023228054A1 (en) 2022-05-23 2023-11-30 Alcon Inc. Method for making hevl-filtering contact lenses
WO2023228055A1 (en) 2022-05-23 2023-11-30 Alcon Inc. Uv/hevl-filtering contact lenses
WO2023228106A1 (en) 2022-05-25 2023-11-30 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2023242688A1 (en) 2022-06-16 2023-12-21 Johnson & Johnson Vision Care, Inc. Ophthalmic devices containing photostable mimics of macular pigment and other visible light filters
WO2024038390A1 (en) 2022-08-17 2024-02-22 Alcon Inc. A contact lens with a hydrogel coating thereon
WO2024127114A1 (en) 2022-12-15 2024-06-20 Johnson & Johnson Vision Care, Inc. Transition metal complexes as visible light absorbers
WO2024134382A1 (en) 2022-12-21 2024-06-27 Johnson & Johnson Vision Care, Inc. Compositions for ophthalmologic devices
WO2024146878A1 (en) 2023-01-04 2024-07-11 Bausch + Lomb Ireland Limited Biomedical devices having a surface coating
WO2024156667A1 (en) 2023-01-24 2024-08-02 Bausch + Lomb Ireland Limited Ophthalmic devices having a high refractive index and abbe number
WO2024161344A1 (en) 2023-02-02 2024-08-08 Alcon Inc. Water gradient silicone hydrogel contact lenses
WO2024180452A1 (en) 2023-02-27 2024-09-06 Alcon Inc. A method for producing wettable silicone hydrogel contact lenses
WO2024183985A1 (en) 2023-03-08 2024-09-12 Bausch + Lomb Ireland Limited Contact lens containing deprotected ultraviolet blockers
WO2024194792A1 (en) 2023-03-20 2024-09-26 Johnson & Johnson Vision Care, Inc. Ophthalmic lenses and their manufacture by in-mold modification
WO2024193881A1 (en) 2023-03-22 2024-09-26 Bausch + Lomb Ireland Limited Silicone hydrogels
WO2024193880A1 (en) 2023-03-22 2024-09-26 Bausch + Lomb Ireland Limited Monofunctional silicone monomers and silicone hydrogels formed therefrom
WO2024194826A1 (en) 2023-03-22 2024-09-26 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2024201156A1 (en) 2023-03-28 2024-10-03 Johnson & Johnson Vision Care, Inc. Grafted opthalmic devices containing deactivated regions and processes for their preparation and use
US12128641B2 (en) 2023-05-19 2024-10-29 Johnson & Johnson Vision Care, Inc. Methods for the manufacture of photoabsorbing contact lenses and photoabsorbing contact lenses produced thereby

Also Published As

Publication number Publication date
HK1001565A1 (en) 1998-06-26
CA2014210A1 (en) 1990-11-02
EP0396364A2 (en) 1990-11-07
EP0396364B1 (en) 1997-06-11
CA2014210C (en) 1999-08-31
US5610252A (en) 1997-03-11
US6166236A (en) 2000-12-26
AU5461690A (en) 1990-11-08
ES2131907T3 (en) 1999-08-01
KR0171402B1 (en) 1999-03-30
JPH0372506A (en) 1991-03-27
BR9002045A (en) 1991-08-13
DE69032984T2 (en) 1999-07-08
DE69030898D1 (en) 1997-07-17
SG49218A1 (en) 1998-05-18
DE69030898T2 (en) 1997-12-04
ES2104583T3 (en) 1997-10-16
EP0757033B1 (en) 1999-03-03
EP0757033A3 (en) 1997-03-05
IE81155B1 (en) 2000-05-03
IE901384L (en) 1990-11-02
DE69032984D1 (en) 1999-04-08
EP0757033A2 (en) 1997-02-05
KR900018164A (en) 1990-12-20
AU645749B2 (en) 1994-01-27
EP0396364A3 (en) 1991-11-27
JP3274681B2 (en) 2002-04-15

Similar Documents

Publication Publication Date Title
US5070215A (en) Novel vinyl carbonate and vinyl carbamate contact lens material monomers
US4711943A (en) Hydrophilic siloxane monomers and dimers for contact lens materials, and contact lenses fabricated therefrom
KR100468803B1 (en) Monomer units useful for reducing the modulus of silicone hydrogels
AU675132B2 (en) Organosilicon-containing materials useful for biomedical devices
KR100462450B1 (en) Monomer units useful for reducing the modulus of low-functional polymer silicone compositions
US4640941A (en) Hydrogels containing siloxane comonomers
EP0611367B1 (en) Novel uv curable crosslinking agents useful in copolymerization
US5981675A (en) Silicone-containing macromonomers and low water materials
US5387663A (en) Macromonomers
WO2000009516A1 (en) Silicon-containing monomers useful for the preparation of contact lens materials
JP2007186512A (en) Fumaric acid derivative and ophthalmic lens using the same
US4690993A (en) p-(2-Hydroxy hexafluoroisopropyl) styrene [HFIS] monomer for ophthalmic applications

Legal Events

Date Code Title Description
AS Assignment

Owner name: BAUSCH & LOMB INCORPORATED, A CORP. OF NY, NEW YOR

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:BAMBURY, RONALD E.;SEELYE, DAVID E.;REEL/FRAME:005078/0467

Effective date: 19890502

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: CREDIT SUISSE, NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNORS:BAUSCH & LOMB INCORPORATED;WP PRISM INC.;B&L CRL INC.;AND OTHERS;REEL/FRAME:020733/0765

Effective date: 20080320

Owner name: CREDIT SUISSE,NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNORS:BAUSCH & LOMB INCORPORATED;WP PRISM INC.;B&L CRL INC.;AND OTHERS;REEL/FRAME:020733/0765

Effective date: 20080320

AS Assignment

Owner name: BAUSCH & LOMB INCORPORATED, NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH;REEL/FRAME:028726/0142

Effective date: 20120518